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Abstract—Extensive lesions of the fimbria-fornix pathways and the cingular bundle deprive the
hippocampusof a substantial part of its cholinergic,noradrenergicand serotonergicafferentsand, among
several other behavioral alterations, induce lasting impairment of spatial learning and memory
capabilities. After a brief presentation of the neuroanatomical organization of the hippocampusand the
connections relevant to the topic of this article, studies which have contributed to characterize the
neurochemicaland behavioral aspects of the fimbria-fornixlesion “syndrome” with lesion techniques
differingby the extent, the location or the specificityof the damageproduced,are reviewed.Furthermore,
several compensatory changes that may occur as a reaction to hippocampal denervation (sprouting,
changes in receptor sensitivity and modifications of neurotransmitter turnover in spared fibres) are
described and discussed in relation with their capacity (or incapacity) to foster recovery from the
lesion-induced deficits. According to this background, experiments using intrahippocampal or
“parahippocampal” grafts to substitutefor missingcholinergic,noradrenergicor serotonergicafferentsare
consideredaccordingto whether the reported findingsconcern neurochemicaland/or behavioral effects.
Taken together, these experimentssuggestthat appropriatelychosenfetal neurons (or other cells such as,
for instance, genetically-modifiedfibroblasts)implanted into or closeto the denervatedhippocampusmay
substitute, at least partially, for missinghippocampalafferentswitha neurochemicalspecificitythat closely
depends on the neurochemicalidentity of the grafted neurons. Thereby, such grafts are able not only to
restore somefunctionsas theycan bedetectedlocally,namelywithinthe hippocampus,but alsoto attenuate
someof the behaviourai(and other typesotj’disturbancesresultingfrom the lesions.In somerespects,also
these graft-induced behavioral effectsmight be consideredas occurringwith a neurochemically-defined
specificity.Nevertheless,if a graft-inducedrecoveryof neurochemicalmarkers in the hippocampusseems
to be a prerequisitefor also behavioral recoveryto be observed,this neurochemicalrecoveryis neither the
one and only condition for behavioral effectsto be expressed,nor is it the one and only mechanismto
account for the latter effects. 0 1997ElsevierScienceLtd. All Rights Reserved.
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1. INTRODUCTION is usually traced back to the turn of the last century
(e.g. Thompson, 1890; Forssrnan, 1900; Saltykow,
The idea of having recourse to brain tissue 1905; for historical reviews, see Bjorklund and
transplantations as a potentially therapeutical means Stenev~ 1985; Gash, 1984; Sladek and Gash, 1984)
to battle with symptoms due to brain diseaseorinjury HoweveL a few years ago, Finger (1990) has
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anecdotely reported a note suggesting that this idea
may be at least three hundred years older. The idea
was from a patient of the French physician Ambroise
Pare (1510-1590). Because this patient was convinced
that his brain was rotten, he besought the king to
warrant his physicians to replace his ill brain by a
healthy one. If nobody would contest that this
ingenuous entreaty was and still is completely
unrealistic in human beings, it is nowadays extremely
well established that fetal neurons can survive
transplantation in the central nervous system (CNS)
of adult mammals.
Although sporadic experiments were attempted
during the first six decades of the twentieth century
(e.g. Bjorklund and Stenevi, 1985; Gash, 1984),
genuine and significant progress in grafting neural
tissue into the brain of adult mammals really began
in the early seventies, with initial contributions of
Sweedish and American research groups (e.g.
Bjorklund and Stenevi, 1985; Gash, 1984). Within
two decades, research on intracerebral grafting has
undergone a radical ascent, accumulating an enor-
mous amount of data that indisputably showed that
intracerebral grafts of various anatomically- and/or
neurochemically-defined fetal nervous tissues can
survive and grow in the mature mammalian brain,
contribute to structural reconstruction and foster
functional recovery in various paradigms of brain
damage. Most of these paradigms were inspired by
current knowledge about the neuropathological
characteristics and/or the functional disturbances
associated with a series of neurodegenerative
diseases in humans. For instance, 6-hydroxydopa-
mine(6-OHDA)-induced lesions of the ascending
nigrostriatal dopaminergic pathways in rats or
monkeys have been used extensively as an exper-
imental model of Parkinson’s disease (PD). This
lesion paradigm allowed comprehensive investi-
gation of both the morphological features and
functional effects of fetal dopaminergic neurons
grafted into the denervated striatum. Although not
unanimously acclaimed (e.g. Landau, 1990), the
successes encountered by such approaches in
animals rapidly led to the application of surgical
grafting techniques in patients with PD (e.g.
Lindvall, 1989, 1994a, 1994b; Lindvall et al., 1990;
Quinn, 1990).
Other types of brain lesions were developed and
utilized as an experimental paradigm of Alzheimer’s
disease (AD). These lesions, which mainly consisted
of depriving major central cholinergic targets such as
the hippocampus or the fronto-parietal cortex of their
cholinergic innervation, were useful to investigate the
effects of intrahippocampal or intracortical grafts
rich in fetal cholinergic neurons. Here also, the
morphological characteristics and many functional
properties of such grafts have been identified. So far
however, and to our knowledge, this approach has
not led to clinical application of the technique in
patients with AD.
As concerns the paradigm of hippocampal
denervation, many experiments have addressed the
problem of the functionality of intrahippocampal
grafts with, in the background, the conceptual view
establishing a crucial involvement of the cholinergic
component of the septohippocampal pathways (see
below) in spatial learning and memory functions. In
numerous experiments reported so far, the hippo-
campus was denervated using unspecific lesion
techniques (aspiration, transection or electrolysis of
the septohippocampal pathways) and cholinergic
neurons from the fetal basal forebrain were
implanted in the hippocampus to substitute for the
missing cholinergic innervation. Such unspecific
lesion techniques also disrupt neurochemically-
defined hippocampal afferents other than the
cholinergic ones (e.g. noradrenergic, serotonergic)
and the substitution for these afferents has revealed
possible with grafts prepared from the locus
coeruleus, a noradrenergic nucleus, or the mesen-
cephalic raph+, a serotonergic nucleus. To address the
question of the functional involvement of cholinergic,
noradrenergic and serotonergic hippocampal affer-
ents, research has also been conducted with lesion
techniques using neurotoxins that produce more
selective damage of neurochemically-defined cell
populations. Also such more specific techniques have
been utilized to explore the extent to which
intrahippocampal grafts of neurons from the fetal
brain could foster recovery from hippocampal
dysfunctions.
The major topic of this article is to review the
studies “which used intrahippocampal grafts rich in
cholinergic, noradrenergic and/or serotonergic neur-
ons in order to characterize their effects from both a
neurochemical and behavioral point of view. After
a brief presentation of the neuroanatomical organiz-
ation of the hippocampus, its principal connected
structures and the relevant pathways, we will consider
the hippocampal denervation paradigms relying upon
anatomically- or neurochemically -defined lesion tech-
niques of/in the fimbria, the fornix and the overlying
cingular bundle in the rat. These lesion paradigms are
described according to: (i) their neurochemical
consequences in the hippocampus; (ii) the structural
and functional compensatory or reactive changes
which may occur spontaneously over the postsurgical
survival time; (iii) the behavioral (essentially
cognitive)modifications which they produce. Each of
these modifications may be used as a control in
assessing the functional effects of various types of
grafts placed into the denervated hippocampus.
These effects are dealt with in the following section
with distinction made according to the neurochemical
specificity of the grafted cell preparations (cholin-
ergic, noradrenergic, serotonergic and co-grafts) and,
within each of these categories, according to whether
the reported findings concern neurochemical or
behavioral effects. In the last part of this article, the
extent to which the neurochemical effects of the grafts
may contribute to the alleviation of some behavioral
dysfunctions induced by various types of lesions is
discussed briefly.
2. NEUROANATOMICAL CONSIDERATIONS
AND PRELIMINARIES
2.1. The Hippocampus
In the adult rat, the hippocampus (i.e. the dentate
gyrus and the Ammon’s horn, see below) is a large,
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complex and layered sausage-shaped allocortical
structure (Fig. IA), measuring approximately 10 mm
in the anteroposterior plan, 3.5 mm in the mediolat-
eral plan and 1.5 mm in the dorsoventral one. Its
anterior extremity, also called the septal pole, is
localized dorsally in the brain and is contiguous to its
contralateral homologue. Laying just behind the
septal region, right above the dorsal thalamus and
underneath the corpus callosum, the anterior
extremity of the hippocampus is dorsally and laterally
bordered by the parietal cortex. From there, the
hippocampus bends both ventrally and laterally up to
a posterior extremity, also designated as the temporal
pole. This extremity is anatomically separated from
its controlateral homologue, extends up to the
ventrolaterally located amygdaloid area and,
roughly, is bordered dorsolaterally by part of the
occipital, temporal and perirhinal cortex and, more
ventrally, by the entorhinal cortex.
Typically, the hippocampus consists in two
U-shaped interlocking subregions (Fig. IB) which
can be identified over the whole anteroposterior
extent of the structure. One, called cornu Anzmonis or
“the hippocampus proper” is usually further divided
A
CORPUSRIGHTHEMISPHERE
CALLOSUM
CEREBELLUM
SEPTALAREA
FIMBRIA
B
CORNUAMMONIS
(AMMON’SHORN)
GranulecellsGYRUSDE’~ATUS
Fig. 1. (A) shows a drawing of a sagittal view of the rat
brain previously deprived of all left forebrain structures
(right hemisphere, colliculi, cerebellum,... in greyish are
intact) in order to free the left hippocampus(curvedblanck
structure with the fimbria in the concave part) which is in
contact with the septal are (stippledstructure). (B) showsa
drawingof a transversesectionthrough the hippocampusat
the level indicated in (A) by the arrow. (A) and (B) are
redrawn after O’Keefeand Nadel (1978).
into four subregions that Lorente de No (1934) has
designated as regions CA], CA2, CA3, CA4 on the
basis of more or less subtil neuroanatomical
differences in terms of cell morphology and/or fibre
projections. In the cornu Ammonis, the main
population of neurons is constituted by large cells
having pyramid-like characteristics. The other U-
shaped region is called the gym dentatus. It is
subdivided in a molecular zone, a granule cell zone
and a zone of polymorphic cells (the hilus). Both the
pyramidal and granule cells are organized in a
compact layer of cell bodies which almost strictly
parallels the external border of its respective
U-shaped subregion.
Beside the fibres constituting a dense intrinsic
connection tircuitry (intra- and inter-hippocampal
connectivity networks), one may distinguish fibres
connecting the hippocampus to other target regions
of the brain (efferents) and fibres connecting several
source structures to the hippocampus (afferents).
Although most hippocampal efferents originate in the
subicular complex (in which they relay), it may be
reasonably accepted that the main hippocampal
(indirect) efferents project to the lateral preoptic and
hypothalamic areas, the septal region, the nucleus
accumbens, the thalamus, the mamillary bodies, the
rostral midbrain as well as on both the subiculum and
the entorhinal cortex. Most of these terminals may
use or are likely using glutamate as their neurotrans-
mitter. The main afferents originate in the medial
septum (MS) and the diagonal band of Broca (DBB:
Cholinergic and GABAergic fibres), the raphe nuclei
(serotonergic fibres), the locus coeruleus (noradren-
ergic fibres) and the entorhinal cortex (glutamatergic
fibres). To review the entire hippocampal connec-
tivity is beyond the scope of this review. The systems
considered hereafter have been selected because of
their importance in the transplantation experiments
considered in this article. Actually, in most studies
using intrahippocampal transplants in order to
substitute for missing afferents, the cell preparations
that have been implanted were rich in cholinergic,
noradrenergic andjor serotonergic neurons. Thus,
among all the structures connected to the hippo-
campus, the ones selected according to the topic of
the present review are the septal area (used to
designate both the MS and the DBB in the following),
the locus coeruleus and the raphe nuclei, with
particular focus on the cholinergic, noradrenergic
and serotonergic innervation of the hippocampus.
The GABAergic afferents from the septal region have
not been studied as extensively as the three other
types of afferents coursing rostrally and will be
considered briefly in a separate section (Section 2.5).
2.2. The Hippocampal Cholinergic, Noradrenergic
and Serotonergic Afferents: Sources
The cholinergic innervation of the hippocampus
mainly originates in three major cholinergic nuclei of
the basal forebrain, namely the MS (Chl in the
nomenclature of Mesulam et al., 1983) and both the
vertical (Ch2) and the horizontal (Ch3) limbs of the
DB13.A few cholinergic terminals (less than 10VOof
the entire hippocampal cholinergic innervation) are
from interneurons located within the hippocampus,
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CORPUSCALLOSUM
supracallosal
dorsal pathway
Fig. 2, Schematic drawing ofa parasagittal view of the
hippocampus and distribution of the main afferent routes
through whichthe cholinergic,noradrenergicandserotoner-
gicaxons reach the hippocampus(sourceis referring tothe
medial septum/diagonalband ofBroca, the locus coeruleus
and the mesencephalicraphe, respectively).
most of which being found in the stratum
lacunosum-moleculare of region CA1 (e.g. Frotscher,
1988). The noradrenergic innervation is exclusively of
extrinsic origin and arises from neurons located in the
dorsal part of the locus coeruleus (A6 in the
nomenclature of Dahlstrom and Fuxe, 1964). Also
the serotonergic innervation is exclusively of extrinsic
origin. In majority, it arises from brain stem neurons
located in the median raphe nucleus (B5 and B8 in the
nomenclature of Dahlstrom and Fuxe, 1964), the
remaining part originating in neurons from the dorsal
raphe nucleus (B6 and B7). Conversely to the
aforementioned basal forebrain nuclei which princi-
pally if not exclusively innervate the hippocampus,
the locus coeruleus and the raphe nuclei provide
massive innervation to several brain regions other
than the hippocampus (e.g. cortex, spinal cord,
thalamus, etc.).
2.3. The Hippocampal Cholinergic, Noradrenergic
and Serotonergic Afferents:
Pathways and Fibre Dispatching
It is now well established that the hippocampal
afferents from the septal area, the locus coeruleus and
the raphe nuclei course in three anatomically distinct
routes (Fig. 2), namely the cingular bundle (overlying
the corpus callosum), the fimbria-fornix complex
(infracallosal dorsal afferents) and a ventral pathway
whose exact anatomical location is not well known at
present but which might reach the hippocampus by
passing in the vicinity of the amygdalar complex.
Both the cingular bundle and the fimbria-fornix
pathways will be designed herein as the rostrally
coursing dorsal afferents of the hippocampus.
Since the mid-1960s, it is known that the
transection of the medial forebrain bundle produces
dramatic depletion of serotonergic and noradrenergic
markers in the hippocampus (e.g. Moore e{ al., 1965;
Heller et al., 1966; both cited in Storm-Mathisen and
Guldberg, 1974), and that the disruption of the
fimbria and the fornix results in cholinergic
denervation of the hippocampus (Lewis et al., 1967).
Fuxe (1965) (cited in Storm-Mathisen and Guldberg,
1974) had already reported that the noradrenergic
fibres reached the hippocampus along three distinct
routes and these data were confirmed later on by
other groups (e.g. Lindvall and Bjorklund, 1974).
Whatever of these systems is considered, most fibres
project on the ipsilaterally located hippocampus and
only 10-1So/o cross the midline to innervate the
controlateral hippocampus (e.g. ACh: Peterson,
1989; NA: Room et al., 1981; 5-HT: Jacobs and
Azmitia, 1992). Storm-Mathisen and Guldberg
(1974) have reported that, just before entering the
hippocampus of the rat brain, most of these three
neurochemical categories of hippocampal afferents
were coursing commonly in the two dorsal and in the
ventral pathways. They also demonstrated that the
cholinergic, noradrenergic and serotonergic inner-
vations of the hippocampus were essentially of
extrinsic origin. From their study, the authors
concluded that: (i) the largest part of cholinergic
afferents were coursing through the fimbria-fornix
pathways (approx. 75~0), the supracallosal and
ventral pathways contributing only a rather small
part of the cholinergic hippocampal innervation
(approx. 250A);(ii) the largest part of the serotonergic
afferents were located in both dorsal pathways
(approx. 750/.), with a majority of these fibres
coursing through the fimbria-fornix (approx. 500/.);
(iii) more than half the noradrenergic afferents
reached the hippocampus via the ventral route
(approx. 600/.). Part of these findings are at some
variance with data reported ten years later by Gage
et al. (1983a, 1983c)) who, using other differential
lesion techniques, found the supracallosal pathways
to carry 300/. of the cholinergic, 45~0 of the
noradrenergic and St)”/oof the serotonergic afferents,
the infracallosal pathways to carry 550A, 150/. and
30V0of them, respectively, the ventral route being in
charge of the remainders. Finally, according to data
of an experiment in which we assessed the
neurochemical effects of electrolytic lesions restricted
to the fimbria and the dorsal fornix (Jeltsch et al.,
1994a), we found the infracallosal pathways to carry
about 55°/0 of the serotonergic afferents of the
hippocampus and about 60Y0of the cholinergic ones.
Due to the fact that we have not assessed the
neurochemical effects of the lesions at a very short
postsurgical delay and because we did not prevent
sympathetic sprouting and thus the contribution of
reactional ingrowth of peripheral noradrenergic
fibres [see below, Section 3.2.2.2], this experiment did
not allow us to assess the proportion of central
noradrenergic afferents coursing through the fimbria
and the dorsal fornix. These variances in the relative
amounts of neurochemically-defined fibres found to
course in each of the three routes are likely due to
differences in the respective lesion techniques (e.g.
transection, aspiration, electrolysis), dissection and
tissue preparation procedures (e.g. subdivisions of the
hippocampus and regions used) or other factors (e.g.
species, gendtx, age. . .). However, beyond these
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variances, one clear-cut and important conclusion
common to all these experiments is that the majority
of the cholinergic and serotonergic afferents of the
hippocampus are unquestionably, although not
exclusively, coursing through both dorsal pathways.
This is noteworthy because, regarding the easy access
to these pathways (they are superposed, separated by
only the corpus callosum and lay just underneath the
cortical surface), the production’ of massive cholin-
ergic and serotonergic hippocampal denervations
ma-y be relying upon a rather simple and rapid
surgical procedure such as, for instance, knife-cut
transection or aspiration of the tissue. To complete
this section, it should also be stated that, in some
respects only, one finds a heterogeneity in the
topographical distribution of the cell bodies from
which the serotonergic and the cholinergic pathways
arise. It is known at present that serotonergic fibres
originating in the dorsal raphe nucleus reach the
hippocampus by the supracallosal and the ventral
pathways, whereas the fibres originating in the
median nucleus reach the hippocampus by both
dorsal pathways (e.g. Azmitia, 1978; Steinbusch,
1981). Also, as regards the cholinergic afferents,
Peterson (1994) recently showed that cholinergic
neurons in the MS and the ventromedial region of the
vertical limb of the DBB project to the hippocampus
via the fimbria and the dorsal fornix, whereas the
fibres arising from cholinergic neurons of the
dorsolateral region of the vertical limb of the DBB
reach the hippocampus via the supracallosal stria.
Concerning the ventral route, it seems that the
cholinergic fibres arise from neurons located in the
vertical and horizontal limbs of the DBB (e.g. Gage
et al., 1984a; Milner and Amaral, 1984).
2.4. The Hippocampal Cholinergic, Noradrenergic
and Serotonergic Afferents: Terminal Fields
Although there may be some variations according
to the neurotransmitter system considered, the
distribution of the terminal fields of the cholinergic,
noradrenergic and serotonergic hippocampal affer-
ents are summarized herein in relation to their routes
of passage. It is established that, in some respects,
there exists a heterogeneity not only in the
mediolateral distribution of these fibres (Dravid and
Van Deusen, 1983, 1984; Gasser and Dravid, 1987),
but also in the topographical distribution of their
terminal fields within the hippocampus (e.g. Gage
and Bjorklund, 1986b; Gage et al., 1983a, 1983c;
Hortnagl et al., 1991b). Overall, there is a
septo-temporal gradient in the distribution of the
neurochemical markers along the septo-temporal axis
of the hippocampus, the lowest terminal density
being found in the septal pole of the hippocampus.
This gradient appears to be less pronounced
regarding the cholinergic innervation ( + 30°/0 in the
ventral pole as compared to the dorsal one (e.g. Gage
and Bjorklund, 1986b; Jeltsch et al., 1994a) than for
the two other innervation systems (from the septal to
the temporal extremities, the noradrenergic markers
exhibit a three-fold and the serotonergic ones a
two-fold increase; e.g. Gage and Bjorklund, 1986b).
Although the terminal field of the fibres coursing
dorsally and ventrally are partially overlapping, it is
well known that the ones coursing dorsally enter and
primarily innervate the dorsal hippocampus, while
the largest amount of fibres in the ventral pathway
enter and innervate the ventral hippocampus.
Additional distinction can be made according to
whether the dorsally coursing fibres are in a medial
(close to the midline: Cingular bundle and medial
fimbria) or a more lateral (mainly the lateral half of
the fimbria) position. Actually, Gasser and Dravid
(1987) showed: (i) the cholinergic fibres coursing
medially and laterally to contribute a similar
proportion of hippocampal innervation provided by
the dorsal pathways, with terminals distributed along
the whole septo-temporal extent of the hippocampus;
(ii) the noradrenergic fibres coursing medially to
contribute 80’Yoof the innervation provided by the
dorsal pathways with terminal fields found exclu-
sively in the dorsal hippocampus, while the fibres
coursing laterally (20°/0 contribution) had terminal
fields exclusively in the ventral hippocampus; (iii) the
serotonergic fibres coursing medially to contribute
60% of the innervation provided by the dorsal
pathways, the ones coursing laterally contributing the
remainder 40°/0, with terminals of both found along
the whole septo-temporal extent of the hippocampus.
If one takes into account the percentages of the
dorsoventral dispatching of the fibres (Gage and
Bjorklund, 1986b) and further subdivide them
according to the mediolateral distinction introduced
by Gasser and Dravid (1987), one may propose the
synthetic picture shown in Table 1.
A final distinction in the terminal fields of these
neurochemically-defined afferents concerns their
distribution in the different hippocampal subfields or
Table 1. Distribution of the Afferentsfrom the Septal Area (Cholinergic),the Locus Coeruleus (Noradrenergic)and the
Mesencephalic Raphe Nuclei (Serotonergic) in the Dorsal Supracallosal Pathway (Supracallosal Striae), the Dorsal
Infracallosal Pathway (Fimbria-FornixComplex)and in the Ventral Route with, where Possible,Particular Distinction as
to Whether the Fibres Course Close to the Midline (Medial) or More Laterally (Lateral).
Neurotransmitter
Acetylcholine Noradrenaline Serotonin
Pathwav Medial Lateral Medial Lateral Medial Lateral
Supracallosal striae 30% — 45% 50~o
Fimbria-fornix 30~o 25% 10’YO < 5Yo 20V0 10%
Ventral route 15% 40% 20?40
This table wasconstructedbyfurther subdivisionof the data reported byGage and Bjorkhrnd(1986a)on the dorsoventral
distribution of thesepathwaysand accordingto data reported by Gasser and Dravid (1987)on the mediolateraldistribution
of these fibres in the two dorsal pathways.
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layers. The density of the cholinergic terminals is
highest immediately underneath and above the
granule cell layer in the dentate gyrus, and
approximately the same picture is found around the
pyramidal cell layer in the Ammon’s horn. The
densest noradrenergic innervation is found in the
hilus of the dentate gyrus, with terminals also present
in the molecular layer of the dentate gyrus as well as
in regions CA1 and CA3 of the Ammon’s horn where
they are in close proximity to the pyramidal cell
bodies and their apical dendrite. For both systems,
there does not appear to be a particular relationship
between the layers in which the axons establish
synaptic contacts and the pathways in which they
course. This is not exactly the case as concerns the
serotonergic terminals (Gage and Bjorklund, 1986b).
The axons of the supracallosal pathway synapse
preferentially in the polymorphic area of the dentate
gyrus and in region CA3. Those of the fimbria-fornix
pathways preferentially synapse in region CA1 and,
although with a weaker density, in the polymorphic
area and the molecular layer of the dentate gyrus.
Finally, the axons of the ventral route synapse
primarily in the molecular layer of the dentate gyrus.
2.5. The Hippocampal GABAergic Afferents:
A Few Words
Kiss et al. (1990) reported the MS and the DBB to
contain many neurones immunostained for parvalbu-
mine, a calcium-binding membrane protein which is
specific of a subpopulation of GABAergic neurons.
That these septal GABAergic neurons project to the
hippocampus has been demonstrated by Kohler et al.
(1984) and, later on, by Freund and Antal (1988). In
their article, the latter authors describe some
morphological features of the GABAergic terminals
which, in virtually all regions of the hippocampus,
show large and multiple en passant boutons. More
recently, Freund (1992) showed that the GABAergic
terminals in the hippocampus preferentially synapse
with inhibitory interneurons of the hippocampus (see
also Freund and Antal, 1988). The anatomical
distribution of the GABAergic fibres is not as well
characterized as is the distribution of the three
aforementioned neurotransmitter systems, but it is
possible that part of it reach the hippocampus via the
same pathways as those of the other fibres.
2.6. Conclusions and Summary
The hippocampus appears to be a well character-
ized structure of the telencephalon, both from a
morphological and a neurochemical point of view
(but also a few other structural and functional ones),
and whether it is considered on the side of its intrinsic
architectural organization, or examined on that of its
connectivity network with other brain structures.
This is a major advantage when one wishes to setup
lesion paradigms in order not only to investigate the
structural links and the functional implications of a
given brain structure within a larger system, but also
to test the efficiency of experimental manipulations
such as the ones relying upon grafting techniques.
According to all aforementioned data, it can be
expected that the disruption of the rostrally-coursing
dorsal hippocampal afferents (cingular bundle and
fimbria-fornix) will be sufficient to induce massive
cholinergic and serotonergic denervations in at least
the two dorsal thirds of the hippocampus, while the
noradrenergic hippocampal innervation should also
be affected, but to a lower degree. Even damage to
only the medial part of the dorsal pathways should
be sufficient to massively denervate the hippocampus
from its cholinergic and serotonergic inputs (see
Table 1). However, important enough to be
emphasized is the fact that even after massive
disruption of the dorsal pathways, an aspiration or a
knife-cut transection of the fimbria, the dorsal fornix
and the cingular bundle is nothing more than a
partial denervation paradigm (i.e. the ventral route is
always spared as are other afferent and efferent
pathways such as, for instance, the per forant paths
originating in the entorhinal cortex).
3. THE PARADIGM(S) OF
FIMBRIA-FORNIX/CINGULAR BUNDLE
LESIONS: NEUROCHEMICAL EFFECTS,
SPONTANEOUS REACTIVE
COMPENSATIONS, AND BEHAVIORAL
EFFECTS
3.1. Why Such an Interest in the Fimhria-Fornix
Lesion Paradigms?
Since many years, the fimbria-fornix pathways
have been one of the privileged targets in experimen-
tal studies that used lesion techniques in order to
investigate the functional implications of the hippo-
campus and its connected structures, or to character-
ize the possibilities to repair the functional
consequences of hippocampal denervation by the
means of drug treatments, administration of neuro-
tropkic factors or intracerebral transplants. Although
there are certainly many other reasons for analysing
the functional implications of the fimbria-fornix
pathways (e.g. Dutar et al., 1995 and part 4.2. of this
review), interest in these pathways begun to increase
exponentially in the mid-1970s, when three indepen-
dent research groups reported that the basal
forebrain from patients with AD exhibited dramatic
degeneration of the cholinergic neurons (Bowen
et al., 1977; Davies and Maloney, 1976; Perry et al.,
1977a, 1977b; White et al., 1977)and showed that the
extent of this degeneration was, in some respects,
correlated with the extent to which cognitive
functions were altered. At that time, AD was
considered to be a cholinergic disease and there was
a crucial need of psychopathologically and neuro-
chemically reliable experimental animal models of
AD in order to test some potentially useful
therapeutical measures (e.g. symptomatic drug
treatments). However, until very recently, there was
a lack of a neurotoxic compound capable of
damaging the cholinergic neurons in the CNS with an
acceptable degree of specificity. Although AF64A has
been claimed to be such a compound, its specificity
failed to unanimously convince the scientific commu-
nity” (see below, Section 3.4.1). Therefore, a large
majority of experimental studies relied upon lesion
paradigms which consisted of destroying more or less
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extensively well delineated regions of the brain
known to contain cholinergic cell bodies (nuclei in the
basal forebrain) or cholinergic axons (pathways
arising from these nuclei). Classically, the lesions of
the cholinergic hippocampal afferents were per-
formed with a large variety of techniques including
electrolytic or radiofrequency lesions of the septal
area and the DBB, intraseptal injections of ibotenic,
quisqualic or kainic acid, colchicine or other
nonspecific neurotoxic compounds, as well as
aspiration, transection or electrolysis of the fimbria-
fornix pathways (e.g. Collerton, 1986; Dunnett, 1990;
Fisher and Hanin, 1986; Olton and Wenk, 1987).
Whatever of these techniques was used, it always
induced a dramatic cholinergic denervation of the
hippocampus (e.g. Collerton, 1986; Dunnett, 1990)
and severely altered cognitive functions, especially
those supposing spatial information to be memorized
and appropriately used (e.g. Collerton, 1986;
Dunnett, 1990; Dutar et al., 1995; O’Keefe and
Nadel, 1978; Olton et al., 1979). Nevertheless, neither
of these lesion paradigms was considered to be a
satisfactory model of AD, primarily because there
were two major technical drawbacks. First, the
surgical destruction of cholinergic nuclei does not
discriminate between different neurochemical cat-
egories of cell bodies, nor does it distinguish cell
bodies and fibres and, therefore, unavoidably resulted
in damage to noncholinergic neurons and fibres en
passage in the vicinity of the lesion locus. Second, due
to their scattered distribution among other neuro-
chemically-defined fibres tvithin anatomically-cir-
cumscribed pathways (e.g. the fimbria and the dorsal
fornix), the disruption or transection of cholinergic
axons without concomitant damage to axons of
other neurotransmitter systems was simply not
feasible with such classical tools. Thus, in both
approaches, the attribution of the functional changes
induced by the lesions to only the disruption of a
cholinergic component remained a very debatable
interpretation, even though some of these functional
changes could be closely mimicked by local or
systemic administrations of anticholinergic agents
(e.g. Collerton, 1986). Some more recent findings on
the neuropathological characteristics of AD (e.g.
Bowen et al., 1983; Haroutunian et al., 1990; Mann
and Yates, 1986)might, however, contribute to partly
circumvent the drawbacks of the lesion paradigms
just mentioned, mainly because some of the
undesirable noncholinergic effects of such lesions are
actually alterations also found in the brain of AD
patients. In fact, AD is no longer considered as a
matter of exclusively cholinergic degeneration, and
memory no longer as a matter of only cholinergic
functions. Other systems of neurotransmitters are
also dramatically affected by the disease, some of
which having, more or less directly, a cognitive
relevance (e.g. Cassel and Jeltsch, 1995; Decker and
McGaugh, 1989; Sirvio et al., 1994; Steckler and
Sahgal, 1995). For instance, histopathological studies
have shown the functional integrity of the 5-HT
system to be altered in patient with AD. Therefore,
it is possible that paradigms of selective cholinergic
lesions are indeed not as appropriate animal models
of some of the neuropathalogical and cognitive
characteristics of AD as are lesion (or pharmacologi-
cal) paradigms producing simultaneous alterations in
several neurotransmitter systems. Interestingly,
fimbria-fornix lesions, whether extensive (aspiration,
transection) or more limited (electrolysis), are able
not only to produce a multitransmitter denervation in
the rat hippocampus, but also, as reviewed in the next
section, to induce some of the compensatory
structural and functional changes as well as some
cognitive perturbations which resemble part of those
found in patients with AD (e.g. Aubert et al., 1992;
Collerton, 1986;Flynn et al., 1995a, 1995b; Gertz and
Cervos-Navarro, 1990; Kalaria et al., 1989; Olton
and Wenk, 1987; Porsolt et al., 1995; Probst et al.,
1988; Vogt et al., 1991; Zilles et al., 1995).
3.2. Neurochemical Effects of Non-Specific
Fimbria-Fornix/Cingular Bundle Lesions
3.2.1. Cholinergic, Noradrenergic and Serotonergic
Denervations of the Hippocampus
3.2.1.1. Cholinergic markers
Using a procedure of non selective damage to the
fimbria, the dorsal fornix and the overlying structures
(i.e. corpus callosum, cingular bundle and part of the
parietal cortex), it could be demonstrated that the
disruption of these pathways resulted in dramatic
depletion of cholinergic, noradrenergic and sero-
tonergic markers in the hippocampus. In vitro/ex
vivo, the assessment of the effects of such lesions on
the cholinergic hippocampal innervation essentially
used: (i) determination of choline acetyltransferase
(ChAT) activity, the enzyme responsible for acetyl-
choline synthesis and which is found in both the cell
body and the axons of cholinergic neurons; (ii)
determination of acetylcholinesterase (AChE) ac-
tivity, the enzyme responsible for the degradation
(rapid inactivation) of acetylcholine and which is
found in close proximity of the synaptic cleft, but not
exclusively in the cholinergic neurons (although in the
hippocampus there is a 95Y0 correlation between
AChE and ChAT activity; e.g. Levey et al., 1983;
Mesulam and Geula, 1992); (iii) measurement of high
affinity [3H]choline uptake by hippocampal synapto-
somes, a rather specific marker of the axonal
terminals (the uptake sites being located on these
terminals); as well as (iv) [14C]acetylcholine synthesis
from [’4C]glucosein hippocampal tissue preparations,
a marker which is more functionally oriented as it
closely depends on the metabolic activity of the
cholinergic neurons. Whatever marker was con-
sidered and depending upon the experiment con-
sidered, the lesions generally induced a 700/oto more
than 900/. reduction of cholinergic markers in the
septal pole of the hippocampus, the reduction in the
temporal pole being usually slightly less pronounced
(e.g. Bjorklund et al., 1983a; Gage et al., 1983a,
1983c, but see Cassel et al., 1993b). Measurements of
cholinergic markers in the hippocampus have also
been performed in uivo on awake rats, the most recent
technique consisting in the intracerebral implantation
of a microdialysis probe with the permeable portion
of the probe inserted in the hippocampus, collection
of a buffer slowly pumped through this probe, and
HPLC detection of choline and acetylcholine
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concentrations in the collected dialysat. After
extensive fimbria-fornix lesions, the cholinergic
markers assessed in vivo by such means were also
reduced by about 800/0to more than 900/oof normal
in the dorsal hippocampus, some values being often
below the detection limit of the HPLC system (e.g.
Leanza et al., 1993a; Nilsson et al., 1992a).
3.2.1.2. Monoaminergic (noradrenergic, serotonergic)
markers
As regards the noradrenergic and the serotonergic
innervation of the hippocampus, the techniques used
were similar to the ones used for measuring
cholinergic markers, whether in vitro or in vivo. These
included determination of the concentration of NA,
5-HT or 5-HIAA in hippocampal homogenates,
measurement of high affinity uptake of [3H]NA and
[3H]5-HT by hippocampal synaptosomes and micro-
dialysis coupled to HPLC measurements of the
neurotransmitters, their precursors or their metab-
olizes. With such techniques, the lesion-induced
hippocampal serotonergic denervation was also
found to be dramatic. Indeed, the different serotoner-
gic markers reached values, lower than 20Y0 of
normal, these effects being usually less pronounced in
the temporal than in the septal pole of the
hippocampus. The initial effects of the lesions on the
noradrenergic markers were not as dramatic as on the
markers of both other neurotransmitter systems,
essentially because the dorsal pathways carry a lower
proportion of the noradrenergic afferents (see above)
and not all approaches took the precaution of
removing the superior cervical ganglia in order to
prevent sympathetic sprouting, an aberrant reac-
tional phenomenon that provides some subregions of
the hippocampus with a peripheral noradrenergic
reinnervation (see below, Section 3.2.2.1). This
sympathetic sprouting response is not the only
technical problem which may arise when one makes
fimbria-fornix lesions to investigate the relationships
that may exist between neurochemical alterations in
the hippocampus and behavioral changes in the
animal. During a long time, starting with Cajal’s
verdict against the regeneration possibilities in the
adult brain (Cajal, 1928), it was thought that the
brain was a rigid inflexible structure in which any
damage would result in definitive structural and
functional alterations. Fortunately, this conception
has been shown to be erroneous. Even in the adult
brain, there exists many compensatory mechanisms
(e.g. Cotman et al., 1981; Finger and Stein, 1982;
Marshall, 1984, 1985; Stein et al., 1995) after brain
injury, some operating at the level of more
morphological or neuroanatomical manifestations
(e.g. regenerative or collateral sprouting), others at
that of more functional ones (e.g. upregulation of
receptors in target structures). From a strictly
experimental point of view, such compensations
might be a major drawback becatise, in some lesion
paradigms, they may lead to misinterpretations of
experimental data or unqualified conclusions, es-
pecially in experiments running over long postsurgi-
cal periods. Such a risk, as summarized in the next
section, is also present in experimental approaches
relying upon a certain type of fimbria-fornix lesion
paradigms, in which both central and peripheral
regrowth processes may contribute to structural and
functional compensations.
3.2.1.3. GABAergic markers
Due to the very high levels of GABAergic markers
which, within the hippocampus, are related to the
intrinsic GABAergic neurons and glial cells, it is
extremely difficult to biochemically detect the
GABAergic denervation due to disruption of the
extrinsic afferents. In a recent report, Lahtinen et al.
(1993) have assessed the hippocampal concentration
of several amino acids in rats given extensive
fimbria-fornix lesions and found the concentration of
GABA to show modest ( – 11%) but significant
reduction in both dorsal and ventral parts of the
hippocampus at a postsurgical delay of four months.
Nevertheless, whether this reduction resulted from
loss of extrinsic GABAergic afferents or intrinsic
GABAergic neurons, whose number may also
decrease subsequently to fimbria-fornix lesions (Chen
et al., 1989), is still unclear. In a pilot experiment
which used an in vivo microdialysis technique (probe
implanted in the dorsal hippocampus), we have not
been able to find any modification of the hippocam-
pal GABA concentration after aspiration lesions of
the fimbria and the dorsal fornix (Whishaw et al.,
unpublished results). In another experiment based on
electrolytic lesions of only the fimbria and the dorsal
fornix, there was no lesion-induced modification of
the GABA concentration assessed in hippocampal
homogenates (Jeltsch et al., 1994c) 10 months after
lesion surgery.
3.2.2. Reactional Sprouting
In a paradigm of fimbria-fornix lesions, the
structural compensatory changes which occur in the
hippocampus may result essentially from two types of
reactional sprouting phenomena, one termed regener-
ative sprouting and referring to regrowth of damaged
axons, the other one termed collateral (or terminal)
sprouting and referring to growth of additional
collaterals and terminals from unsevered axons.
Collateral sprouting is further distinguished accord-
ing to whether it originates on fibres that normally
innervate a given structure (homotypical sprouting)
or on fibres that do not normally project to the
structure or the subregion which they invade after the
injury (heterotypical sprouting). Interestingly, such
sprouting responses are also observed in the brain of
AD patients (e.g. Booze et al., 1993; Cotman et al.,
1990).
3.2.2.1. Homotypical reactiona[ sprouting
As shown by Gage et al. (1983b, 1983c) and
summarized in Fig. 3, collateral sprouting sub-
sequently to extensive disruption of both dorsal
pathways (Fig. 2) mainly originates in the undamaged
fibres of the ventral route and concerns the
cholinergic, noradrenergic and serotonergic afferents
of the hippocampus. The terminals of the fibres in the
ventral route are normally confined to the temporal
portion of the hippocampus. The degree to which this
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Fig. 3. Illustration of the collateral sprouting phenomena
originating in the ventral route after disruption of the
supracallosal and the infracallosal dorsal pathways (other
sproutingphenomenainducedbysuchlesionsare not shown
on this figure).
sprouting may provide the hippocampus with a new
innervation as well as the topographical completeness
of this innervation are both closely dependent upon
which dorsal hippocampal afferents have been
initially severed and the time elapsed since the lesion
surgery (e.g. Dravid and Van Deusen, 1983, 1984;
Gage and Bjorklund, 1986b; Gasser and Dravid,
1987). Common to the three systems of neurotrans-
mitters, when the lesion disrupts both the cingular
bundle and the fimbria-fornix pathways, this
sprouting response has a rather slow onset and needs
several weeks to a few months before significant
neurochemical effects can be detected (Gage and
Bjorklund, 1986b; Gage et al., 1983a). Conversely,
when the lesion is restricted to the cingular bundle,
sprouting occurs more rapidly and neurochemical
effects can be detected within only a few weeks (Gage
et al., 1983b, 1983c).
Gage et al. (1983a, 1983c) showed that ten months
after disruption of both dorsal components (cingular
bundle and fimbria-fornix) of the hippocampal
afferents, the ChAT activity, intially (within one
week) reduced to less than 5°/0of normal in the septal
portion of the hippocampus, had increased to slightly
more than 1OO/.(two-fold increase), whereas, in the
temporal portion, in which it was initially reduced to
150/o of normal, it had reached 45Y0 of normal
(three-fold increase). As regards NA uptake by
hippocampal synaptosomes at the same postsurgical
delay, the initial reduction to 20!4. of control or even
less in the most septal portion had been compensated
for to a higher degree than ChAT activity, with values
reaching 70°/0 to 800/0 of control. This partial
compensation was due to the sprouting of central
noradrenergic fibres as Gage et al. (1983a, 1983c) had
removed the superior cervical ganglia several days
prior to the sacrifice of the rats (see Section 3.2.2.2).
In the most temporal pole, the reduction of NA
uptake due to the lesion was weak and failed to be
significant. Unfortunately, the effects of fimbria-
fornix lesions on 5-HT markers in the hippocampus
have not been assessed in this paper. Evidence that
undamaged serotonergic afferents of the hippo-
campus may sprout and attenuate the initial
lesion-induced serotonergic deficit was reported by
Azmitia et al. (1978), Zhou and Azmitia (1984) and
Gage et al. (1983a). The former used a technique of
5,7-DHT-induced lesions of the supracallosal sero-
tonergic pathways, while the latter used a suction
technique. Both types of approaches allowed to
demonstrate that compensatory collateral sprouting
may account for partial recovery of serotonergic
markers in the hippocampus. To give just one
illustration, after aspiration of the cingular bundle,
Gage et al. (1983a, 1983c) have shown that the high
affinity 5-HT uptake by hippocampal synaptomoses
from the dorsal third of the hippocampus was
reduced to about 35°/0 of control 2 weeks after
lesion-surgery and, four weeks later, had recovered to
about 600/0of normal, a level at which it remained
stable for 1,5 year.
3.2.2.2. Heterotypical reactional sprouting
Although several examples of heterotypical reac-
tional sprouting have been demonstrated in the
hippocampal formation (e.g. Azmitia and Whitaker-
Azmitia, 1995; Goldberger and Murray, 1988;
Marshall, 1984, 1985; Steward, 1989), this part will
exclusively consider the phenomenon termed sym-
pathetic sprouting which, regarding some of the
graft-induced neurochemical effects presented further
on, clearly deserves a few lines of presentation and
comments. Noradrenergic sympathetic fibres are
commonly found in association with some large
blood vessels in the CNS (e.g. Crutcher, 1987), but
they also innervate other peripheral targets such as,
for instance, the cardiac muscle, the iris or the
salivary glands. In the CNS, the sympathetic axons,
which have terminals in structures such as, for
instance, the choroid plexus or the pineal gland
(Crutcher, 1987), are also found to be associated with
longitudinal parahippocampal blood vessels. The
latter terminals arise from the superior cervical
ganglia and provide the densest vasculatur inner-
vation near the temporal pole of the hippocampus
(Crutcher, 1987). Sympathetic sprouting in the
hippocampus designates the invasion of the hippo-
campal parenchyma by such peripheral noradren-
ergic fibres subsequently to a rostral denervation of
the hippocampus. A sine qua non condition for
sympathetic ingrowth to occur in the hippocampal
parenchyma is that the hippocampus must be
deprived of at least a part of its cholinergic
innervation, whether by lesioning the cell bodies or
by disrupting the afferent fibre tracts (e.g. Bjorklund
and Stenevi, 1981; Cassel et al., 1992b; Loy et al.,
1980). As to which mechanism(s) might account for
this aberrant sprouting response, a problem that is
beyond the scope of this review, the reader is referred
to review articles by Crutcher (1987, 1990). Following
cholinergic denervation of the hippocampus, sym-
pathetic fibres begin to grow within the temporal pole
of the hippocampus, mainly into the hilus of the
dentate gyrus and along the pyramidal cell layer in
Fimbria-Fornix/CingularBundlePathways 673
subregions CA4 and CA3 of the Ammon’s horn (e.g.
Crutcher, 1987; Crutcher and Davis, 1981). This
ingrowth has a rapid onset (evidence for sympathetic
terminals in these regions can be found within a few
days after the lesions, e.g. Milner and Loy, 1980) and
seems to continue during the whole postsurgical life
span of the lesioned animal, as suggested by the
observation that over up to 10 months, the
hippocampal NA concentration increases slowly but
inexhaustively (e.g. Madison and Davis, 1983;
Jackisch et al., 1995). Madison and Davis (1983)
investigated the time course of the recovery of
noradrenergic markers in the hippocampus following
septal lesions that also disrupted part of the central
noradrenergic hippocampal afferents. In part of their
rats, they additionally performed removal of the
superior cervical ganglia in order to be able to
estimate the degree to which collateral sprouting of
central fibres contributed to the recovery of
noradrenergic markers. Madison and Davis (1983)
found that two weeks after the lesions, there was an
approximately 50°/0 decrease of the hippocampal
NA concentration (entire hippocampus), whether the
rats had been ganglionectomized or not. As evident
from the rats which sustained bilateral ganglionec-
tomy, sprouting of the non-severed central noradren-
ergic fibres had contributed to normalize both the
concentration of hippocampal NA and the high
affinity NA uptake by hippocampal synaptosomes (a
better marker for the density of the terminals) by 12
weeks after surgery. In the rats which did not sustain
a ganglionectomy, the NA concentration was
near-normal after already four weeks and, 16 weeks
after surgery, it exceeded control values by more than
100?’.. In the experiment by Jackisch et al. (1995), the
lesions consisted of aspiration of the fimbria-fornix
and overlying structure, no ganglionectomies were
performed and the postsurgical delay was extended to
40 weeks with several intermediate delays. After the
40-week survival time, we found the concentration of
NA to largely exceed that found in the intact control
animals, with a maximal effect in the two temporal
thirds of the hippocampus (about + 200’Yo).Thus,
conversely to collateral homotypic sprouting of
hippocampal noradrenergic afferents which at most
normalize noradrenergic markers of the hippo-
campus, the sprouting of noradrenergic axons from
the peripheral nervous system may contribute to
largely overcompensate the depletion of some
hippocampal noradrenergic markers which follows
septal lesions or disruption of the dorsal septo-
hippocampal pathways.
3.2.3. Supersensitivity and Metabolic Reactions
In addition to the compensatory changes due to
sprouting and/or regeneration, there is also a series of
perhaps more functional modifications which are
generally more rapid in that they produce detectable
effects within a few days after lesion surgery. Such
compensations may occur at essentially three levels of
the neuronal communication, two of which being
operating on the presynaptic side, the remaining
being found postsynaptically. Presynaptically, these
compensations may affect the metabolic machinery in
the spared neurons (e.g. acceleration of neurotrans-
mitter synthesis), as well as the amount of
neurotransmitter released by the spared terminals
(they release more and/or show downregulated
autoinhibitory mechanisms). Postsynaptically, the
changes essentially concern the status of the receptor
towards its ligands. Such compensatory phenomena
were first described in the dopaminergic nigro-striatal
system and were found to also operate in patients
with PD (Bernheimer and Hornykiewicz, 1962). After
experimentally-induced degeneration of the nigrostri-
atal pathways, the residual dopaminergic neurons
synthesize and release more dopamine than normal
ones (e.g. Hefti et al., 1980), and this dopamine acts
on unregulated receptors (e.g. Creese et al., 1977;
Ungerstedt, 1971).
Supersensitivity is a term which designates a
phenomenon by which postsynaptic receptors in-
crease their sensitivity to chemical agents in reaction
to (sub)total denervation. Such an adjusting mechan-
ism was known for a long time in the peripheral
nervous system (glands, muscles. . .). In the CNS, one
of the clear-cut demonstration of one previously
suspected mechanism (Ungerstedt, 1971) underlying
such an adaptative event was by Creese et al. (1977).
Using the so-called “Ungerstedt” (e.g. 1971)model of
PD, these authors found that following a unilateral
lesion of the dopaminergic nigrostriatal pathway, rats
injected with apomorphine, a dopaminergic agonist,
repeatedly turned in a direction opposite to the side
of the lesion, a side on which they also found the
striatal [3H]haloperidol binding sites to be increased
dramatically as compared to the controlateral
unoperated striatum.
More recently, the aforementioned mechanisms
have also been identified in the residual hippocampal
innervation systems following partial denervation,
perhaps more particularly as regards the sensitivity of
the cholinergic, noradrenergic and serotonergic
receptors.
3.2.3.1. Cholinergic system
As concerns cholinergic neurons, L,apchak et al.
(1991), using partial or complete fimbria-fornix
transections in the rat, have compared the effects of
both lesions on hippocampal cholinergic markers,
with evaluations performed 3 weeks postsurgery both
in vitro (determination of [3H]acetylcholine synthesis
in hippocampal slices, ChAT activity and synaptoso-
mal uptake of choline) and in uivo (hippocampal
acetylcholine and choline content, newly synthesized
acetylcholine and rate of acetylcholine synthesis).
These authors found both lesions to deplete all
in vitro markers, with the depletion being less
dramatic after partial ( – 35% to – 60VO)than after
complete lesions ( —7i)0/0to —900/0). Whereas the
in vivo markers were depleted as severely as the
in vitro ones following a complete transection, they
were not significantly modified after a partial
transection. The latter finding clearly demonstrates
that surviving cholinergic neurons in the septo-
hippocampal pathways may functionally compensate
for the partial loss of cholinergic hippocampal
innervation by increasing the synthesis and the
release of acetylcholine. Using an in vivo microdialy-
sis technique, Leanza et al. (1993a) have reported that
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subsequently to fimbria-fornix transections relatively
more extensive than in the case of the partial lesions
used by Lapchak et al. (1991), the acetylcholine
turnover can be increased dramatically in the
denervated hippocampus. Another adaptative mech-
anism in cholinergic neurons surviving a lesion may
consist in the modification of their sensitivity to
neurotrophic factors. Such a possibility has been
recently suggested by Willson and Hanin (1995) who
used AF64A-induced lesions of the hippocampal
cholinergic afferents followed by intraventricular
administrations of NGF which was continued over
two weeks. In their lesioned rats, Willson and, Hanin
found the surviving cholinergic neurons to exhibit an
increased sensitivity to NGF treatment, as both the
ChAT and the AChE activities were increased by
about twice as much as in the NGF-treated
unlesioned control rats. Wall et al. (1994) have also
reported some changes at the postsynaptic level.
After basal forebrain lesions, Fuji et al. (1993) found
the number of [3H]QNB binding sites to be increased
in the hippocampus, an indication for occurrence of
muscarinic hypersensitivity. That a cholinergic
denervation of the hippocampus may induce an
upregulation of muscarinic receptors seems to be a
well documented fact, even if a small number of
studies failed to find the sensitivity of hippocampal
muscarinic Ml receptors to be affected by medial
septal (Bauer et al., 1992) or partial (Araujo et al.,
1993) as well as extensive (Cassel et al., 1991a)
fimbria-fornix lesions.
Following unilateral aspiration of the dorsal
septohippocampal pathways, Araujo et al. (1993)
showed that 10 to 24 days after surgery, the total
amount of hippocampal muscarinic receptors had
increased by 17°/0,with the density of the Ml, Mj and
Mb subtypes being increased by 14Y0,77% and 29V0,
respectively, and that of the Ml subtype being
decreased by 22% (probably because of their partly
presynaptic location). It is noteworthy that the
number of hippocampal M~ receptors was also
decreased after lesions of the MS (Bauer et al., 1992),
but that the affinity of the remaining M2 receptors
was actually increased (Kolasa et al., 1995). These
data are in line with a more recent report by Levey
et al. (1995) who found Ml and M4 receptors to be
upregulated in the hippocampus subsequently to
fimbria-fornix lesions, but not subsequently to lesions
produced by the immunotoxin 192-IgG which is
specific to cholinergic neurons (e.g. Wiley, 1992;
Wiley et al., 1991, 1995; but see also Rossner et al.,
1995; Walsh et al., 1995; and Section 3.4.1). That
some of these adapative changes (M, upregulation)
may be lasting for several weeks or months after
lesion surgery has been shown in earlier reports (e.g.
Benson et al., 1989; Dawson et al., 1989; Joyce et al.,
1989). An upregulation of the muscarinic receptors in
the denervated hippocampus has also been found
with a technique assessing the metabolic cascade of
the second messengers associated with the activation
of these receptors. The postsynaptic muscarinic
receptor is linked to a second messenger system in
which phosphatidylinositol is hydrolyzed into diacyl-
glycerol and inositol triphosphate. The latter
compound can be measured in response to carbachol-
induced activation of the receptor. Using such an
approach, Connor and Harrell (1989); (see also
Harrell et al., 1992)demonstrated that 4 months after
large septal lesions, the carbachol-induced formation
of inositol triphosphate in hippocampal slices was
still increased by 60°/0, a result showing that these
receptors had undergone a lasting upregulation in
response to cholinergic denervation. Also Lapchak
et al. (1993); but see Cassel et al., 1991a) found that
after partial fimbria-fornix lesions, the carbachol-
evoked production of inositol triphosphate (involved
in the second messenger cascade of M, receptor
activation), was upregulated in the hippocampus
( + 80%), whereas the density of M, and M,
receptors was not affected. Alterations in muscarinic
receptor sensitivity have also been found in the
hippocampus of aged rats (Fordyce and Farrar, 1991)
as well as in some brain regions of patients with AD
(Flynn et al., 1995a, 1995b; Nordberg et al., 1983).
Interestingly, not only muscarinic receptors may
undergo functional changes after cholinergic hippo-
campal denervation. Actually, using AF64A-induced
lesions of the hippocampal cholinergic afferents,
Potter and Nitta (1993) have found that two weeks
after surgery, the inhibitory muscarinic autoreceptor
of the cholinergic terminal had undergone downregu-
lation, whereas the facilitator nicotinic autoreceptor
had undergone upregulation, a finding confirmed by
a subsequent experiment (Thorne and Potter, 1995).
Interestingly, both these changes might underly some
of the aforementioned findings reported by Lapchak
et al. (1991) in the partially denervated hippocampus.
Finally, there is evidence that cholinergic denervation
of the hippocampus increases the transcription of
mineralo- and glucocorticoid hippocampal receptors.
It is also noteworthy that some of the aforementioned
lesion-induced changes in receptor sensitivity, es-
pecially as regards the muscarinic receptors, can be
partially altered (generally attenuated) by the
ingrowth of sympathetic noradrenergic fibres orig-
inating in the superior cervical ganglia (e.g. Harrell
et al., 1994, 1995; Kolasa et al., 1995).
3.2.3.2. Noradrenergic system
Gage et al. (1983b) performed bilateral fimbria-
fornix aspirations which, three weeks later, had
decreased the NA concentration by 90%, 55~0 and
20Y0 in the dorsal, “middle” (a part intermediate
between the dorsal and ventral thirds of the
hippocampus) and ventral hippocampal regions,
respectively. Estimations of the DOPA/NA ratios
were used to determine the turnover of noradrenaline
in the spared noradrenergic terminals. These esti-
mations showed a dramatic increase in the dorsal
hippocampus, a less pronounced one in the middle
part and no significant change in the ventral
hippocampus. Interestingly, this adaptation of the
metabolic machinery was no longer observed seven
months later, when the NA concentration had
recovered a near-normal level. Evidence for a
transient upregulation of the noradrenergic turnover
in undamaged neurons after fimbria-fornix lesions
has also been obtained using in vivo microdialysis
methods with the dialysis probe implanted in the
denervated hippocampus at various postsurgical
delays. Indeed, Leanza et al. (1993a) have reported
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that four weeks after a fimbria-fornix transection, the
NA turnover showed a 3-fold increase in the dorsal
hippocampus (estimated as the dialysate level/tissue
content ratio). Concerning the noradrenergic inner-
vation of the hippocampus, Zahniser et al. (1986)
found that one to two weeks following specific
DSP4-induced destruction (see Section 3.4.2) of the
hippocampal noradrenergic afferents, the number of
hippocampal /i’-adrenergic receptors was increased by
20 to 25V0.This upregtdation seems to last for several
months and to be still detectable one year after DSP-4
treatment, a delay at which the markers for
noradrenergic function in the hippocampus had
recovered a near-normal level (Wolfman et al., 1994).
Interestingly, an upregulation of ~, and flz receptors
was also observed in the hippocampus of patients
with AD (Kalaria et al., 1989). All these data showing
an adrenoceptor supersensitivity due to noradren-
ergic denervation of the hippocampus are in line with
two earlier reports relying upon different lesion
paradigms. Morrow et al. (1983) performed unilat-
eral or bilateral transections of the fimbria and the
fornix or radiofrequency lesions of the septal area
(through which part of the hippocampal noradren-
ergic afferents are coursing) and, with both lesions,
found a subpopulation of hippocampal adrenergic
receptors (presumably from the a type) to be enlarged
for at least one month after surgery, with the
enlargement being detected as early as 6 days after
surgery. There is also evidence that the sensitivity of
hippocampal noradrenergic CX2receptors can be
modified (downregulated in the dorsal hippocampus
and upregulated in the ventral hippocampus) after
partial fornix transection (e.g. Dyon-Laurent et al.,
1993, 1994) and that DSP-4-induced lesions which
decrease the noradrenergic markers in the hippo-
campus may produce behavioral supersensitivity
mediated presumably by al and a2 receptors. In
another study, Heal et al. (1993) showed that
subsequently to DSP-4 lesions, there was an initial
reduction of the hippocampal Uz adrenoceptors
( – 18% 3 days after administration of the neuro-
toxin) followed, 12 days later, by an increase to a
slightly above-normal level ( + 80/0).Finally, there is
evidence that after DSP-4 or 6-OHDA lesions of
central noradrenergic fibres, the number of hippo-
campal corticosteroid (Maccari et a/., 1992) and
cholec~tokynin receptors (Harro et al., 1992) is
increased, whereas that of somatostatin binding sites
is decreased (Lopez-Sanudo and Arilla, 1992).
3.2.3.3. Serotonergic system
Similar changes may occur in spared serotonergic
neurons. It has been repeatedly reported that a
serotonergic denervation of the hippocampus in-
duced an increase of the 5-HIAA/5-HT ratio, an
indicator of the 5-HT turnover in the spared neurons.
For instance, 5,7-DHT-induced lesions of the
hippocampal serotonergic afferents increased this
turnover by approximately 300/o(e.g. Daszuta et al.,
1988; see also Auerbach et al., 1985). Aspiration
lesions of the supracallosal and infracallosal path-
ways were found to increase this ratio in the dorsal
hippocampus to about 400~0 of normal (Cassel et al.,
1993b) and electrolytic lesions restricted to the
infracallosal pathways to about 2500/0(Jeltsch et al.,
1994b). As regards the status of the 5-HT receptors
in the denervated hippocampus, previous studies
have reported the density of the hippocampal 5-HT,
receptors (with no distinction of the subtype) to be
reduced by approximately 500/0after fimbria-fornix
lesions (Quirion and Richard, 1987) and the binding
to non-5 -HT,~ sites to be reduced by 20% after septal
lesions (Kiedrowski et al., 1990). Such results,
however, rather than indicating compensatory mech-
anisms, might be regarded as reflecting a decrease in
the number of 5-HT receptors located on the severed
terminals of serotonergic or even other types of
neurons such as the cholinergic ones (e.g. Cassel and
Jeltsch, 1995). At the level of the spared serotonergic
terminals, receptors mediating autoinhibitory mech-
anisms of 5-HT release were shown to undergo
downregulation (Chaput et al., 1990). Conversely,
after serotonergic denervation, the postsynaptic
hippocampal 5-HT receptors may be unregulated: In
that concern, Nelson et al. (1978) found that after
5,7-DHT-induced lesions (i.c.v. injection; see Section
3.4.3) of the serotonergic system, the [3H]-5-HT
binding in the hippocampus was increased by about
40% within a few days as compared to noninfected
control rats, a finding that was confirmed later in two
other studies using 5,7-DHT-induced lesions (Mor-
row et al., 1985; but see Quick and Azmitia, 1983) or
fimbria-fornix transections (e.g. Morrowet al., 1985).
However, again with 5,7-DHT-induced lesions of the
serotonergic system, Fischette et al. (1987) found
that, in the hippocampus, there was no apparent
upregulation of either 5-HT, or 5-HTZ receptors, a
result also supported by the data of Miquel et al.
(1992). Absence of hippocampal 5-HT,A receptor
alterations have been reported in 5,7-DHT-treated
neonates (Pranzatelli et al., 1994) and in adults given
intrahypothalamic injections of 5,7-DHT (Frankfurt
et al., 1993). Evidence that 5-HTC receptors are not
altered in 5,7-DHT-treated rats has been obtained
more recently (e.g. Gerard et al., 1996). In rats given
intracisternal injections of 5,7-DHT, the number of
hippocampal 5-HT,. receptors was, however, in-
creased (Pranzatelli, 1994), as was that of 5-HTZC
(5-HT,C in the authors’ terminology) binding sites
after intracerebroventricular administration of the
neurotoxin (Rocha et al., 1993). In another recent
report, Sijbesma et al. (1991) showed that sub-
sequently to 5,7-DHT-induced destruction of the
serotonergic neurons in the dorsal and the median
raphe nuclei, rats exhibited an increased 5-HT,
receptor binding in various subregions of the
hippocampus ( + lq~o to + 27~0), as well as in
various other regions of the brain (see also Frankfurt
et al., 1993). Finally, using microinjections of
5,7-DHT directly into the cingular bundle and the
fimbria-fornix pathways, Patel et al. (1995) reported,
that two weeks after surgery, the 5-HTIA immunore-
activity was significantly increased in the dentate
gyrus and region CA1 of the hippocampus as
compared to that seen in virtually intact rats. Some
of the discrepancies among these different reports
might be due to the differences in the lesion
techniques used (location, extent, amount of neuro-
toxin injected), the age of the animals (neonates
versus adults) or other factors such as, for instance,
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the duration of the postsurgical delay. This comment
also applies to the discrepancies in the results of the
studies mentioned in previous sections (3.2.3.1 and
3.2.3.2). Finally, central 5-HT depletions were found
to decrease the transcription and the number of
hippocampal mineralo- and glucocorticoid receptors
(Yau et al., 1994; Novotney and Lowy, 1995) and to
increase the number of glutamate binding sites
(Mennini and Miari, 1991), initially in subregion CA3
and, later on, in all hippocampal subregions. The
latter effect is not found in 5-HT-depleted neonates
(Ogawa et al., 1994).
3.2.3.4. Conclusions
Taken together, these results (summarized in
Table 2) show that, among the different functional
compensation possibilities which may occur in the
partially denervated hippocampus, neurons spared by
fimbria-fornix lesions may upregulate their metabolic
machinery, downregulate presynaptic receptors in-
volved in a tonic inhibitory regulation of neurotrans-
mitter release and, should the case arise, upregulate
the presynaptic receptors mediating an autofacilita-
tion of neurotransmitter release (e.g. nicotinic
receptors on cholinergic terminals). In addition, at
the postsynaptic level, the cholinergic, noradrenergic
and serotonergic receptors may become hypersensi-
tive to their endogeneous ligand. There is also some
evidence suggesting that the alteration of one specific
neurotransmitter system afferent to the hippocampus
may induce modifications of receptor sensitivity in
other neurotransmission systems (e.g. Alonso and
Soubrie, 1991; Donnerer et al., 1992; Maccari et al.,
1990, 1992). Obviously, these adaptative modifi-
cations in receptor sensitivity and neurotransmitter
turnover have an earlier onset and a less protracted
timing than the modifications briefly described in
Section 3.2.2 (sprouting). In some respects, one might
consider that the adaptative changes described above
might even be in a balanced relationship as it was
shown that the receptor upregulations resulting from
denervation are progressively attenuated by the
protracted ingrowth of sprouted fibres originating in
the spared neurons and by that of sympathetic fibres
from the superior cervical ganglia.
3.3. Behavioral Effects of Non-Specific
Fimbria-Fornix/Chsgular Bundle Lesions
In behavioral neuroscience, the notion of
behavioral task can be roughly regarded as referring
to a particular situation (using a specific apparatus
and a particular procedure) in which the animal is
supposed to do something in relation to the
experimenter’s expectations and the experimenter to
Table 2. SummaryTable of the Neurochemicaland PharmacologicalConsequencesof Lesionsin the Fimbria-Fornix/Cin-
gular Bundle Pathways with Focus on the Associated Neurochemically-DefmedHippocampal Denervations, Functional
Compensationsand Structural Changes
Denervation* Rapid compensatorylesion-inducedchanges Slowprotracted compensatory lesion-inducedchanges
Cholinergic –synthesisand release of acetylcholineincreased <ollateral homotypicsproutingof spared
GABAergic
Noradrenergic
Serotonergic
in spared neurons
–sensitivityto neurotrophic factors increased
in spared neurons
–upregulationof postsynapticreceptors
(e.g. Ml, M3, M4)t
–upregulationof presynapticfacilitator
nicotinicreceptors
–upregulationof mineralo-and glucocorticoid
receptors
Aownregulation of presynapticinhibitory
autoreceptors (e.g., M2) and heteroreceptors
(e.g., 5-HTIB)
–no data availableso far
–noradrenaline turnover increasedin spared
neurons
-upregulation of a,, u,, ~, and ~, receptors
–upregulationof corticosteroidand
cholecystokyninreceptors
+lownregulation of somatostatin receptors
–serotonin turnover increasedin spared
neurons
–upregulationof 5-HT,~and 5-HT*creceptors~
–upregulationof ghstamatergicreceptors
downregulation of mineralo- and
glucocorticoidreceptors
+lownregulation of autoinhibitoryserotonin
receptors
axons
–regenerativehomotypicsprouting of
damaged axons
–nonregenerativeheterotypicsprouting of sympathetic
fibres
–no data availableso far
+ollateral homotypicsprouting of spared
axons
–regenerativehomotypicsprouting of damaged axons
+ollateral homotypicsproutingof spared
axons
–regenerativehomotypicsprouting of damaged axons
* Extent of the denervation dependingupon the lesion extent with maximal effects on cholinergicand noradrenergic
markers, intermediate effects on noradrenergic ones and weak effects on GABAergicones.
1’Some of these changes can be altered by sympathetic ingrowth.
~The occurrenceand subtype of receptor(s)concernedare still subject to controversyand regulatory phenomena seem
to be absent in neonate rats subjected to serotonin depletion.
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record something in relation to the animal’s
behavioral capabilities. The constraints of this
situation are defined such as to induce the animal to
do something particular which the experimenter will
record in terms of quantitative or qualitative data and
from whose the latter will be able to infer knowledge
about the animal’s capabilities. When one considers
a behavioral variable (e.g. latency to find an
submerged platform in a water tank), one has to keep
in mind that all testing situations irrevocably involve
a large series of psychological processes covering
motivational, attentional, perceptual, sensory-motor,
cognitive . . . processes and that, therefore, the risk of
interpretational bias is omnipresent. Nevertheless,
such a risk might be minimized by analyzing the
behavioral consequences of a given brain lesion
using an as large as possible battery of tests, with each
test being more sensitive to one of these processes
than to all other ones. It is clear that all behavioral
perturbations associated with lesions in the fimbria-
fornix and cingular pathways are potential concerns
in studies aimed at characterizing the possibilities of
intrahippocampal grafts to foster functional recov-
ery. Regarding the behavioral effects of fimbria-
fornix lesions reported so far in the literature, most
studies have focused attention on the mnesic sequelae
of such lesions (some reasons to that may be found
in Section 3.1) and only a few were concerned by
behavioral aspects in which the mnesic component
may be considered more negligible.
3.3.1. Main~enance %ehaviours
Maintenance behaviors cover eating, drinking,
moving, perceiving and, in some respects, sexual,
social and maternal behaviors. Though having a
cognitive dimension which one should not ignore, it
may be considered that the mnesic/cognitive load of
such maintenance behaviors is rather low as
opposed to the cognitive demand of, for instance, a
large variety of maze learning problems. The effects
on such behaviors of a disruption of the
septohippocampal pathways have not been subject to
systematic investigations during the last twenty-five
years. Furthermore, when examined, most studies
relied upon more or less extensive lesions of the
hippocampus rather than of the afferent or efferent
hippocampal pathways. In one of the last reviews in
which this topic was dealt with, namely that by
O’Keefe and Nadel (1978), it has been concluded that
lesions affecting the integrity of the hippocampal
formation (in its broadest sense) do not result in
critical or major perturbations of the aforementioned
behavioral aspects. Nevertheless, according to some
early reports and to a few more recent ones, an
alteration of the hippocampus may produce more or
less subtle consequences on several aspects of
maintenance behaviors or some underlying regulat-
ory mechanisms such as, for instance, circulation,
modulation or emission of hormonal information.
Although the majority of studies have investigated
the effects of different hormones on functional or
structural, sometimes ontogenetic, aspects of the
hippocampus or, more generally, of various brain
structures (e.g. McEwen and Parsons, 1982), there
exists a few experiments suggesting that hippocampal
lesions may result in alterations of regulatory
processes based upon hormonal communication,
especially as regards the hypothalamic-pituitary-
adrenocortical axis (e.g. Jacobson and Sapolsky,
1991). For instance, Soulairac and Soulairac (1978)
have reported that in male rats, the hippocampus is
an important relay structure in the circuits involved
in regulation of emotional and sexual aspects of
behaviour, a statement which is in line with the report
by Kim (1960) who showed adult male rats given
hippocampal lesions to exhibit exaggeratedcopulatory
activity (see also Bermant et al., 1968). In female rats,
hippocampal damage induces perturbations in estrus
cycle (e.g. Borker and Mascarenhas, 1990 but see
Capobianco and Hamilton, 1973). Hippocampal
lesions are also able to transiently alter the circadian
rhythm of plasma corticosteroids (e.g. Mason, 1958),
and so are lesions of the fimbria-fornix (e.g.
Nakadate and de Groot, 1963), or to perturbate the
responsivity of the pituitary-adrenal axis to mildly
stressful situations (e.g. Coover et al., 1971).
However, whether these modifications in the func-
tional integrity of hormonal systems may influence
behaviour does not appear to be a major concern in
the literature.
Lesions of the hippocampal formation in female
rats were also found to increase food intake and
hoarding behaviour, thus accelerating weight gain
(Borker and Mascarenhas, 1990; King et al., 1994).
Such alterations are not observed in hippocampal
male rats (Forloni et al., 1986), although male rats
with hippocampal damage were found to be impaired
in using information provided by their “hunger state”
(Davidson and Jarrard, 1993). Male rats with
fimbria-fornix lesions show abnormal patterns of
consummatory behaviour in that they drink and eat
more frequently than their unlesioned counterparts
with, however, an unchanged total amount of food
and water intake (Osborne and Dodek, 1986). The
latter findings might be in some respects explained by
the fact that fimbria-fornix lesions result in an overall
increase of activity.
Actually, regarding locomotor activity, it is well
established that hippocampal as well as fimbria-
fornix lesions induce a dramatic increase in
locomotor activity in both familiar (e.g. the home
cage) and unfamiliar (e.g. an open field) environ-
ments (e.g. Capobianco and Hamilton, 1976; Cassel
et al., 1991b; Dunnett et al., 1982; Jeltsch et al.,
1994a, 1994b). Hippocampal lesions also attenuate
the cyclic activity changes (Jarrard, 1968). Other
aspects of maintenance behaviour such as, for
example, maternal behaviour (Kimble et al., 1967)
and social interactions (Kolb and Nonneman, 1974)
may also be altered by hippocampal lesions. Finally,
it seems that sensory-motor capabilities are not
disrupted by hippocampal lesions when the lesion is
bilateral. When made on only one side, as is the case
with unilateral lesions of many other brain structures,
hippocampal lesions induce a sensory-motor deficit
that consists in ipsilateral turning and orienting
biases. Using two types of fimbria-fornix lesions
(aspiration versus electrolysis), we recently found
(Hofferer and Cassel, 1996) that, whereas both lesions
induced qualitatively similar cognitive deficits, the
lesion made by aspiration induced a sensorimotor
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deficit (presumably due to the partial damage to
the medial parietal cortex) which the otherone did
not.
As briefly summarized in this section, hippocampal
lesions may alter more or less subtly maintenance
behaviors. For most of them, the question of
whether fimbria-fornix lesions do mimick the effects
of hippocampal lesions remains to be addressed more
directly than was done in the past. A major drawback
with such effects is that part of them might introduce
some bias in the accuracy of the various procedures
used to assess cognitive functions. However, one may
assume that the impact of such effects may be
minimal when test situations used to assess cognitive
capabilities are designed in such a way as to reduce
the influence of maintenance behaviour upon the
accuracy of cognitive performance or, should the case
arise, to get this influence under sutlicient experimen-
tal control to enable the measurement of the
importance of the bias and to do appropriate
corrections.
3.3.2. Learning and Memory
In 1957, Scoville and Milner (1957) reported the
now famous H.M. case, an epileptic patient who
exhibited a severe anterograde amnesia subsequently
to bilateral resection of several temporal lobe
structures including the amygdala and most of the
hippocampus. Since that time, a majority of studies
investigating the behavioral functions of the
hippocampus with lesion or stimulation techniques
have focused attention on the implication of the
hippocampus and some of its connected structures in
mnesic processes. As to which mnesic processes are
affected by hippocampal lesions or denervations has
become a large debate in which controversy is fed
with competition between theories, more or less
subtle differences between conceptual views, and the
fact that findings in one species or with one given task
cannot be generalized to another species or another
task without qualification (e.g. Eichenbaum, 1992;
Eichenbaum et al., 1994). Even in the rodent
literature, there is no consensus yet, neither as to
which type of memory the hippocampus is mainly
dealing with (constructing and learning spatial
representations, storing and managing information in
the working memory, memorizing contextual at-
tributes, establishing configural associations, etc.),
nor as to which theoretical categorization of the
memory types related to hippocampal function may
be considered as having the highest heuristical value.
For extensive reviews relative to all these aspects
(including the controversies) the reader is referred to,
e.g. Eichenbaum, 1992; Eichenbaum et al., 1992,
1994; Gray and McNaughton, 1982; Kesner, 1984;
O’Keefe and Nadel, 1978; Olton et al., 1979; Squire,
1992; Sutherland and Rudy, 1989. Therefore, we
would like to only summarize a few simple ideas
along which neurobiologists using intrahippocampal
transplants have addressed the question of whether
the grafts of fetal brain tissues may contribute to
foster recovery of cognitive functions such as learning
and memory, which are impaired by various lesions
in the hippocampal system.
3.3.2.1. Lesions of or in thejimbria-fornix jibre track
and mnesic consequences
A brief review of the intrahippocampal transplant
Literature (see also below) clearly shows that
essentially three types of testing situations having a
more or less prominent spatial load were used
extensively: The food-rewarded (learned) T-maze
alternation, the radial arm-maze and the Morris
water-maze tasks. In the two latter situations, a
distinction was made sometimes between the
so-called working memory and reference memory
performances (see below). Behavioral tests relying
upon passive or active avoidance retention, operant
conditioning tasks or others based on resolving
maze-learning problems different from the aforemen-
tioned ones (e.g. Hebb and Williams maze) have also
been used occasionally in intrahippocampal grafting
experiments.
The food-rewarded alternation task uses a T-
shaped maze. Although there are several variants of
the testing procedure, the basic principle of this test
can be summarized as follows: A trial is conducted in
two steps. In the first step, a rat previously subjected
to a restricted food or water diet is placed at a start
point in the central alley and, from there, is allowed
(or forced) to visit one of both arms at the extremity
of which he will be reinforced with a food-pellet or
a small amount of water placed in an excavation so
that the rat cannot see the pellet or the water from
the choice point between the goal branches of the
maze. In the second step (which can be separated
from the first one by a delay of variable length), the
rat is returned from the just visited arm to the start
point. From there, he has the possibility to visit either
arm, but only the visit of the arm that was not visited
in the first trial is reinforced. Over repeated trials,
normal rats learn easily the task and may reach stable
alternation rates approximating 100°A.
The radial maze typically consists of a central
platform from which radial arms (most often eight)
extend over a few tens centimeters (e.g. Olton et al.,
1978). At the extremity of each arm, a pellet of food
is placed into a small excavation. For a given trial, a
food-deprived rat is placed on the central platform
and allowed to choose freely among the arms and to
collect the pellet in each arm. In each arm, the
collection of a food pellet is possible only once within
a given trial. With such a procedure, a normal rat
progressively learns to consume all food pellets with
a minimum of arm choices, and thus a minimum of
errors; errors are defined as the re-entries within a
given trial into already visited arms. Without any
other constraint, this task is considered as measuring
typically spatial working memory. Modifications of
this standgwd testing protocol allow to distinguish
between errors due to either working memory or
reference memory failures (e.g. Jarrard et al., 1984b
for more details on the protocol). Briefly, according
to Olton’s theory (e.g. Olton et al., 1978), the notion
of working memory is considered to refer to mnesic
processes encoding items related to the temporal/per-
sonal context of an event or a test situation, whilst
reference memory encodes context-independent rules
and procedures that are specific to a given situation
and which remain valid each time this given situation
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is encountered. To illustrate these memory categories
by a concrete example, one may consider four
persons playing cards. In their reference memory,
these persons have memorized the rules of the game
(pinocle, tarot, bridge or whatever). Their working
memory will be utilized to remember the cards that
are played in each turn. When all cards have been
played, information stored in their working memory
are not longer meaningful, and thus can be “deleted”.
Conversely, the rule of the game stored in the
reference memory will be the same for the next and
all subsequent deals.
The Morris water maze task (e.g. Morris, 1983)
uses a large circular pool of water in which an escape
platform is hidden just underneath the water surface.
Generally, water is made opaque with addition of
powdered milk. From whatever position it is released
in the pool, the rat has to find this hidden platform
which he uses as a refuge. When the location of this
platform is kept stable over trials, normal rats quickly
learn to navigate directly to the appropriate position
right after having been released in the pool and they
are able to do so regardless of the position from
which they are released. According to O’Keefe and
Nadel’s theory (0’ Keefe and Nadel, 1978), this task
is a typical place learning task (as opposed to a taxon
learning task) requiring an intact ability to construct
and use a cognitive map, i.e. an allocentric
representation of their environment. In Olton’s view
(e.g. Olton et al., 1978), this task requires intact
(spatial) reference memory operations (as opposed to
working memory operations) through which rats
have to learn a given rule (the platform’s location)
that remains efficient as long as the location of
the platform is constant. Modifications in the
aforementioned standard testing protocol allow to
distinguish between impairments due to either
working memory (the platform is placed in a new
location each other day) or reference memory
dysfunctions the platform is kept at the same location
from day to day).
In each of these three test situations, rats with a
disrupted fimbria-fornix system show clear-cut
deficits, whether after partial or extensive lesions of
the pathways, after lesions restricted to nuclei such as
the MS or the DBB, or after lesions performed with
more (e.g. AF64A, IgG 192-saporin; see below,
Section 3.4.1) or less (ibotenic, kainic or quinolinic
acid) specific neurotoxic treatments (e.g. Olton and
Wenk, 1987; MacDonald and Sirvio, 1993). Almost
always, these deficits have been interpreted as due to
disruption of the ability of the rats to handle,
remember and/or appropriately use spatial infor-
mation (e.g. O’Keefe and Nadel, 1978) to be
processed in the working memory compartment (e.g.
Olton et al., 1979). This interpretation certainly
applies to the deficits found in the T-maze alternation
task and in the radial maze task used with a standard
testing procedure. There is, however, evidence that
operations in the reference memory compartment are
also altered. Indeed, the deficits found in the Morris
water maze do typically reflect an impairment of
spatial reference memory, a finding which has also
been observed in the radial maze task performed with
the procedure described by Jarrard et al. (e.g. Jarrard
et al., 1984b).
As stated above, the disruption of the fimbria-
fornix pathways deprives the hippocampus of several
neurochemical types of afferents. Thus, an interesting
question is which of these neurochemical systems
accounts for the modulation of the cognitive
operations altered following fimbria-fornix lesions?
There is a series of converging arguments consolidat-
ing the view of an important role of the cholinergic
component of these pathways. Actually, most mnesic
deficits found in nonspecific lesion studies can be
mimicked by systemic or local administration of
antimuscarinic compounds such as, for instance,
atropine, pirenzepine or scopolamine (e.g. Cassel and
Kelche, 1989;Collerton, 1986; Hagan et al., 1987). In
addition, there is evidence that these deficits can also
be attenuated, in some respects and under some
conditions: (i) by the acute administration of
cholinergic agonists such as, for instance, the
muscarinic agonists oxotremorine and pilocarpine
(e.g. Matsuoka et al., 1991; but see Greene et al.,
1994); (ii) by the administration of neurotrophic
factors acting more specifically on the central
cholinergic system (e.g. nerve growth factor; Pallage,
1990; Pallage et al., 1986; Will and Hefti, 1985); (iii)
as reviewed hereafter, by the implantation into the
denervated hippocampus of grafts rich in cholinergic
neurons (e.g. Dunnett, 1990; Sinden et al., 1995;
Tarricone et al., 1996). Furthermore, AF64A-in-
duced or IgG 192-saporin-induced lesions (e.g.
Berger-Sweeney et al., 1994; Book et al., 1994;
Heckers et al., 1994; Nilsson et al., 1992b), which
both are or have been claimed to alter more
specifically the cholinergic afferents of the hippo-
campus with only minimal damage to other
neurochemical fibre systems (e.g. Book et al., 1994;
Hanin, 1990; Heckers et al., 1994; see also below,
Section 3.4), produce cognitive deficits qualitatively
comparable to those found after fimbria-fornix
lesions (e.g. Chrobak et al., 1989; Chrobak and
Walsh, 1991; Fisher and Hanin, 1986; Gower et al.,
1989). Finally, there is also some evidence that the
reduction of cholinergic function due to ageing is
paralleled by the emergence of cognitive deficits that
resemble some of the deficits due to experimental
disruption of the fimbria-fornix pathways and, under
some conditions, these deficits are sensitive to
cholinomimetic therapy (e.g. Brandeis et al., 1990;
Matsuoka et al., 1992; Ohta et al., 1991; Riekkinen
et al., 1991a, 1991b; but see Sirvio et al., 1992;
Yamazaki et al., 1995) or intrahippocampal grafts
rich in cholinergic neurons (e.g. Dunnett, 1990; Gage
and Bjorklund, 1986a). These converging arguments,
however, do not appear to be sufficient to accept that
the sole disruption of the cholinergic neurons in the
fimbria-fornix lesion paradigm is accounting for all
aspects of the mnesic deficits associated with such a
lesion. It is clear at present that in all approaches
mentioned above there are drawbacks, at least in
terms of the neuroanatomical or neurochemical
selectivity of the methods used: (i) lesions with
neurotoxins such as ibotenic, quisqualic or kainic
acid, although leaving the fibres en passage intact,
damage any kind of neuron as well as glial cells in the
vicinity of the injection sites; (ii) the specificity of
AF64A towards cholinergic neurons has been
disputed and (e.g. Hanin, 1990; Jarrard et al., 1984a;
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MacDonald and Sirvio, 1993; Walsh and Opello,
1994); (iii) there is not enough experience with IgG
192-saporin to consider it as a good cholinergic
neurotoxin and, in addition, it only works on the
neurons expressing the low-affinity NGF receptor
which is not evenly associated with all cholinergic
terminals in the brain; (iv) drugs given systemically
act simultaneously on several cholinergic systems and
there is no possibility to conclude where in the brain
the neuroanatomical substrate of the effects observed
is located; (v) grafts have various other possibilities
than releasing a neurotransmitter for exerting
functional effects in a given denervated structure of
a brain-damaged organism (e.g. Dunnett and
Bjorklund, 1987, 1994); (vi) covering co-jointly all
these drawbacks, there has been enough experimental
evidence accumulated showing that many neuro-
transmitter systems other than the cholinergic one
may have cognitive implications, whether directly or
indirectly (e.g. Cassel and Jeltsch, 1995; Decker and
McGaugh, 1989; Haroutunian et al., 1990; Levin
et al., 1992; Sirvio et al., 1994; Steckler and Sahgal,
1995; Wenk et al., 1987). As regards the fimbria-
fornix lesion paradigm, especially the noradrenergic
and the serotonergic systems are concerned, both of
which being able to modulate the functionality of
cholinergic terminals in the hippocampus as well as
the cognitive consequences of cholinergic blockade
(e.g. Cassel and Jeltsch, 1995; Decker and McGaugh,
1991; Haroutunian et al., 1990; Starke et al., 1989for
reviews). For all these reasons, the deficits reported
after fimbria-fornix lesions cannot be simply and
solely ascribed to the disruption of the cholinergic
component of this fibre track.
3.3.2.2. Reactive compensations and behavioral
correlates
As summarized in Sections 3.2.2.1 and 3.2.2.2,
fimbria-fornix lesions induce compensatory changes
such as denervation supersensitivity and reactional
sprouting. The question of whether such adaptative
changes may be involved in postoperative recovery
(or impairment) of behavioral function has been
addressed experimentally, and, under some pro-
cedural circumstances, has been answered positively.
One of the first studies aimed at such a goal was
reported by Azmitia et al. (1978). In rats subjected to
5,7-DHT-induced unilateral lesions of the cingular
bundle, these authors found a systemic injection of
5-hydroxytryptophane to elicit a rotational asymetry.
By approximately 1.5 months postsurgery, this
response was no longer observed, a result which the
authors attributed to serotonergic reafferentation of
the dorsal hippocampus by sprouted serotonergic
fibres, as the initially observed rotational assymetry
reappeared subsequently to a second 5,7-DHT
injection. In another study, Gage et al. (1983c) have
assessed T-maze alternation at varying postoperative
delays in rats that had sustained bilateral transection
of the cingular bundle. By two weeks after lesion
surgery, neurochemical markers such as NA and
5-HT high affinity uptake by hippocampal synapto-
somes and ChAT activity were reduced. Between 6
and 24 weeks after surgery, this reduction had been
attenuated substantially, and even completely com-
pensated for in the whole hippocampus as regards
ChAT activity (see Section 3.2.2.1). In parallel, rats
with such lesions were impaired in learning a
food-rewarded T-maze alternation task to a degree
similar to that found in rats with fimbria-fornix
aspiration lesions. However, this deficit was less
pronounced at 3 and 6 months after surgery, an effect
which the authors imputed to the attenuation of the
neurochemical deficits by cholinergic, noradrenergic
and serotonergic sprouted fibres. In a book chapter,
Gage and Bjorklund (1986b) reported that two weeks
after aspiration lesions of the medial cingulate cortex
and the cingular bundle, rats showed a dramatic
impairment in the acquisition of a Morris water maze
task. By 10 and 20 weeks after surgery, two other
groups given identical lesions had recovered a level of
performance close to normal. Interestingly, [3H]5-HT
and [3H]NA uptake by hippocampal synaptosomes as
well as ChAT activity, which were reduced to
respectively about 25°/0,50°/0and 700/0of normal two
weeks after surgery, had recovered to more than 800/0
of normal by 20 weeks. These results further support
the assumption that reactional sprouting may foster
recovery of complex cognitive functions.
Regarding the modification of receptor sensitivity,
a review of the literature clearly shows that the
involvement of this adaptative phenomenon in
behavioral recovery from hippocampal denerva-
tions has not been investigated to the same extent as
it has been in the 6-OHDA lesion paradigm of the
nigrostriatal pathways. It can however be assumed
that postsurgical changes in receptor sensitivity may
also play some (yet not precisely determined) role in
the behavioral sparing and/or recovery which may
be observed following hippocampal denervation.
As summarized in Section 3.2.2.2, fimbria-fornix
lesions also induce an aberrant reactional sprouting
phenomenon termed sympathetic sprouting (or
ingrowth) which is able to normalize and even
overcompensate some noradrenergic markers in the
denervated hippocampus. There has been a series of
studies aimed at investigating whether this ingrowth
of peripheral noradrenergic fibres was able to
influence behavioral functions altered by hippocam-
pal denervation. The first studies to address this issue
were reported by Kimble et al. (1979a, 1979b, 1979c,
1980) who failed to find any significant contribution
of sympathetic ingrowth on the recovery of
spontaneous alternation, maze learning, conditioned
taste aversion and open-field activity scores after
lesions of the dorsal hippocampus. Crutcher et al.
(1983) have reported similar conclusions in rats tested
in a radial-maze learning task after lesions of the MS.
These findings, however, are at variance with more
recent reports in which sympathetic ingrowth into the
cholinergically denervated hippocampus was found
to have some influence upon the postsurgical
behavioral recovery. Actually, using adult male rats,
Ayyagari et al. (1991) have shown that following
lesions of the MS, sympathetic ingrowth was able to
alter the retention of a passive avoidance task, to
attenuate gustatory neophobia and to cause hyperac-
tivity in an open-field test. That sympathetic
sprouting may also influence maintenance behaviour
was reported in an earlier study by Harrell et al.
(1987). She and her co-workers found that after MS
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lesions in male rats, sympathetic ingrowth allowed a
better post-operative weight gain as compared to rats
with identical lesions and additional sympathectomy.
In another study, Harrell and Parsons (1988) have
compared the postoperative radial maze reacquisition
performances of male and female rats subjected to
MS lesions combined or not with ablation of the
superior cervical ganglia. They found sympathetic
ingrowth to exert detrimental effects on recovery of
cognitive functions in males and beneficial effects in
females. These findings have been confirmed in more
recent studies by Harrell et al. (1990a, 1990b, 1993)).
In two of these (Harrell et al., 1990a, 1990b), it was
reported that the detrimental effect of sympathetic
ingrowth in males was partly dependent upon
circulating sex hormones (Harrell et al., 1990b) and
upon an a-adrenoreceptor-mediated mechanism
(Harrell et al., 1990a). More recently, Bratt et al.
(1995) failed to find detrimental effects of sympathetic
ingrowth in adult female rats subjected to electrolyti-
cal fimbria-fornix lesions.
3.4. More Specific Lesions of
Neurochemically-Defined Fibres in the
Fimbria-Fornix/Cingular Bundle Pathways
In this part, we will consider studies relying upon
the utilization of neurotoxins producing more
selective lesions of neurochemically-defined cell
populations sending fibres to the hippocampus
through the fimbria-fornix, the cingular bundle and
the ventral pathways. Essentially cholinergic, sero-
tonergic and to a lesser degree noradrenergic fibres
have been the focus of such approaches, both for
neurochemical and behavioral studies. The present
section will briefly deal with these more specific lesion
paradigms and their most prominent functional
effects, essentially because some of these paradigms
have also been used to address the question of the
neurochemical and behavioral functionality of
intrahippocampal grafts.
3.4.1. Cholinergic Denervation Paradigms
Although there exist many tools to induce more or
less durable cholinergic dysfunctions in the brain (e.g.
Hortnagl and Hanin, 1992), two technical approaches
have been favoured because the compounds on which
they rely are able to induce true and irreversible
degeneration of cholinergic neurons. The first of these
compounds is commonly termed AF64A (or ECMA
for ethylcholine mustard aziridinium) and consists of
a nitrogen mustard derivative of choline which is
highly similar to choline and is assumed to exert its
specific neurotoxic effects in two steps (Hortnagl and
Hanin, 1992). In an early step, AF64A may be taken
up by the high-affinity choline transport system
located at the cholinergic terminal where it starts to
exert its cytotoxic action, an action which must be
supposed to subsequently operate by retrograde
propagation. In a later step, it lastingly blocks the
high-affinity choline transport system, a mechanism
that may also contribute to the degeneration of
cholinergic neurons as prolonged hemicholinium-3
treatment, a specific and highly potent inhibitor of
the high-affinity choline transport system, was shown
to induce atrophy of some cholinergic neurons
(Hortnagl and Hanin, 1992). AF64A may also bind
to a low affinity system involved in the incorporation
of choline into phospholipids and other components
of the cell membrane, a mechanism that might
account for some of the nonspecific effects of AF64A
as choline incorporation into membranes is not
specific to cholinergic neurons (Hanin, 1990). Also,
some lack on specificity of AF64A may be due to the
technical difficulties which are encountered during the
preparation of this compound (e.g. Walsh et al.,
1995). The other compound is termed 192 IgG-sa-
porin and consists of a monoclinal antibody raised
against the (low-affinity) p75 nerve growth factor
receptor subsequently conjugated to saporin, a
ribosome-inactivating protein. Although it recognizes
antigens in many regions of the brain, this
toxin-carrying antibody has the advantage of having
its highest affininity for axons of cholinergic neurons
located in the basal forebrain (MS, DBB and nucleus
basalis magnocellularis).
AF64A and 192 IgG-saporin are generally injected
into the cerebral ventricles, although in some studies,
AF64A was injected directly into the parenchyma of
the hippocampus, MS or other structures in the brain
(e.g. Hanin, 1990 for a review), and so has been the
case with 192IgG-saporin (e.g. Berger-Sweeney et al.,
1994; Heckers et al., 1994). Depending on the studies,
the doses used, the hippocampal tissue dissection or
preparation and the neurochemical marker deter-
mined, hippocampal cholinergic markers such as, for
instance, ChAT or AChE activity, high affinity
uptake of [3H]choline by hippocampal synaptosomes
and acetylcholine tissue content are depleted to
values between 500/0and more than 900/oof normal.
Interestingly, many of the behavioral deficits
exhibited by rats that sustained intraventricular or
intraparenchymal injections of AF64A actually
resemble those reported after more or less extensive,
nut non-specific lesions of the septal region or the
fimbria, the dorsal fornix and the cingular bundle
(e.g. Collerton, 1986; Dunnett, 1990; Jeltsch et al.,
1994a, 1994b, and references in Section 3.3.2.1).
These rats show increased levels of activity in both a
familiar and an unfamiliar environment, impaired
performance in passive and active avoidance tests, as
well as severely perturbated capabilities of T-maze,
radial maze and Morris water maze learning (e.g.
Hanin, 1990).
Controversy upon the specificity of AF64A has
emerged with the demonstration that neurotransmit-
ter systems other than the cholinergic one are also
altered, although the corresponding markers are
reduced to a much lower degree than the cholinergic
ones and, under appropriate dosage, most of these
effects appear to be reversible andJor might be
functional consequences of the cholinergic degener-
ation rather than a direct effect of the toxin (Hanin,
1990; Hortnagl and Hanin, 1992). Rats sustaining
i.c.v. injections of high doses of AF64A were found
to exhibit transient or more lasting depleted
dopamine, glutamate, NA or 5-HT levels in brain
regions such as the hippocampus, the cortex or the
striatum (e.g. Abe et al., 1994; Hortnagl et al., 1991a;
Jarrard et al., 1984a). Effects on glutamate decar-
boxylase activity in the interpeduncular nucleus have
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also been reported (Villani et al., 1986). Nevertheless,
with low doses of a pure compound, the effects on the
cholinergic system are still present and the nonspecific
functional modifications do not seem to be lasting
over long postsurgical periods (e.g. Dong et al., 1994;
Gaal et al., 1986; Hanin, 1990; Hortnagl and Hanin,
1992; Potter et al., 1986). Thus, when AF64A is
injected with an appropriate dosage ( <4-5 nM/ven-
tricle) into adequate sites (e.g. into the lateral
ventricles), it seems to reach a satisfactory degree of
specificity towards cholinergic neurons and to
produce dramatic and lasting cholinergic denervation
of the hippocampus.
So far, drawbacks qualitatively or quantitatively
similar to those of AF64A have not been reported
with 192 IgG-saporin. For instance, between 3 and 28
days after injection, Waite et al. (1994) examined the
effects of the intracerebroventricularly-administered
immunotoxin on various neurochemical markers in
several regions of the rat brain. At 28 days, they
found ChAT activity to be reduced dramatically in
the parietal and the frontal cortex ( > -80Yo), in the
olfactory bulbs (close to -100’%) and in the
hippocampus (close to -95~0). A weaker reduction
was found in the septal region (-400/o) and no
significant modification occurred in the striatum (but
see Heckers et al., 1994)and the pens. With exception
of the olfactory bulbs in which 3,4-dihydroxypheny-
lacetic acid (DOPAC), homovanillic acid (HVA) and
dopamine levels were increased by 60’7., 60Y0 and
30%, respectively, there was no significant
modification of 3-methoxy-4-hydroxyphenylglycol
(MHPG), 3,4-dihydroxyphenylalanine (DOPA),
dopamine, DOPAC, norepinephrine, HVA, epineph-
rine, 5-hydroxyindolacetic acid (5-HIAA) and 5-HT
levels in the other structures where ChAT activity was
reduced. Nevertheless, 192 1gG-saporin was found to
have other types of unspecific effects and, surpris-
ingly, to lack some (a priori obvious) behavioral
consequences unless an important degree of cholin-
ergic denervation was attained (e.g. Steckler et al.,
1995; Waite et al., 1995; Walsh et al., 1995; Walsh
et al., 1996). Indeed, 192 IgG-saporin may damage,
in some respects dose-dependently (e.g. Wiley et al.,
1995), part of the cerebella Purkinje cells (e.g.
Heckers et al., 1994; Wiley et al., 1995) as well as
some cholinergic interneurons in the striatum
(Heckers et al., 1994). 192 IgG-saporin may also alter
noradrenergic markers in the hippocampus (Walsh
et al., 1996). From a behavioral point of view, it was
found that an average of 80% ChAT-activity or of
60-800/6 HACU depletion must be achieved simul-
taneously in various cholinergic targets (frontal,
parietal, occipital cortex, hippocampus and olfactory
bulbs) to observe substantial behavioral deficits in a
Morris water maze (Leanza et al., 1995; Waite et al.,
1995;Walsh et al., 1995)and a passive avoidance task
(Leanza et al., 1995; Waite et al., 1995), whereas, in
the same tasks, clear-cut deficits can be observed after
partial (neurochemically nonspecific) septo-
hippocampal damage producing a weaker reduction
of ChAT activity in only the hippocampus. In
another recent study (Berger-Sweeney et al., 1994), it
has been reported that rats almost completely
deprived of their AChE-positive hippocampal inner-
vation by intraseptal 192 IgG-saporin injections only
showed a very modest deficit in a spatial learning task
(in which a similar cholinergic denervation produced
by fimbria-fornix lesions induce dramatic impair-
ments), whereas their counterparts receiving the
immunotoxin into the substantial innominata (cholin-
ergic denervation of the cortex) were approximately
as dramatically impaired in performing the task as
the rats given the toxin into the cerebral ventricles
(basalocortical and septohippocampal cholinergic
systems destroyed conjointly). The latter finding is
somewhat puzzling as one largely accepted view
considers the septohippocampal cholinergic system to
play a more important role in spatial memory
processes than does the basalocortical system.
Finally, Leanza et al. (1996) have found that, when
injected in the brain of neonate rats, 192 IgG-saporin
produced a dramatic and apparently lasting loss of
cholinergic neurons in both the MS and the nucleus
basalis magnocellularis. However, when tested 8
months later, the rats showed no impairment in both
a water maze task and a locomotor activity test.
Despite these few little problems, from the overall
picture in the literature, it seems that in our present
state of knowledge, most behavioral deficits found
after septal or fimbria-fornix lesions are also found in
rats injected with 192 IgG-saporin, at least in terms
of their qualitative features.
3.4.2. Noradrenergic Denervation Paradigms
Noradrenergic denervations of various brain
regions have usually been achieved with 6-hydroxy -
dopamine (6-OHDA), a toxin having a high affinity
for the uptake sites of catecholaminergic neurons and
which, therefore, does not discriminate between
dopaminergic and noradrenergic neurons without the
additional utilization of drug treatments which
selectively protect the dopaminergic neurons. For
instance, after pretreatment with a selective dopa-
mine uptake blocker such as GBR 12909or amfonelic
acid (see MacDonald and Sirvio, 1993), 6-OHDA
induces dramatic degeneration of the noradrenergic
neurons, whereas the dopaminergic neurons
are relatively preserved. Selective destruction of
noradrenergic neurons is also achieved with
N-(2 -chloroethyl)-N-ethyl-2 -bromobenzylamine, a
compound better known under the appellation of
DSP-4 and which, being taken up by the noradren-
ergic terminals, does not affect the dopaminergic
neurons. Usually, 6-OHDA is injected intracere-
broventriculady or into the cerebral parenchyma (e.g.
Langlais et al., 1993), although, in some experiments,
the compound was also given systemically, particu-
larly in neonate animals (e.g. Mohammed et al., 1986;
Sutherland et al., 1982). DSP-4 is administered
systemically (50 mg/kg is the usual dosage) and
induces the most dramatic noradrenergic denerva-
tions (more than 80°%depletion) in the frontal cortex,
hippocampus, cerebellum and spinal cord, with
moderate to negligible damage to other monoaminer-
gic systems (i.e. dopaminergic and serotonergic).
There is evidence that this neurotoxin induces
degeneration of the noradrenergic neurons in the
locus coeruleus (e.g. Zhang et al., 1995). In the
studies using DSP-4 as the depleting agent and where
the effects of this neurotoxin were assessed in both the
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cortex and the hippocampus, it is noteworthy that the
NA depletions in both structures were generally of
similar magnitude (e.g. Berridge and Dunn, 1990; but
see Bennett et al., 1990), and so seems also to be the
case with systemically administered 6-OHDA in
neonates (Mason and Iversen, 1975, 1977) or
6-OHDA infused into the dorsal noradrenergic
bundle (e.g. Langlais et al., 1993).
As regards the functional involvement of the
central noradrenergic neurons, essentially two types
of approaches have been developed, one concerned
with the functions of NA in postsurgical plasticity
phenomena in the CNS (e.g. Gordon et al., 1988), the
other one with the implication of this neurotransmit-
ter in cognitive and other aspects of behaviour. As
regards the former, it appears that NA depletions
abolish both the functional sparing observed after
neonatal frontal cortex damage (Sutherland et al.,
1982; Kolb and Sutherland, 1992) and the possibility
for physically and socially enriched housing con-
ditions to attenuate the learning and memory deficits
resulting from entorhinal cortex or other types of
lesions (e.g. Mohammed et al., 1986; Pappas et al.,
1987). Lesions to central noradrenergic fibres are also
able to substantially attenuate learning deficits
resulting from damage of the nucleus basalis assessed
in reinforced T-maze alternation task (Moran et al.,
1992) and in the 8-arm radial maze (Sara et al., 1992).
As regards the second approach, central NA
depletion was found to disrupt social behaviour
(Zagrodzka et al., 1994), to induce transient
hyperactivity (e.g. Berridge and Dunn, 1990)
followed by more or less lasting hypoactivity and
hypoexploration (e.g. Archer, 1982; Archer et al.,
1983; Bennett et al., 1990; Semenova et al., 1987; but
see Harro et al., 1995), to increase perseverance
during the extinction of a running for food-reward
behaviour (Mason and Iversen, 1975, 1977), to
slightly decrease attention (Carli et al., 1983), to
slow-down the acquisition of a temporal discrimi-
nation (e.g. Ho et al., 1995) as well as that of a
reinforced right-turning response in a modified
T-maze (Archer et al., 1983), to impair spontaneous
T-maze alternation (e.g. Pisa and Fibiger, 1983b),
active avoidance (probably through a peripheral
mechanism; e.g. Bennett et al., 1990) and water maze
performance assessed under stressful (i.e. cold water)
conditions (Selden et al., 1990). There are also several
studies in which central NA depletions had no
detectable effects on acquisition and retention of a
delayed and a non-delayed food reinforced T-maze
alternation task, on passive avoidance retention (e.g.
Haroutunian et al., 1990), on performing discrimi-
nation tasks involving selective attentional processes
(e.g. Pisa and Fibiger, 1983a, 1983b), and on 8-arm
radial maze learning (e.g. Chrobak et al., 1985).
Finally, another series of studies showed that central
noradrenergic lesions which had no proper effect in
various tasks were able to potentate the disruptive
effects on cognitive functions of muscarinic blockade
or cholinergic lesions (e.g. Decker and McGaugh,
1989, 1991; Ohno et al., 1993; Riekkinen et al., 1990,
1992; but see Langlais et al., 1993). Overall, it appears
that NA depletions have never been found to induce
as consistent and as dramatic cognitive alterations as
those found in rats with cholinergic lesions or
centrally acting muscarinic blockade. Thus, regarding
the aforementioned literature, one essential role of
the central noradrenergic system might be to exert a
neuromodulatory action on other systems of neuro-
transmitters more directly involved in cognitive
processes. Finally, another consistent finding in rats
is that after damage to the noradrenergic afferents of
the hippocampus decreases the threshold to epilepto-
genic manipulations such as, for instance, hippocam-
pal kindling (see description and references in
Section 5.4).
3.4.3. Serotonergic Denervation Paradigms
As for selective destruction of cholinergic or
catecholaminergic neurons in the brain, techniques
allowing to specifically damage the serotonergic
neurons in the fimbria-fornix and other neu-
roanatomically-detined serotonergic systems are now
in use for more than thirty years. These techniques
rely upon the intraparenchymal or intracerebroven-
tricular injection of two dihydroxytryptamines
termed 5,6-dihydroxytryptamine (5,6-DHT) and
5,7-dihydroxytryptamine (5,7-DHT), as well as on
the systemic administration of the amino acid
p-chlorophenylalanine (PCPA) or the amphetamine
derivative p-chloroamphetamine (PCA). More re-
cently, another amphetamine derivative, 3,5-methyl-
enedioxymethamphetamine (MDMA, “Ecstasy”) has
also been used in order to damage central
serotonergic neurons (e.g. Finnegan et al., 1988;
MacDonald and Sirvio, 1993; Ricaurte et al., 1988).
The administration of PCPA or PCA requires no
surgical operation, in contrast to that of 5,6-DHT or
5,7-DHT. PCPA and PCA have been used extensively
before 5,6-DHT and 5,7-DHT were introduced.
PCPA induces a long lasting inhibition of 5-HT
synthesis and PCA, although its mechanism of action
is still subject to debate (e.g. MacDonald and Sirvio,
1993), is taken up by serotonergic terminals where it
produces cytotoxic effects. It is however noteworthy
that with both compounds, the 5-HT depletion is
reversible within weeks or months, depending on the
dose used and the number of daily injections made.
Other drawbacks include the fact that PCPA causes
degeneration also of catecholaminergic neurons
(dopaminergic, noradrenergic, adrenergic) in various
regions of the brain and fails to affect all markers of
serotonergic function (e.g. 5-HT uptake sites are
preserved). As concerns the drawbacks of PCA,
substantial 5-HT depletion can be obtained only in
the mature brain and, somewhat paradoxically, its
initial effect consists in increased 5-HT release.
Furthermore, there exists a subpopulation of
serotonergic neurons resistant to PCA; these neurons
provide approximately 10Yo, 20Y0 and 150/. of the
cortical, striatal and hippocampal serotonergic
innervation, respectively (e.g. Schmidt and Kehne,
1990). 5,6-DHT and 5,7-DHT have been introduced
by Baumgarten et al. in the early seventies (e.g.
Baumgarten et al., 1971, 1973; Baumgarten and
Lachenmayer, 1972). These compounds are taken up
by the serotonergic terminals and cause a true
neuronal degeneration by acting on the neuronal cell
bodies (further detail in Tabatabaie et al., 1993).
Their effects are only poorly compensated for over
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Table 3. Summaryof the PossibleRelationshipsBetweenthe Extent of An ExperimentalHippocampal Denervation, the
Acute Neurochemicaland Behavioral Effectsof the Lesions,the Contingencyof Functional and Structural Postsurgical
Compensations(SeeTable 2), the Chancesfor Neurochemicaland Behavioral Recoveryto OccurOverTimeand the Type
of Palliative Treatments to be Most Relevant (Suitable) in Each Case.
Extent of hippocampal denervation
Type of variable considered Small Intermediate Large to maximal
Acute neurochemicaleffects none to weak moderate to large dramatic
Acute behavioral effects none to weak moderate to large dramatic
Receptor sensitivityand
neurotransmitter turnover possible yes yes
Homotypic and/or
heterotypic sprouting possible yes
Neurochemicalrecovery
yes (weak*)
complete from partial to complete none to weak
Behavioral recovery complete at most partial none
Possible palliative treatments to
influenceneurochemical
or behavioral recovery –drug treatments? -drug treatments~ -drug treatments~
–neurotrophic factors~ –neurotrophic factors~ –neurotrophic factors~
–intrahippocampal grafts~ –intrahippocampal grafts$
* For the cholinergicand serotonergicafferents, more pronounced for the central noradrenergic afferents, massive for
the noradrenergic afferents originating in the superior cervical ganglia.
t In order to accelerate recovery.
~In order to ameliorate or maximizerecovery,
$In order to induce recovery which does not occur spontaneously,
time and can therefore be considered as durable.
When given to neonates, the serotonergic depletion
lasts for the whole life (e.g. Breese and Cooper, 1975).
The utilization of 5,6-DHT and 5,7-DHT requires
some precautions as both toxins are also active on
dopaminergic and noradrenergic neurons. The
protection of both types of catecholaminergic
neurons or at least a substantial attenuation of their
destruction can be obtained by pretreatment with
uptake-blocking drugs such as desmethylimipramine
or nomifensine. For further detail, the reader is
referred to the book chapter by MacDonald and
Sirvio (1993) and the reviews by Reader (1989) or
Sinhababu and Borchardt (1985). All these com-
pounds have particular advantages which must be
balanced against their respective drawbacks accord-
ing to the question to be experimentally addressed.
However, one consensus is that they all produce
dramatic alterations of serotonergic function in the
brain and that, beside the frontal and other parts of
the cortex, one of the regions to be affected to the
highest degree is the hippocampus.
The serotonergic systems of the brain were found
to be involved in many aspects of behaviour including
anxiety, appetite, arousal, attention, circadian rhyth-
micity, cognition, sexual motivation . . . (e.g. Jacobs
and Azmitia, 1992; Whitaker-Azmitia and Peroutka,
1990). More in line with the topic of this review, the
role of serotonergic afferents of the hippocampus has
been more specifically studied in terms of their
cognitive implications. In the relevant literature, it
seems that there is no general agreement on whether
the ascending serotonergic system has a direct
involvement in cognitive function, and more particu-
larly in those underlying learning and memory. For
instance, on the one hand, Altman et al. (1990) found
that infusions of 5,7-DHT into the fimbria-fornix and
the cingulum of rats resulted in enhanced perform-
ance in a positively reinforced spatial discrimination
task as compared to the performance of virtually
intact rats. Also Richter-Levin and Segal (1991)
found an intracerebroventricular administration of
5,7-DHT to enhance performance in rats submitted
to a passive avoidance task. On the other hand,
Yehuda et al. (1995) have reported that in a Morris
water maze reference memory task, rats given
5,7-DHT into the fourth ventricle showed acquisition
performance which were almost as dramatically
impaired as those found in rats with AF64A-induced
cholinergic lesions. Dringenberg et al. (1995) found
rats given systemic administrations of PCPA (800/0
decrease of the whole brain 5-HT content) to exhibit
reduced activity scores with no sensory-motor
impairment.
However, in a large majority of studies using rats,
central serotonergic depletions performed with
5,7-DHT, PCA or PCPA were found to have no
direct effect on learning and memory abilities assessed
in various cognitive tasks (e.g. Asin et al., 1985;
Cuadra and Molina, 1990; Jakala et al., 1992, 1993;
Nilsson et al., 1988b, 1990a; Richter-Levin et al.,
1994; Richter-Levin and Segal, 1989; Santucci et al.,
1995; Vanderwolf et al., 1990; Volpe et al., 1992;
Williams et al., 1990; see also references considered
in the reviews by Cassel and Jeltsch, 1995; Sirvio
et al., 1994; Steckler and Sahgal, 1995). This,
however, should not lead to the conclusion that the
ascending serotonergic fibres have absolutely no
involvement in cognitive function. Actually, as
reviewed recently (Cassel and Jeltsch, 1995; Sirvio
et al., 1994; Steckler and Sahgal, 1995; see also Levin
et al., 1992), manipulations such as systemic blockade
of the central serotonergic neurotransmission, lesions
(5,7-DHT, PCA) or functional depletions (PCPA) of
central serotonergic fibres were almost always found
to potentate the cognitive alterations induced by
lesions of central cholinergic nuclei (nucleus basalis
magnocellularis, MS and DBB) or by centrally acting
blockade of the muscarinic neurotransmission (at-
ropine, scopolamine). Thus, as already stated for
noradrenergic functions, it seems that the serotoner-
gic system in the brain is involved in cognitive
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processes more indirectly as a neuromodulator of the
functional contributions of other systems such as the
cholinergic one.
3.5. Conclusions
More or less extensive classical (aspiration,
transection, electrolysis...) lesions of the fimbria-
fornix fibre track and the overlying cingular bundle
induce cholinergic, noradrenergic and serotonergic
denervation of the hippocampus. Roughly, the
severity of this denervation can be considered as
proportional to the extent of the damage. Sub-
sequently to the lesions, two types of reactive changes
may occur. One of these changes can be detected soon
after the injury. It may consist of: (i) a downregula-
tion of presynaptic inhibitory autoreceptors (e.g.
muscarinic receptors on cholinergic terminals) and,
under some circumstances, heteroreceptors (e.g.
5-HT,, receptors on cholinergic terminals); (ii) an
upregulation of presynaptic activator autoreceptors
(e.g. nicotinic receptor on spared cholinergic termi-
nals) or of postsynaptic receptors specific to each
neurotransmitter system (e.g. muscarinic Ml recep-
tors, noradrenergic ~-receptors or serotonergic 5-HT,
receptors); (iii) in the undamaged afferent fibres, an
overall increase in neurotransmitter synthesis and an
augmentation of the release potential. The other
postsurgical change involves neuroanatomical reor-
ganizations and needs a much longer time before its
effects become detectable. It mainly consists in
regenerative (severed axons) or collateral (intact
axons) sprouting of fibres which normally innervate
the hippocampal parenchyma, as well as in
heterotypical nonregenerative sprouting of fibres
which normally do not innervate the hippocampal
parenchyma (e.g. sympathetic sprouting). With
lesions more specific of a neurotransmitter system,
there may be similar modifications with, however, a
more or less pronounced specificity towards the
neurochemical identity of the altered system, a
specificity depending upon the type and severity of
the undesirable side effects of the neurotoxic
compound used.
All these modifications are not necessarily suffi-
cient to compensate for the behavioral deficits
induced by lesions of the fimbria-fornix and cingular
pathways. It seems that beneficial effects of these
changes can be observed only when a substantial part
of the hippocampal afferents has been spared by the
lesion procedure. Otherwise, the deficits appear to be
permanent or, if attenuated over time, never
completely compensated for. Looking at the litera-
ture, it is tempting to speculate that in the
firnbria-fornix lesion paradigm, the chances of such
compensatory neuroanatomical and functional
modifications to foster behavioral recovery are
inversely proportional to the extent of the lesion: the
larger the latter, the smaller the former. This
relationship is certainly not that simplistic in reality
and far from being linear. However, from a
theoretical point of view (summarized in Table 3),
one might distinguish at least three “windows”, each
of which being both delineated by a minimal and a
maximal lesion extent. In the first window, the lesion
extent is small, the neurochemical and behavioral
consequences are weak and the neuroanatomical and
functional compensatory phenomena might be
sufficient to normalize both the neurochemical and
behavioral functions. It is just a matter of time. In
the next window, the lesion extent is larger, the
neurochemical and behavioral consequences are
more pronounced, and the structural and functional
compensatory phenomena may only contribute to
attenuate the extent of the lesion-induced deficits.
Here, partial recovery is still expectable, normaliza-
tion no longer. In the last window, the lesion extent
is massive, the neurochemical and behavioral
consequences are dramatic, and the structural and
functional changes occurring after injury, which may
account only for a weak attenuation of the
neurochemical deficits, are insufficient to induce
significant behavioral recovery. This view is
extremely reductionistic, especially because it does
not include a large series of other processes that may
underly recovery of function (e.g. Finger ef al., 1988;
Finger and Stein, 1982; Marshall, 1984, 1985; Stein
et al., 1995) and also, because it excludes consider-
ation of neuroanatomical reorganizations such as
sympathetic sprouting which, under some conditions,
may account per se for detrimental behavioral
effects (see Section 3.3.2.2). However, this extrepely
caricatural view proposes three theoretically-defined
frames in which the relevance of recoursing to
therapeutical tools such as drugs, neurotrophic
factors or grafts may be addressed and discussed, In
the first window, drugs and neurotrophic factors are
probably appropriate measures to accelerate the
recovery processes, but intracerebral grafts, because
permanent once implanted (and for many other
reasons; see discussion in Cassel et al., 1992a), do not
appear to be pertinent palliative. In both other
windows, all these tools may be used (in the second
one to potentate neurochemical and behavioral
recovery, in the third one to induce it), each being one
possible focus of experimental approaches. This is
precisely what intracerebral grafting techniques have
most often been during the last 25 years and what will
be the concern of the next part of our review in
relation with fimbria-fornix lesions, their neuro-
chemical effects in the hippocampus and their
behavioral consequences.
4. NEUROCHEMICAL EFFECTS OF
INTRAHIPPOCAMPAL (OR
PERIHIPPOCAMPAL) GRAFTS
4.1. Introductory Remarks
The very first experimental studies in the “recent”
history (see Introduction) of intracerebral grafts of
neural tissue were aimed at characterizing the
possibilities for such grafts to survive and develop in
the mature mammalian brain. Therefore, these
studies had almost exclusively recourse to approaches
relying upon histological and morphological tech-
niques. Rather quickly, various technical factors,
physiological constraints or limits, and surgical
procedures allowing grafts of fetal neurons to survive
and become integrated into a host structure which
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they contributed to reinnervate were identified and
characterized (fora retrospective see, e.g. chapters 1
to lOin Bjorklund and Stenevi, 1985). Thereafter, a
progressivelyincreasingnumber ofresearchgroupsin
the world started to address the question ofwhether
well surviving grafts were also functional and, ifso,
which type of mechanism(s) could be considered to
account for their functionality. The two first lesion
paradigms to be used most extensively in such a
perspective consisted of animal model(s) of PD and
AD, namely 6-OHDA lesions .of the nigrostriatal
pathways and disruption of either the fimbria-fornix
or the basalocortical pathways, respectively (for a
retrospective see, e.g. chapters 34,39,40-52 in
Bjorklund and Stenevi, 1985). In that concern and
although various methodologies had become avail-
able (e.g. in OCU1O,intracavitary or intraventricular
transplantation of tissue blocks, intraparenchymal
cell suspension grafts or peripheral nerve implan-
tation to bridge two disconnected brain structures),
essentially intracavitary (tissue blocks placed into a
lesion cavity) and intraparenchymal (minced tissue or
cell suspensions placed into the brain structure to
be reinnervated) transplantation techniques were
used to investigate the neurochemical and be-
havioral effects of grafts implanted close to or
within the denervated hippocampus. Occasionally,
the grafts have been placed in one or the other
cerebral ventricle.
The question of the functionality of such grafts has
also been addressed using electrophysiological
methods, but this aspect, which by itself deserves a
large review, will not be taken into account herein
(information can be found in, e.g. Buzsaki et al.,
1988; Buzsaki and Gage, 1989; Segal, 1987; Segal
et al., 1988; Shapiro et al., 1989;Vinogradova, 1995).
In Section 3, we have seen that lesions of the
fimbria-fornix/cingular bundle pathways disrupted
most of the cholinergic and serotonergic hippocam-
pal innervation, whilst the hippocampal noradren-
ergic and GABAergic markers were less dramatically
affected. Thus, it is not a real surprise to establish
that, in the literature, the majority of studies
investigating the functional effects of intrahippocam-
pal grafts have used preparations from regions of the
fetal brain such as the basal forebrain (e.g. the MS
and the DBB, which both are rich in cholinergic
neurons and are the normal source of hippocampal
cholinergic afferents) or the mesencephalic raphe
(which is rich in serotonergic neurons and is the
normal source of hippocampal serotonergic affer-
ents). Only a few experiments used grafts rich in
noradrenergic neurons. More recently, there have
also been studies relying upon new approaches such
as the intracerebral implantation of genetically
modified cell lines in order to restore altered aspects
of hippacampal organization or functionality. It is
the purpose of the first part of this section to deal
with the neurochemical and neuropharmacological
effects of the various types of grafts placed into the
denervated hippocampus and, in the second part,
with the graft-induced recovery of behavioral
(essentially mnesic) functions and, in case of grafts
rich in noradrenergic neurons, with their effects on
epileptic thresholds assessed with hippocampal
kindling paradigms.
4.2. Grafts Rich in Cholinergic Neurons and Other
Grafts Exerting Cholinergic Effects
4.2.1. Blocks of Fetal Basal Forebrain Tissue
Placed into a Lesion Cavity
From a technical point of view, this procedure is
rather simple and can be applied in two almost
simultaneous steps (lesion and implantation, respect-
ively) or with a delay inserted between the first and
the second step. The first step consists in preparing
the lesion cavity, generally with a glass pipette
connected to a suction apparatus and through which
the cerebral tissue to be removed is aspirated. The
second step consists in dissecting and cutting off the
desired region of the fetal brain, laying this region
down on the bottom of the cavity and covering the
graft with gelfoam. Further technical details may be
found in Stenevi et al. (1985).
Using such a transplantation technique and, after
a postsurgical delay of several months, a technique of
AChE histochemistry, it has been demonstrated that
grafts of fetal basal forebrain are able to provide the
denervated hippocampus with a new organotypic
cholinergic innervation (i.e. innervate hippocampal
regions where cholinergic terminals make normally
synapses in intact rats; e.g. Dunnett et al., 1982;
Ezerman and Kromer, 1987; Kelche et al., 1988;
Kromer, 1982; Leanza et al., 1993b; Lewis and
Cotman, 1983; Low et al., 1982). From a neuro-
chemical point of view, using an in viuo microdialysis
technique coupled to HPLC detection of neurotrans-
mitters present in the dialysat, grafts of basal
forebrain tissue blocks were found to increase the
baseline release of acetylcholine in the fimbria-fornix
denervated rat hippocampus to at least normal levels
(Nilsson et al., 1990b). This release was stimulated
( + 21OYO)in a manner comparable to that found in
intact rats when potassium chloride (KC1, 100 mM)
was added to the perfusion fluid, and was reduced to
the baseline level found in lesion-only rats by the
addition of tetrodotoxin (TTX, 1 ,aM), a sodium
channel blocker. Neither of these responses was
observed in lesion-only rats. Interestingly, the release
of acetylcholine could also be augmented by gentlly
handling the rats ( + 60VO)or by electrical stimu-
lation of the habenula ( + 65Yo), but this augmenta-
tion was not as pronounced as that seen in intact rats
( + 100’Yoand + 200Y0, respectively). In all cases,
these results demonstrate that the grafts are under
control of host afferents, part of which originate in
the habenular complex. According to Leanza et al.
(1993b), some of these afferents are from catechol-
aminergic neurons as the systemic treatment with
apomorphine (a dopaminergic agonist; 2 mg/kg, s.c.)
or amphetamine (a cetacholamine uptake inhibitor
that also activates catecholamine synthesis and
release; 2.5 mg/kg, s.c.) was found to increase the
release of acetylcholine in the grafted rats ( + 58°/0
and + 112°/0, respectively), although not to a level
similar to that found in intact rats ( + 1900/oand
+ 300Y0, respectively).
4.2.2. Intraparenchymal Injections of Cell
Suspensions
The principal steps in this procedure consist in
dissecting out the region to be grafted as for the
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implantation of the tissue blocks, collecting the
dissected regions into a medium containing
trypsin(0.05-0.1°/i) or another enzyme such as
collagenase, incubating the whole at 37°C for a given
period of time (20-30 rein), washing the trypsin away.
Using a Pasteur pipette, the tissue pieces are
subsequently dissociated by repeated pipetting into a
homogeneous cell suspension. Under stereotaxic
control, this suspension (50,000-100,000 ceils/pl) is
then injected into the implantation region of the host
brain through a Hamilton syringe. Generally, the
amounts injected are calculated such as half the cells
obtained from one septal tissue piece are implanted
in each hippocampus. Further technical details may
be found in Bjorklund and Stenevi (1985).
This technique was the one to be used most
frequently in studies aimed at providing the
experimentally denervated hippocampus with a new
graft-derived cholinergic innervation. As was the case
with the tissue blocks placed into a lesion cavity, the
suspension grafts rich in cholinergic neurons were
found to provide the denervated hippocampus with a
new organotypic AChE-positive reinnervation (e.g.
Bjorklund et al., 1983b; Dunnett et al., 1982; Nilsson
et al., 1988a).
Regarding the neurochemical effects of such grafts,
several cholinergic (but also noncholinergic) markers
were found to be partially compensated for,
normalized or, in some experiments, even slightly
overcompensated in the vicinity of the implantation
sites. Using determination of ChAT activity as a
marker for cholinergic function, Bjorklund et al.
(1983a) reported the over 850/. fimbria-fornix
lesion-induced reduction of this marker to be
compensated for completely in the dorsal hippo-
campus, the region in which the grafts had been
injected, and only partially in the ventral hippo-
campus, a region in which no graft had been
implanted. Interestingly, Bjorkhrnd et al. (1983a,
1983b) also showed that: (i) this graft-induced effect
occurred progressively over time, with a dramatic
increment between 10 days and 1 month; (ii) the
earliest effects were detectable in the close vicinity of
the injection sites; (iii) even after long delays, the
highest levels of ChAT activity were inevitably found
in the regions where the suspensions had been
injected (a significant effect was also detected in the
most ventral portion of the hippocampus, but only
after 6 months). The latter observation (confirmed in
other studies; e.g. Cassel et al., 1993b; Jeltsch et al.,
1994b), demonstrates that, when grafts are implanted
in the dorsal half of the hippocampus, there always
exists a decreasing septo-temporal gradient of the
graft-induced effects on the cholinergic markers. That
this graft-induced increase in ChAT activity actually
reflected increased cholinergic function was
confirmed in the same study by the determination of
[14C]acetylcholine synthesis from [’4C]glucose (recov-
ery to 94°/0 of normal; lesion effect: 60°A decrease).
In another series of experiments which used either
aspiration of the dorsal septohippocampal pathways
(fimbria-fornix/cingular bundle) or electrolytic le-
sions of only the fimbria and the dorsal fornix (see
Fig. 4, top), we also found that, after &10 months,
cell suspension grafts rich in cholinergic neurons had
increased the ChAT activity to levels between 5f)0/o
and 110°/0 of normal after aspiration lesions and
70~0–12t)’%0after electrolytic ones (ventral and dorsal
hippocampus, respectively). In these studies, we also
assessed the effects of other cell suspension grafts or
non-cholinergic effects of grafts rich in cholinergic
neurons as will be discussed in Sections 4.3 and 4.4,
respectively. Evidence of graft-derived cholinergic
terminals in the hippocampus was obtained in studies
which used the determination of high affinity
[3H]choline uptake (HACU) by hippocampal synap-
tosomes, a specific marker of cholinergic terminals.
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Fig. 4. ChAT activity (top) and synaptosomalhigh affinity
uptake of [3H]choline(bottom)determinedbetween8 and 10
months after surgery in the dorsal (D), median (M) and
ventral (V) hippocampus of rats with only aspiration (left
panel) or electrolytic (right panel) lesions of the fimbria-
fornixpathwaysand of rats which,in addition to the lesions,
were subjected to intrahippocampal grafting of cell
suspensionsprepared from the region includingthe medial
septum and the diagonal band of Broca (septum; Section
4,2) or the mesencephalicraphe (raphe; Section4.3) of the
fetal brain, or of a mixture of both suspensions(co-grafts;
Section4.5).All valuesare expressedas a percentageof the
averageabsolutevaluesfound in virtuallyintact rats (lOOO/O;
dotted lines). The hatched bars in each panel delimit
approximately the hippocampal region in which the grafts
had been implanted and where histological verifications
generallyshowedthem to be located. Data are from Cassel
et al., 1993b (aspiration) and Jeltsch et al., 1994b
(electrolytic);for further details, see these two references.
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For instance, Kaseda et al. (1989) found in-
trahippocampal cell suspension grafts rich in
cholinergic neurons to increase the HACU to 90°/0
and 75°/0of normal in the dorsal and ventral portions
of the hippocampus, respectively, a marker which
was reduced by 70°/0and 600/0after aspiration lesions
of the dorsal septohippocampal pathways (see also
Tarricone et al., 1991). In our own experiments (see
Fig. 4, bottom), we also found that the synaptosomal
HACU was increased by septal grafts to a
supranormal level in the dorsal hippocampus after
aspiration lesions of the fimbria-fornixicingular
bundle (130%; Cassel et al., 1993b) and to a normal
level after electrolytic lesions of only the infracallosal
component of these pathways (1040/o;Jeltsch et al.,
1994b).
Using hippocampal slices from sham-operated,
lesion-only and septal-grafted rats, we recently found
(Cassel et al., 1995) that the electrolytic fimbria-
fornix lesion-induced decrease ( – 65VO)of electri-
cally-evoked [3H]overflow in the slices preincubated
with [3H]choline was restored to slightly more than
normal values in the lesioned rats which had received
the grafts.
Results qualitatively similar to the aforementioned
ones were also obtained using other lesion paradigms
including lesions of the MS (e.g. Pallage et al., 1986),
i.c.v. injections of AF64A (e.g. Emerich et al., 1992;
Ikegami et al., 1991), daily ethanol intoxication for
several months (e.g. Arendt et al., 1989), or using
aged rats exhibiting central cholinergic dysfunctions
(e.g. Gage and Bjorklund, 1986a; Gage et al., 1984b).
A few experiments based on a fimbria-fornix lesion
paradigm also investigated the effects of other sources
of cholinergic neurons in the fetal brain. For instance,
Heuschling et al. (1988) reported that cortical,
hippocampal, septal and striatal grafts survived best
when transplanted into their respective regions of
origin which had been lesioned four days before
transplantation surgery. With the exception of
striatal grafts which showed reasonable survival only
when grafted into their region of origin, good survival
was also achieved between regions that are anatomi-
cally related. Heuschling et al. (1988) also reported
in vitro experiments leading to similar conclusions. Li
et al. (1992) reported that intrahippocampal grafts of
fetal striatal cells in fimbria-fornix lesioned rats are
also able to increase synaptosomal HACU, although
the reported effect was weaker than after the
implantation of neurons from the septal region of the
fetal brain (see also Clarke et al., 1986, 1990; Gibbs
et al., 1986; Lewis and Cotman, 1983).
Regardless of the lesion paradigm or the origin of
the grafted cholinergic cells, it is quite obvious that
all these in vitro techniques do not allow to infer
unequivocally, that the grafts rich in cholinergic
neurons are actually working in vivo, nor do they
inform, should the case arise, about the mechanisms
which may underly an autoregulation orjand a
host-derived regulation of the functional output from
the grafted neurons (i.e. release of acetylcholine).
Such more functional aspects have been evidenced in
several recent reports. Similarly to what they found
with tissue block grafts implanted into the fimbria-
fornix lesion cavity, Nilsson et al. (1990b), using a
microdialysis technique, reported that after such
lesions, intrahippocampal fetal septal cell suspension
grafts were able to normalize or even overcompensate
the baseline release of acetylcholine. Whilst the
addition of KC1 (100 mM) to the perfusion fluid
resulted in a 1400/oincrease of the release, an effect
which was also partly mimicked by gentle handling of
the rats ( + 57Yo) or electrical stimulation of the
habenula ( + 68Yo),the addition of TTX reduced the
release to the level found in lesion-only rats (see also,
Kalen et al., 1991a, 1991b). Among other results,
Nilsson and Bjorklund (1992) have also shown that
the release of acetylcholine by grafted cholinergic
neurons was increased during the second session of a
swimming task ( + 500/ocompared to a + 900/oin the
intact control rats). These data do not only
demonstrate that septal grafts do actually work
in viuo (they release acetylcholine under rest
conditions and respond to depolarisation), but also
indicate that the grafted cholinergic neurons are
regulated by host afferents. In another report by the
same group (Leanza et al., 1993b), it has been
demonstrated that part of these afferences might be
catecholaminergic. Again with a microdialysis ap-
proach, the authors showed that in fimbria-fornix
lesioned rats which sustained suspension grafts rich in
cholinergic neurons, a systemic treatment with
apomorphine (2 mg/kg, s.c.) or amphetamine
(2.5 mg/kg, s.c.) increased the release of acetylcholine
by 91V0and 112Y0,respectively ( + 190 and + 300Y0
in intact rats). The amphetamine-induced response
could be abolished by pretreatment with cc-methyl-
para-tyrosine, a catecholamine synthesis blocker. All
these findings clearly indicate that the functional
expression of grafts rich in cholinergic neurons are
under a modulatory influence of the host brain.
Another mechanism by which graft-induced
neurotransmitter release may be modulated involves
auto- and heteroreceptors receptors located at the
terminals of the axons grown from grafted neurons.
We recently found that cholinergic neurons from the
basal forebrain grafted into the denervated hippo-
campus possessed muscarinic inhibitory autorecep-
tors, as well as 5-HT,~ heteroreceptors. Both types of
receptors were found to exhibit almost normal
functional properties (Cassel et al., 1995). In
hippocampal slices preincubated with [3H]choline and
exposed to electrical filed stimulation, the application
of atropine, a muscarinic antagonist, increased the
electrically-evoked release of [3H] by 209°/0 in
sham-operated rats, 80°A in the lesion-only ones and
117V0in the grafted ones (compared to the release
found in absence of drug applications). Conversely,
the application of oxotremorine, a muscarinic
agonist, induced a dose-dependent decrease of the
evoked [3H]release, as did that of CP 93129, a specific
5-HT,, agonist. Interestingly, in both the lesion-only
and grafted rats, the sensitivity of the muscarinic and
5-HT,B receptors to atropine and CP 93129,
respectively, was lower than in the sham-operated
control rats, suggesting that these two receptor types
had undergone a downregulation andlor had failed to
develop normally on the terminals of the grafted
neurons. This experiment also allowed us to exclude
a presynaptic modulatory influence on acetylcholine
release of nicotinic, 5-HT,,4, 5-HT, and 5-HT,
receptors, in intact, lesion-only and grafted rats, a
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finding which does not, however, preclude the
possibility for such receptor subtypes to mediate a
polysynaptic modulatory influence on the activity of
grafted cholinergic neurons in vivo, perhaps in a
manner similar to that reported in intact rats or
guinea pigs (e.g. Consolo ef al., 1994; Izumi et al.,
1994; Wilkinson et al., 1994). Although the latter
possibility needs further investigation, we recently
obtained preliminary data (Erb, Klein, Koppen,
Loffelholz, Jeltsch and Cassel, submitted) with an
intrahippocampal microdialysis approach suggesting
that the graft-derived release of acetylcholine can be
stimulated by systemic injection of 8-OH-DPAT, a
selective 5-HT1~ receptor agonist. Another type of
control has been suggested in the study by Kaseda
et al. (1989) who reported that the almost normalized
HACU by hippocampal synaptosomes was further
increased by systemic treatment (just before sacrifice
of the rats) with scopolamine (muscarinic antagonist)
or picrotoxine (a GABAergic antagonist), the
drug-induced increase being comparable to that
found in intact rats with either drug ( + 45% and
+ 36Y0, respectively). Thus, the grafted cholinergic
neurons are also able to respond to the modulatory
action of a GABAergic input which might involve
GABAergic neurons located outside andlor inside the
grafts, as previous reports described septal grafts to
also contain a subtype of GABAergic neurons
positively immunostained for parvalbumin(e.g.
Buzsaki et al., 1992; Cassel et al., 1991b). The latter
observation is consistent with the close proximity of
GABAergic and cholinergic neurons in the septal
region of the rat brain (e.g. Kiss et al., 1990).
Using hippocampal slice preparations, we failed to
observe any lesion- or graft-induced effect on the
carbachol evoked-formation of inositol monophos-
phate (Cassel et al., 1991a), a product involved in the
second messenger system related to muscarinic Ml,
M, and M, activation. However, in other studies it
was found that intrahippocampal grafts affected the
lesion-induced modifications of the hippocampal
muscarinic receptor density or sensitivity (see above,
Section 3.2.3.1). Actually, Dawson et al. (1989); (see
also Dawson et al., 1988) reported that the
fimbria-fornix lesion-induced increase of hippocam-
pal Ml (in region CA2) and M, (in regions CA2, CA3
and CA4) binding sites was counterbalanced by
intrahippocampal grafts rich in cholinergic neurons
at eight months after surgery, an effect which was also
found by others with a technique assessing the
[3H]QNB binding in the hippocampus after fimbria-
fornix or medial septal lesions (Segal et al., 1989;
Tarricone et al., 1993). Using a shorter postsurgical
delay, also Joyce et al. (1989) found that grafts rich
in cholinergic neurons were able to normalize the
fimbria-fornix lesion-induced increase of the number
of hippocampal Ml and M2 receptors (in regions
CA1, CA3 and in the dentate gyrus). Interstingly,
such results were obtained with grafts of septal tissue
as well as of striatal fetal tissue (the striatum also
contains cholinergic neurons but these do not project
to the hippocampus in intact rats). With striatal
tissue, however, the reversal of the lesion effect on
muscarinic receptors was observed only when the
graft had provided the hippocampus with a
substantial cholinergic reinnervation. Histological
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Fig. 5. Noradrenaline concentration determined between8
and 10months after surgery in the dorsal (D), median (M)
and ventral (V) hippocampus of rats with only aspiration
(left panel) or electrolytic (right panel) lesions of the
fimbria-fornixpathways and of rats which, in addition to
the lesions,were subjectedto intrahippocampal grafting of
cell suspensions prepared from the region including the
medial septum and the diagonal band of Broca (septum;
Section4.2)or the mesencephalicraphe (raphe; Section4.3)
of the fetal brain, or of a mixture of both suspensions
(co-grafts; Section 4.5). All values are expressed as a
percentageof the averageabsolute values found in virtually
intact rats (lOOO/O;dotted lines). The hatched bars in each
panel delimit approximately the hippocampal region in
whichthe grafts had been implantedand wherehistological
verificationsgenerallyshowedthem to be located. Data are
from Cassel er al,, 1993b(aspiration) and Jeltsch et al.,
1994b (electrolytic); for furtber details, see these two
references.
evidence for a cholinergic reinnervation of the
hippocampus by grafts of striatal cells (or cells from
other cholinergic neurons) have been reported earlier
(e.g. Gibbs et al., 1986; Lewis and Cotman, 1983; but
see Clarke et al., 1990 and Ikegami et al., 1991).
4.2.3. Cholirrergic Grafts and Sympathetic
Sprouting: A Particular Case
This paragraph deals with a neurochemical effect
of grafts rich in cholinergic neurons which is
particular because it does not concern markers of
cholinergic function in the hippocampus, although it
obviously involves the cholinergic neurones present
in the grafted cells. In an article published in 1992, we
ICassel et al., 1992b; see also Cassel et al., 1993b)
have demonstrated that grafts rich in cholinergic
neurons (but not grafts rich in serotonergic ones)
were able to prevent an aspiration fimbria-fornix
lesion-induced increase of hippocampal NA concen-
tration, a postsurgical modification related to the
ingrowth of sympathetic fibres (see Section 3.2.2.2).
Noteworthy, the values of the concentration of
hippocampal NA were inversely correlated with the
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HACU data. This finding was confirmed in two other
experiments showing: (i) that the inhibitory effects of
the grafts were maximal in the regions where the
cholinergic restoration was the highest, a finding
again corroborated by a negative correlation between
the NA concentrations and the HACU as well as the
ChAT activity values (Cassel et al., 1992, 1993); (ii)
that a qualitatively similar effect of the grafts could
be observed after electrolytic lesions of only the
infracallosal component of the septohippocampal
pathways (Jeltsch et al., 1994b). Part of our
contributions is summarized in Fig. 5. With this
article on that matter (Cassel et al., 1992b), we
believed we were first to report such a finding. Since
that time, however, we found an article on a similar
topic that was published 10 years earlier by Kromer
(1982). Kromer reported that, in the denervated
dentate gyrus, there was histological evidence of the
co-existence of cholinergic axons originating in septal
implants (intracavitary) and sympathetic fibres from
the superior cervical ganglia. He finished the
discussion of his results with the following sentence:
“If there is indeed competition for a common
postsynaptic factor that is released after septal
deaflerentation, then it appears that the ingrowing
septal~bresfrom the implant have a greater afinityfor
this signal since they are able both to invade the
neuropil which already contains sympathetic jibres and,
lf the density offibres is great enough, to cause some
reduction in the number of anomalous sympathetic
jibres.” A few years earlier, Bjorklund and Stenevi
(1977) had investigated whether grafts of superior
cervical ganglia were able to provide the hippo-
campus with a new noradrenergic innervation and, in
their discussion of the results, they speculated that “it
would seem possibie that afler-ents coming through the
jimbria -above all, probably, the cholinergic septal
ones, - act to inhibit the ingrowth of the noradrenergic
ganglionic fibres.” (Redde Caesari quae sunt Cae-
saris ...)
4.2.4. Alternative Approaches
A small, although currently growing, number of
studies have investigated the neurochemical effects of
grafts prepared from sources other than the basal
forebrain region of the rat. Essentially, these
experiments first relied upon the utilization of grafts
from other brain regions rich in cholinergic neurons
(e.g. the striatum, the brain stem and even the spinal
cord) or from the same region dissected out from the
fetal brain of other species (e.g. mouse to rat or even
human to rat; e.g. Daniloff et al., 1984, 1985; Nilsson
et al., 1988a; Wells et al., 1991). Although Daniloff
et al. (1984) have reported mouse-to-rat basal
forebrain cells to result in increased ChAT activity in
the denervated hippocampus, most studies have used
only a histological approach to assess the graft-in-
duced effects. Altogether, it was found that the best
reinnervation (with respect to both the innervation
pattern and the fibre morphology) is generally
obtained with cholinergic neurons from the basal
forebrain region (e.g. Clarke et al., 1990; Nilsson
et al., 1988a), whereas preparations from the
striatum, the brain stem or the spinal cord are able
to survive and develop correctly, but exhibit a weak
to extremely poor potential to reinnervate the host
structure. Also the grafts prepared from the basal
forebrain of the mouse or the human brain were
found to provide the denervated rat hippocampus
with a new organotypic cholinergic innervation
pattern (e.g. Daniloff et al., 1985; Nilsson et al.,
1988a), but one of the major problems in this case,
as stated elsewhere, resides in the immunological
compatibility between the host and the donor tissues
(see e.g. Section IV in Cassel et al., 1992a; Widner
and Brundin, 1988 for details).
A second alternative has consisted in the
intracavitary implantation of regeneration bridges,
the principle of such bridges being to provide a
neurotrophic and a physical support for the regrowth
of axonal processes from severed cholinergic neurons
of the MS and the DBB. When this goal has to be
achieved, both peripheral nerve bridges or non
cholinergic tissue blocks from the fetal brain have
been frequently utilized as the axonal regrowth
substrate (e.g. Varon et al., 1991). Technical details
about the procedure may be found, for instance, in
David and Aguayo (1985), and the reader should be
aware about the fact that most studies performed
with such techniques were carried out not in the
septohippocampal system, but in the visual system or
in the spinal cord. In more direct relation with the
scope of this review, Kromer et al. (1981a, 1981b)
have reported that fetal hippocampal tissue strips
implanted into a unilateral fimbria-fornix lesion
cavity were able to allow regrowing axons from septal
neurons to reach the hippocampus and to invade its
most dorsal part within a few months after the
implantation. Interstingly, in additon to the demon-
stration that these regrowing axons were at the origin
of an increased AChE-positive staining in the
denervated hippocampus, the authors have measured
the levels of hippocampal ChAT activity. In the most
septal region of the hippocampus of lesion-only rats,
this activity was lastingly reduced to less than 1OO/.of
the activity found on the unlesioned side (for up to
24 postsurgical months), whereas, in the grafted rats,
it had increased to 300/oof control within 12 months.
In another study using the same model, electro-
physiological evidence was presented demonstrating
that the regrown axons formed atropine-sensitive
excitatory synapses in the denervated hippocampus
(Segal et al., 1981). Such grafts were also found to
result in increased NGF levels in the septal region,
but not in the hippocampus, (Messersmith et al.,
1991) and some of their effects (AChE-positive
reinnervation of the hippocampus) could be mim-
icked qualitatively with intracavitary implantations
of a purified Schwann cell preparation (e.g.
Montero-Menei et al., 1992; Neuberger et al., 1992).
In another study using rats with fimbria-fornix
lesions, Tuszynski et al. (1990a, 1990b); Tuszynski
and Gage, 1995) have combined the hippocampal
tissue bridging technique to intracerebroventricular
infusions of NGF over a 9-week period and found the
tissue bridges to allow: (i) a significicant saving of
ChAT-positive neurons in the MS, as the number of
septal neurons expressing ChAT reached 580/. of the
number found on the unoperated control side in the
grafted rats given NGF, 40V0 in the grafted rats
which did not receive NGF, 44°/0 in the nongrated
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NGF-treated rats, and only 32% in the lesion-only
rats; (ii) a partial AChE-positive reinnervation of the
hippocampus which was not significantly augmented
by the NGF treatment, although the average fibre
density was 76V0of normal in the NGF-treated rats
with grafts, against 45°/0 in the group of grafted rats
which did not receive NGF. In another study
(Springer et al., 1988), mouse submaxillary glands
which synthesize high levels of NGF were grafted
intraventricularly to rats which had sustained a
unilateral knife cut transection of the dorsal
septohippocampal pathways. Two to four weeks
later, Springer et al. (1988) found lesion-only rats to
have lost 70–80’Yocell bodies positively stained for
AChE or for the p75 NGF receptor in the medial
septal region ipsilateral to the lesioned hemisphere; in
the grafted rats, there was only a 25–3&70cell loss.
The last but not least alternative approach was
developed more recently and consists of grafting cells
previously subjected to gene-transfer techniques
(astrocytes, schawnn cells, pheochromocytoma cells,
hepatocytes...; e.g. Doering, 1994; Fisher and Gage,
1993, 1994; Gage, 1990; Gage et al., 1987; Neuwelt
et al., 1995). In a first step, such techniques suppose
the cells to be infected by a retroviral vector
containing the cDNA sequence coding for a given
protein such as, for instance, nerve growth factor
(NGF) or tyrosine hydroxylase, whereby these cells
acquire the capacity to synthesize and release this
protein both in uitro and from their implantation site
into the host parenchyma. After transection, the cells
are grafted (as a suspension or after encapsulation in
a polymer-matrix) into the hippocampus or the
ventricles where they will synthesize and release the
protein coded by the transgene. Although the largest
number of studies have assessed the ability of
intrastriatal implants of cells expressing tyrosine
hydroxylase, the enzyme involved in dopamine
synthesis, to attenuate the neurochemical and
behavioral deficits induced by 6-OHDA lesions of
the nigrostriatal pathways (e.g. Fisher and Gage,
1993; Horellou et al., 1990a, 1990b; Kordower et al.,
1995), there have been a few experiments addressing
the question of the efficiency of such an approach on
some of the fimbria-fornix lesion-induced deficits,
with the rationale being to supply the denervated or
lesioned structure with neurotrophic factors that may
promote maintenance, repair and regeneration of
neurons (e.g. Blottner and Baumgarten, 1994; Varon
et al., 1995). It is well established that subsequently
to fimbria-fornix lesions, numerous cholinergic
neurons in the MS show a decreased expression of
ChAT activity, and that this reduction may be
prevented by intraventricular infusions of NGF (e.g.
Hefti et al., 1989; Will and Hefti, 1985; Williams
et al., 1986) or by the intraventricular implantation
of a polymer matrix preloaded with NGF (e.g.
Hoffman et al., 1990). Rosenberg et al. (1988)
reported that two weeks after the implantation of
fibroblasts genetically modified to synthesize NGF,
the unilateral fimbria-fornix lesion-induced decrease
of the number of ChAT-positive neurons in the
ipsilateral MS was attenuated dramatically: 92°/0 of
the neurons expressing the acetylcholine synthesizing
enzyme had survived and the growth of AChE-posi-
tive terminals in the dorsal septum had been
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stimulated substantially. Similar results have been
reported by Hoffman et al. (1993) who encapsulated
the genetically modified fibroblasts into a polymeric
matrix before implanting the latter into a cerebral
ventricle: Two weeks after the implantation, the
grafted rats showed slightly more than 80Y0 of the
septal cholinergic neurons to express ChAT com-
pared to the proportion of only 25!/. in the
lesion-only rats. Similar results could be obtained
with other cell lines such as, for instance, cells derived
from a mouse neuroblastoma (HT4; Whittemore
et al., 1991), or with a paradigm of 192 IgG-saporin-
induced cholinergic lesions (Rossner et al., 1996).
Using a paradigm of lesions of the septohippocam-
pal, Lucidi-Philippi et al. (1995) found that
fibroblasts genetically modified to express brain-de-
rived neurotrophic factor (BDNF), another neuro-
trophic protein allowing to rescue septal cholinergic
neurons when infused into the cerebral ventricles (e.g.
Knusel et al., 1992; Morse et al., 1993), did not exert
such a preventive effect, in contrast to the fibroblasts
synthesizing NGF. Finally, Schinstine et al. (1995)
grafted encapsulated Schwann cells genetically
modified to synthesize human NGF and found such
an approach to produce the saving of 800/0
ChAT-positive cells in the rat septum. Evidence
that primary astrocytes modified to produce NGF
may also stimulate the cholinergic reinnervation
of the hippocampus has been reported recently (Eagle
et al., 1995). Unfortunately, none of these studies
has assessed the neurochemical effects of such
treatments in either the MS or the denervated
hippocampus.
4.2.5. Summary and Conclusions
There is no doubt nowadays that grafts rich in
cholinergic neurons, whether placed into a lesion
cavity within the dorsal septohippocampal pathways
or directly into the hippocampal parenchyma, are
able to provide the denervated hippocampus with a
cholinergic reinnervation. This reinnervation, which
is more pronounced after basal forebrain tissue grafts
than after grafts of cells from other cholinergic nuclei
or of tissue blocks bridging the septal and
hippocampal regions, increases and, sometimes, even
normalizes several markers of cholinergic function in
the hippocampus (ChAT and AChE activity,
synaptosomal uptake of choline.. .). This reinner-
vation contributes also to attenuate, sometimes to
completely reverse, part of the reactional modifi-
cations induced by the lesions (sympathetic sprout-
ing, muscarinic receptor up- or downregulations.. .).
All these graft-induced modifications, however, do
not necessarily involve a single mechanism which, for
the immature neurons, would consist in providing the
hippocampal targets deprived of their cholinergic
afferents with a new operational axonai input
establishing synoptical contacts with cells in the host
structure. As reviewed by Dunnett and Bjorklund
(1987); see also Cassel et al., 1992a), various
mechanisms other than re-establishment of synaptic
contacts may also account for graft-induced effects,
including non-specific side effects of the transplan-
tation surgery, diffuse paracrine “minipump-like”
release of hormones. neurotransmitters or other
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molecules, acute or chronic release of growth-pro-
moting or neurotrophic factors which may stimulate
the growth of intact or damaged cells in the host
brain . . . In most studies reported so far, eventhough
it is probable that alI these mechanisms may have
played a more or less important role in the
restoration of cholinergic markers in the denervated
hippocampus, we might assume that the outgrowth of
cholinergic axonal processes from the grafts and not
those from the host brain, whether these grafts have
established new synaptic contacts or not, have
accounted for a large part of the histological and
neurochemical effects reported in the literature. This
assumption is partly in line with the tindings that
grafts bridging the septal region and the hippo-
campus, whereby cholinergic neurons from the host
may reinnervate the hippocampus, only produce
modest effects on cholinergic markers in the
hippocampus.
4.3. Grafts Rich in Noradrenergic Neurons
Most studies which assessed the effects of grafts
rich in catecholaminergic neurons have been carried
out using animal models of PD (e.g. 6-OHDA lesions
of the nigrostriatal pathways) and either intrastriatal
grafts of dissociated tissue from the adrenal medulla
(autografts) or the substantial nigra (heterografts), or
grafts of cell lines genetically modified to express
tyrosine hydroxylase and secrete catecholamines
(dopamine). As regards the denervated hippocampus,
there have been several experiments that, in the
course of the seventies, investigated the possibility for
intrahippocampally grafted noradrenergic cells (from
the locus coeruleus or the superior cervical ganglia)
to survive and reinnervate the structure in which they
were implanted. For instance, in one of their
pioneering experiments, Bjorklund and Stenevi
(1977) have shown that superior cervical ganglia
grafted into a lesion cavity made at the level of the
septohippocampal junction were able to survive and,
along the timbria, to develop axonal processes which
enter the hippocampus where they form a new
organotypic adrenergic reinnervation pattern. Similar
observations were made with grafts of fetal locus
coeruleus tissue (for details see, e.g. Bjorklund and
Stenevi, 1977, 1979). As for grafts of cholinergic
neurons, it seems that the survival and the integration
of noradrenergic grafted neurons is favorized by an
adrenergic neurotrophic factor released after nor-
adrenergic denervation of the hippocampus (e.g.
Bjorklund and Stenevi, 1981). Curiously, the
neurochemical effects of such grafts have not been
investigated as extensively as were grafts rich in either
cholinergic (see previous section) or serotonergic (see
Section 4.3) fetal neurons, at least when the
preparations rich in noradrenergic neurons were
grafted into the hippocampus. A last preliminary
note concerns the preparation of the grafts: The
achievement of a satisfactory survival of noradren-
ergic neurons grafted into the brain as a cell
suspension supposes that the fragments of fetal
tissues are not exposed to trypsin prior to their
dissociation (e.g. Bjorklund et al., 1986); collagenase
or other proteolytic enzymes may be used instead.
4.3.1. Grafts Rich in Noradrenergic Neurons Placed
into a Lesion Cavity
Kokaia et al. (1994b) have reported a study in
which the neurochemical effects of grafts rich in
noradrenergic neurons were examined in rats
subjected to a 6-OHDA lesion of the central
catecholaminergic fibres followed by an aspiration
lesion cavity at the septohippocampal junction and a
bilateral sympathectomy (to prevent sympathetic
ingrowth elicited by lesion procedure). Using a
microdialysis approach, Kokaia et al. (1994b) found
grafts of locus coeruleus and superior cervical
ganglion tissue blocks placed into the lesion cavity to
partially reverse the almost complete lesion-induced
abolition of spontaneous NA release in the
denervated hippocampus: The baseline level reached
36°4 of normal in the rats with locus coeruleus grafts
and only 15°/0in those with superior cervical ganglion
grafts, both values being however significantly higher
than in the lesion-only rats. Effects much higher than
those reported by Kokaia et al. (1994b) have been
described by Cenci et al. (1993) who used a lesion
paradigm and a grafting technique identical to those
used in the study of Kokaia et al. (1994b). Cenci et al.
(1993) found 6-OHDA lesions to reduce the NA
overflow to 30/o of control values. Whereas the
superior cervical ganglion grafts increased this
baseline overflow to 15% of normal, the grafts of
locus coeruleus tissue even overcompensated the
lesion-induced deficit (180% of control value). As
was the case in the intact rats, this release was
enhanced in both groups of grafted rats when KC]
(100 mM; eight- to ninefold increase) or desipramine
(5 PM; fourfold increase) were added to the perfusion
fluid. Conversely, the release of NA was dramatically
reduced by addition of TTX (1 pM). Handling of the
rat or forced immobilization resulted in increased
release of NA, but only in the group of intact rats;
in both groups of grafted rats there were only
marginal effects, with, however, some of the rats
being unambiguously responding to this physiologi-
cally relevant stimulations.
4.3.2. Intraparenchyma[ Cell Suspension Grafts
An early demonstration that locus coeruleus cell
suspension grafts could contribute to compensate for
some biochemical defects was in a paradigm of
intracortical fetal cell implantations in rats subjected
to diffuse catecholaminergic lesions induced by
systemic postnatal administration of 6-OHDA
(Semenova et al., 1987). The authors found the
cortical concentration of NA to be reduced by more
than 85°A in lesion-only rats and to be augmented to
60?’o of normal in the lesioned rats with grafts.
Similar neurochemical effects have been reported
with grafts of locus coeruleus or superior cervical
ganglia cells into the 6-OHDA denervated hippo-
campus, but most approaches relied upon an in uivo
microdialysis technique. In rats subjected to an i.c.v.
injection of 6-OHDA and, subsequently, to the
intrahippocampal implantation of fetal cell suspen-
sion rich in noradrenergic neurons, Bjorklund et al.
(1986) have measured the total hippocampal nor-
adrenaline content and estimated its turnover in the
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grafted noradrenergic neurons (determination of the
DOPA/NA ratio under pharmacologically-induced
inhibition of dopamine decarboxylase activity). The
authors found the hippocampal NA concentration to
be reduced by 98!4. in the lesion-only rats, whereas it
reached 550/. of control in the grafted rats. Also, the
turnover of the noradrenergic neurons was increased
10-fold in lesion-only rats and reduced to a
near-normal value in the grafted ones. Using a
paradigm of fimbria-fornix transection combined or
not with bilateral intrahippocampal implantations of
superior cervical ganglion tissue, Wang et al. (1994)
found the hippocampal NA content to be reduced by
approximately 50°/0in lesion-only rats and to be very
close to normal (95°/0) in grafted ones. Using an
in vivo microdialysis technique, Bengzon et al. (1991,
1993) have found suspension grafts of locus coeruleus
tissue placed into the 6-OHDA cetacholamine
depleted hippocampus to normalize the baseline
release of NA, as well as the release observed
subsequently to electrical stimulation of the hippo-
campus, a stimulation which remained ineffective in
lesion-only rats (Bengzon et al., 1991). Regarding the
functional characteristics of intact hippocampal
noradrenergic afferents, Kalim et al. (1988) have
shown the baseline release of NA to be increased by
about 700°/0 after perfusion (through the dialysis
probe) of the NA re-uptake inhibitor desipramine
(5 MM), and by more than 2600% when 100 mM KC1
were added to the perfusion fluid. Conversely, this
release was decreased in presence of TTX (1 KM). In
another study, these authors (Kalen et al., 1989) also
demonstrated that the release of NA was higher
during the night (light otT,Ithan during the day (lights
on) periods, and that it was transiently augmented by
gentle handling of the rat or by pinching its tail. A
few days after 6-OHDA lesions of the central
catecholaminergic system, the baseline release of
hippocampal NA was reduced by more than 99Y0
compared to intact rats (Kalen et al., 1988) and none
of the aforementioned stimulating treatments were
able to affect this release. When assessed between 3
to 12 months after intrahippocampal grafts of cell
suspensions prepared from the locus coeruleus, the
baseline release of NA had been restored to a level
which did not differ from that found in intact control
rats (Kal&n et al., 1990; 1991a; 1991b). Also, these
grafted neurons responded to the infusion of
desipramine (5 PM), a high concentration of KC1
(100 mM) or that of TTX (1 KM) in a near normal
manner. Furthermore, the increase of NA release
elicited by electrical stimulation of the habenular
complex under halothane anesthesia could be
mimicked in the grafted rats, but was not observed in
the lesion-only ones. These results have been
replicated in a later study (Kalen et al., 1991a, 1991b)
in which the authors also showed that the release of
NA could also be stimulated by handling (in 3 out of
6 grafted rats) and forced immobilization, and that
the release elicited by the electrical stimulation of the
habenula was dramatically reduced, but not abol-
ished, by a transection of the fasciculus retroflexus. In
intact rats, all these manipulations were also found to
affect the release of NA in a qualitatively similar
manner, but the effects of forced immobilization were
more pronounced than in the grafted rats and, unlike
the latter, the intact rats also showed an increased
release of NA when placed in a situation in which
they had to swim.
4.3.3. Summary and Conclusions
As was the case with grafts containing cholinergic
fetal neurons, noradrenergic cells grafted into the
denervated hippocampus may survive and contribute
to provide the hippocampus with a new noradren-
ergic innervation. These grafted cells may, under
some conditions (see preceding section), be regulated
by host afferents, although the overall picture is not
as clear as it was seen for cholinergic or serotonergic
neurons (see next section). As regards the graft-in-
duced reinnervation and its neurochemical effects, the
most satisfactory results seem to be achieved with
grafts of locus coeruleus cells, thus from the nucleus
that normally provides the hippocampus with its
noradrenergic input. Alternative sources of neurons
or cells to be grafted are the superior cervical
ganglion, or even the adrenal medulla, but the
neurochemical effects of grafts prepared from these
structures are much weaker than those described with
grafts of locus coeruleus cells. Finally intrahippocam-
pal grafts of cell suspensions apparently induce more
pronounced effects as compared to those observed
following intracavitary grafts of tissue blocks.
4.4. Grafts Rich in Serotonergic Neurons
Intracerebral grafting of neurons dissected from
central serotonergic nuclei of the fetal brain (mainly
from the dorsal raphe nucleus) was most frequently
performed with a technique of intraparenchymal
injections of a cell suspension. From a neurochemical
point of view, most studies published so far have
concentrated on the possibility to restore serotonergic
functions in the hippocampus denervated by neuro-
transmitter-specific lesion techniques (i.e. 5,7-DHT)
or by techniques disrupting the supracallosal and/or
the infracallosal component(s) of the so-called
septohippocampal dorsal pathways (e.g. aspiration,
knife cut, electrolysis). There are also a few
experiments which performed the grafts into the
intact hippocampus of the rat (e.g. Zhou et al., 1987,
1988) and even the cat (Trulson et al., 1986).
Information concerning the electrophysiological
effects of such grafts can be found, for instance, in
Richter-Levin and Segal (1991) and Segal (1987).
4.4.1. Studies on Excised Tissue Preparations
(Homogenates, Synaptosomes)
As was the case with the cholinergic grafts, it has
been repeatedly demonstrated that fetal serotonergic
neurons also had the capacity to survive when grafted
into an adult brain, to develop and to provide a
denervated host structure such as the hippocampus
with a new serotonergic innervation (e.g. Anderson
et al., 1986; Azmitia et al., 1981; Bjorklund et al.,
1976; Daszuta et al., 1991a; Steinbusch et al., 1987;
compare also Oleskevich et al., 1991 with Daszuta
et al., 1991a). As for fetal cholinergic neurons, the
survival and development of serotonergic neurons
grafted into the denervated hippocampus is probably
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stimulated by a molecule having neurotrophic
properties and whose hippocampal concentration is
increased subsequently to denervating lesions (e.g.
Azmitia, 1987; Zhou and Azmitia, 1990).
The graft-induced serotonergic reinnervation is
accompanied by substantial neurochemical effects.
Auerbach et al. (1985) found that in 5-HT depleted
rats (5,7-DHT injected into the dorsal and median
rapke nuclei), the intrahippocampal implantation of
minced tissue from the fetal raphe area had increased
the hippocampal concentration of 5-HT and 5-HIAA
(lesion-induced decrease: About – 50%) to slightly
supranormal levels (138°/0 and 1180/0 of intact,
respectively), an effect which was detected already at
a postoperative delay of one month. In experiments
using longer post-grafting survival periods, the grafts
were found to largely overcompensate the deficits
induced by 5,7-DHT lesions, whether the neurotoxin
was injected directly into the serotonergic nuclei or
into the cerebral ventricles. For instance, Daszuta
et al. (1988) reported that in rats given intraventricu-
lar injections of 5,7-DHT which resulted in a lasting
reduction – 9f)Yo) of hippocampal 5-HT and
5-HIAA concentrations, intrahippocampal rapt’tecell
suspension grafts had normalized both markers at
approximately five weeks after grafting surgery. At
longer delays, i.e. 7 weeks and 5 months post-graft-
ing, the 5-HT concentration had been overcompen-
sated to 146°/0 and 218°/0 of normal, respectively,
whilst the concentration of 5-HIAA had reached
levels of 136’Yoand 147~0. In addition to the
determination of the same markers, Van Luijtelaar
et al. (1991) assessed the accumulation of [3H]5-HT
by hippocampal slices and the KC1-evoked release of
tritiated serotonin in rats given bilateral injections of
5,7-DHT and intrahippocampal grafts of fetal raphe
tissue. In the hippocampal region closest to the graft
injection sites, they found that 11 months after
grafting, the accumulation of [3H]5-HT had reached
194°A of control, the release of [3H]5-HT about
]55Y0, the concentration of 5-HT and 5-HIAA 199~0
and 1500/., respectively. All these effects were less
pronounced when the distance from the graft
increased in the direction of the temporal region, an
observation confirming earlier findings by Steinbusch
et al. (1987). Effects even larger than the aforemen-
tioned ones have been described in experiments by
Zhou et al. (1987), as well as in our own experimental
contributions. Using the 5,7-DHT lesioned rats,
Zhou et al. (1987) found intrahippocampal grafts to
increase the 5-HT concentration to 445°/0 of control
and the synaptosomal uptake of [3H]5-HT to 3550/..
Our own studies on tissue content of 5-HT and
5-HIAA, as well as on synaptosomal [3H]5-HT
uptake in the hippocampus of rats which sustained
either aspiration or electrolytic lesions of the so-called
septohippocampal pathways and grafts rich in
serotonergic neurons are summarized in Fig. 6.
Even when injected into the intact hippocampus,
thus in a structure in which the graft survival and
development do not meet ideal conditions, grafts of
raphe cell suspensions are able to increase serotoner-
gic markers above normal levels (e.g. Zhou et al.,
1987). In some reports, such grafts placed into the
5-HT depleted hippocampus were also shown to
contribute to the normalization of the 5-HT turnover
or even to decrease the latter below normal levels (e.g.
Cassel et al., 1993b; Daszuta et al., 1988). In these
studies, the 5-HT turnover was measured by
computation of the ratio between the 5-HIAA and
5-HT tissue levels.
4.4.2. In Vivo Approaches (microdia[ysis)
Similar results have been reported with in viuo
approaches relying upon intrahippocampal micro-
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Fig. 6. Serotonin concentration (top) and synaptosomal
high affinity uptake of [3H]serotonin (bottom) determined
between 8 and 10 months after surgery in the dorsal (D),
median (M) and ventral (V) hippocampusof rats with only
aspiration (left panel) or electrolytic(right panel) lesions of
the fimbria-fornixpathways and of rats which, in addition
to the lesions,were subjectedto intrahippocampal grafting
of cell suspensionsprepared from the region including the
medial septum and the diagonal band of Broca (septum;
Section4.2)or the mesencephalicraphe (raphe; Section4.3)
of the fetal brain, or of a mixture of both suspensions
(co-grafts; Section 4.5). All values are expressed as a
percentageof the averageabsolute valuesfound in virtually
intact rats (l OOO/.;dotted lines). The hatched bars in each
panel delimit approximately the hippocampal region in
whichthe grafts had been implanted and where histological
verificationsgenerallyshowedthem to be located. Data are
from Cassel et al., 1993b(aspiration) and Jeltsch et al.,
1994b (electrolytic); for further details, see these two
references.
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dialysis techniques. For instance, Sharp and Foster
(1989) found that 6 months after grafting, raphe
grafts had increased the 5-HT baseline release to
171% of normal in the 5-HT depleted rat
hippocampus, and that this effect was partly
mimicked by grafts of medullary raphe tissue (880/0of
normal), a region containing serotonergic neurons
that normally innervate targets in the spinal cord.
Whereas the medullary raphe grafts contributed to
normalize the KC1-evoked 5-HT release, those of
mesencephalic raplre cells more than doubled this
release as compared to that found in intact rats. With
a similar technique, it was described that the release
of 5-HT in the hippocampus of the freely moving
intact rat was fluctuating according to both the
circadian period (extrinsic modulator) and the rat’s
behavioral activity state (intrinsic modulator):
During the night period, the intrahippocampal
release of 5-HT increase was about 40°/0 higher than
that found during the light period. Also, during states
of high behavioral activity, this release was
approximately 450/. higher than during states of
resting or sleep (Kalen et al., 1989). Gentle handling
of the rat or pinching its tail produced a 72°/0 and
48% increase of 5-HT release, respectively. 5,7-DHT
serotonin depletion decreased the 5-HT baseline
release underneath the detection limit, whilst in
response to KC1- or pCA-induced stimulations, this
release amounted only 5–100/0of that found in intact
rats (Daszuta et al., 1989). In the 5,7-DHT-lesioned
rat, grafts of raphe cells were found to increase the
5-HT tissue content to more than 300V0of normal,
while the baseline release was comparable to that of
intact rats (Daszuta et al., 1989). The addition of KC1
(60 mM) to the perfusion fluid or the i.p. injection of
pCA (2.5 mg/kg) raised the levels of 5-HT release to
177Y0 and 151V0, respectively, of those found in
intact control rats. Under the perfusion of indalpine
(1 KM), a 5-HT re-uptake blocker, the baseline
release was increased by approximately 380°/0 in the
hippocampus of intact rats, as well as in the grafted
hippocampus of the lesioned rats. Also, under
indalpine perfusion, the addition of KCI to the
medium further increased the release (45 fold) in the
intact and grafted hippocampus, but was ineffective
on the nongrafted denervated side. Conversely,
perfusion of TTX reduced the indalpine steady-state
release to a level close to that found in the nongrafted
denervated hippocampus. Similar results were re-
ported by Kalen et al. (1991a, 1991b). These results
did not only clearly show that the grafted
serotonergic neurons are spontaneously active (base-
line release levels restored) and release 5-HT at
near-normal levels, but they also strongly suggest that
these neurons are under control of host brain (effects
of either handling or tail-pinch) and possess
autoregulatory mechanisms (levels of 5-HT release
are normal despite a graft-derived hyperinnervation
of the hippocampus). Although the following
possibility has not been addressed so far, it could be
that some of these autoregulatory mechanisms
involve 5-HT, Bautoreceptors present at the terminals
of the grafted neurons as they are on the serotonergic
terminals in the hippocampus of intact rats (e.g.
Bolanos-Jimenez et al., 1993, 1994). Another
alternative has been demonstrated by Sharp and
Foster (1991): In rats previously subjected to 5-HT
denervation of the hippocampus, they found the
release of 5-HT from transplants of embryonic
medullary or raphe neurons to be under an inhibitory
tonic control involving 5-HT1~ receptors, as this
release was decreased by systemic administration of
8-OH-DPAT, a selective agonist of this receptor
subtype. With the exception that 5-HTIAreceptors are
the somatodendritic autoreceptors of the serotonergic
raphe neurons, in other brain regions such as the
cortex or the hippocampus, these receptors are
mainly, if not exclusively located postsynaptically
(e.g. Hoyer et al., 1994). Thus, in the study reported
by Sharp and Foster (1991), it can reasonably be
assumed that the reduced 5-HT release in response to
systemic 8-OH-DPAT treatment was mediated by
5-HT,. receptors located on the dendrites and the cell
body of the grafted serotonergic neurons.
4.4.3. Summary and Conclusions
Regarding the overall layout of the present
subsection, it was not possible to follow the same
progression as that followed for grafts of cholinergic
neurons. Some of the reasons to that are that: (i)
grafts of raphe cell preparations have not been carried
out as blocks implanted into a lesion cavity; (ii) the
intracavitary implantation of a substrate allowing
guidance and stimulation of host serotonergic
neurons regrowth has not been attempted so far in
the paradigm of fimbria-fornix/cingular bundle
lesions, probably because the source-to-target dis-
tance is much larger than that separating the septum
from the hippocampus, but also because the source
nucleus of the serotonergic hippocampal innervation
is not directly adjacent to any edge of the lesion
cavity; (iii) cells genetically modified to synthesize and
release neurotrophic substances acting on serotoner-
gic neurons (although such a factor is certainly
released after 5-HT depletion, its molecular charac-
teristics have not been identified so far) are not
available; (iv) the graft-induced effects on the
lesion-induced modifications of the properties of the
serotonergic receptors (e.g. upregulation) have not
been addressed, probably because the knowledge
about which serotonergic receptors are upregulated
and, if so, where in the hippocampus they are
upregulated is not as clear as that concerning the
functional changes of the muscarinic receptors after
cholinergic denervation.
One clear conclusion, however, is that grafts of
mesencephalic raphe tissue have an extremely high
reinnervation potential which certainly accounts for
the graft-induced hyperinnervation almost systemati-
cally found in the denervated hippocampus, whether
following an aspiration, knife cut or electrolytic
lesions of the fimbria-fornix pathways, or sub-
sequently to intracerebral injections of the neurotoxin
5,7-DHT. There are at least two, probably comp-
lementary mechanisms which may account for this
high reinnervation potential of serotonergic neurons
from the fetal mesencephalic raphe. First, it has been
described that, after hippocampal serotonergic
denervation, a soluble and very potent neurotrophic
factor is synthesized and released by hippocampal
cells. This factor rather specifically stimulates the
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growth of serotonergic neurons. Evidence for the fact
that the increased availability of this neurotrophic
factor is not the only mechanism involved in the
serotonergic hyperinnervation has been provided by
Zhou et al. (1987). These authors found that
serotonergic markers can reach above normal levels
when raphe tissue is grafted into the intact
hippocampus, and thus an hippocampus in which the
neurotrophic activity is probably not increase. The
second mechanism has been suggested by Daszuta
et al. (1991a, 1991b): These authors first emphasized
that serotonergic terminals originating in the raphe
nuclei are found in various brain regions other than
the hippocampus, a fact suggesting that during
embryogenesis, once differentiation, growth and
axonal arborization are ongoing processes, raphe
neurons must necessarily have a (“innately pro-
grammed”) high innervation potential to cover all
targets to be reached by their axonal terminals. In the
case of an intrahippocampal implantation of fetal
raphe cells, due to both the limited ability of
graft-derived fibres to grow over long distances
through the parenchyma of the recipient and an
increased neurotrophicfneurotropic influence in the
host target, it is conceivable that the expression of
this “innate” potential remains solely confined to the
host structure. The plausibility of such an expla-
nation is reinforced by studies in which the fetal
serotonergic neurons have been grafted in denervated
brain structures other than the hippocampus and in
which hyperinnervation patterns were also clearly
observed (e.g. Daszuta et al., 1991b; Wright et al.,
1991; but see Foster et al., 1990). This hyperinnerva-
tion potential, however, does not allow grafts
containing serotonergic neurons to provide the
denervated hippocampus with a homogeneous
density of serotonergic terminals. As for the grafts
rich in cholinergic neurons, there is a reinnervation
gradient which decreases proportionally to the
distance from the implantation site. Finally, the
remarks raised above (see 4.1.5.) on the nature and
the specificity of the basal forebrain graft-induced
mechanisms on cholinergic functions in the dener-
vated hippocampus may be integrally recalled as
concerns the nature and specificity of the neuro-
chemical effects produced by grafts of serotonergic
neurons.
4.5. Co-Grafting Approaches
Strictly speaking, each study using grafts of neural
tissue prepared from any given region of the fetal
brain basicaly uses co-grafts of different cell
categories including various glial cells (microglial
cells, olygodendrocytes, astrocytes) and neurons with
various neurotransmitter-specific identities. . .Except
when using genetically-modified cell populations, it is
actually not possible with the usual dissection and
preparation procedures to isolate or extract the
neurons expressing one given neurochemical pheno-
type in order to graft only these neurons at the
exclusion of all other ones. A cell suspension or a
tissue block to be implanted into a brain structure is
considered to be particularly rich in one category of
neurons because it is prepared from a brain region
clearly identified as including a nucleus containing,
for instance, cholinergic, noradrenergic or serotoner-
gic cell bodies, as compared to another region in
which such types of cell bodies are not present.
Another acceptation of the term “co-graft” refers to
a grafting procedure consisting in the implantation of
neuroanatomically- and/or neurochemically -defined
fetal neurons concomitantly with other cell prep-
arations (e.g. extracts of target tissue or other tissues
promoting neuronal survival and fibre extension)
supposed to provide the former with neurotrophic
andlor neurotropic support. This topic has been
reviewed in a recent article by Collier and Springer
(1994).
Herein, the term co-grafts is used in a third
acceptation referring to a grafting procedure of
preparations in which the cells from at least two
neurochemically -characterized nuclei (e.g. cholinergic
and serotonergic) have been co-implanted in order to
determine their functional effects as compared to
those found when separate preparations from each
region are implanted as “single grafts”. In the
denervated hippocampus, such a procedure has been
used to implant cells from the septal region together
with cells from the mesencephalic rap/ze after lesions
of at least the cholinergic and serotonergic hippocam-
pal afferents. In the first study published, Nilsson
et al. (1990a) have reported histological evidence
showing that such co-grafts were able to provide the
denervated hippocampus with both a cholinergic and
a serotonergic reinnervation pattern, as if they would
simply combine the reinnervation potential of each
single graft (septal cells alone or raphe cells alone). In
a series of experiments performed in rats given more
(Cassel et al., 1992, 1993) or less extensive lesions
(Jeltsch et al., 1994b) of the so-called septohippocam-
pal pathways, we have confirmed these data both
neurochemically and neuropharmacologically: Septal
grafts not only normalized or increased cholinergic
markers such as HACU and ChAT activity, but also
attenuated the increase of hippocampal NA concen-
tration due to sympathetic ingrowth, whereas raphe
grafts normalized or overcompensated serotonergic
markers such as HASU and tissue levels of both
5-HT and 5-HIAA. Interestingly, the co-grafts
increased, normalized or overcompensated all these
markers co-jointly (see Figs 4 – 6).
4.6. Other Neurochemical Effects of
IntrahippocampalGrafts
Briefly, there have been a few studies in the
literature suggesting that intrahippocampal grafts of
cells from various regions of the fetal brain might
exert neurochemical effects other than those expected
from the resources of each region in a given
neurochemical category of neurons. It must be
emphasized that: (i) the evidence for the plausibility
of such “side” effects is indirect as it is based
exclusively on morphological observations and (ii) so
far, most studies simply did not address whether
neurons other than cholinergic, noradrenergic or
serotonergic ones in basal forebrain, locus coeruleus
or raphe grafts, respectively, could be identified. The
best example known so far concerns the presence of
GABAergic neurons in basal forebrain transplants.
After Cassel et al. (1991b), Buzsaki et al. (1992) have
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found transplants of cell suspensions prepared from
the septal region of the fetal brain to contain
numerous neurons immunostained for parvalbumin,
a calcium binding protein which is present in the
membrane of a subpopulation of GABAergic
neurons. Such morphological observations suggest
that the grafts, in addition to the expression of some
cholinergic function, might also contribute to modify
the availability of GABA within the hippocampus, or
even to modulate, through a GABAergic mechanism,
some of the functional aspects of the neurons located
in the grafts themselves. In a study in which we
measured the hippocampal concentration of various
amino acids after electrolytic fimbria-fornix lesions
and intrahippocampal grafts of cell suspensions rich
in cholinergic and/or serotonergic neurons (Jeltsch
et al., 1994c), we did not find the concentration of
GABA (as well as that of many other amino acids)
to be significantly modified by either type of graft.
Another case concerns grafts of mesencephalic raphe
tissue. Such grafts show a dense AChE-positive
staining, although they do not provide the denervated
hippocampus with more than a very poor AChE-
positive fibre ingrowth (e.g. Cassel et al., 1992b,
1992c; Jeltsch et al., 1994a; Nilsson et al., 1990a). As
the dissection procedures of the fetal brain do not
allow to discriminate between various types of cells
within a given region, the type of neurons which
might be found in basal forebrain, locus coeruleus
and mesencephalic raphe grafts can be infered from
the populations of neurons found in each of these
regions in the adult rat brain. Beside cholinergic and
GABAergic neurons, the septal region also contains
neurons positively stained for galanin, while the
diagonal band of Broca contains neurons positively
stained for N-acetyl-aspartyl-glutamate. These popu-
lations of neurons give rise to approximately 20’Yoof
the septohippocampal projections. A smaller pro-
portion of septal neurons were also found to be
stained for other peptides such as substance P,
somatostatine enkephalins or vasoactive intestinal
polypeptide (e.g. see references in Dutar et al., 1995).
In the dorsal raphe, about 30Y0of the neurons do not
stain for 5-HT (Jacobs and Azmitia, 1992). Some of
these neurons are certainly GABAergic (e.g. Stamp
and Semba, 1995), others stain for enkephalin (e.g.
Jacobs and Azmitia, 1992). Finally, one also has to
consider the neurons present in regions immediately
adjacent to the one used for the preparation of the
grafts (e.g.GABAergic neurons close to the locus
coeruleus). Indeed, the risk that small parts of these
neighboring regions may be included during the
dissection procedure can never be reduced to zero
and this is an interpretation that we have proposed
to account for some small cholinergic effects of grafts
prepared from the mesencephalic raphe region in on
of our previous experiments (Cassel et a[., 1992b,
1992c).
4.7. General Conclusions
In this general conclusion, the term reinnervation
will be used indistinctly to designate histological as
well as neurochemical evidence showing or suggesting
that grafts are actually able to supply the denervated
hippocampus with new axonal processes, regardless
of whether these processes do establish functional
synaptic contacts with other neurons of the host
structure or fail to do so. As concerns the grafts of
fetal brain tissues rich in cholinergic, noradrenergic
or serotonergic neurons, a few common character-
isticslproperties may be recalled. First, cells or tissue
blocks show the best reinnervation potential and
induce the highest neurochemical recovery when they
are from the normal innervation source, as compared
to preparations from other sources, namely sources
rich in neurons having the same neurochemical
specificity as those from the normal innervation
source and which do not normally project to the
structure to be reinnervated. Second, whatever of
these various grafts is considered, the reinnervation is
always maximal in the vicinity of the grafted tissue
and clearly declines when the distance from the
implantation site increases. A major difference
between basal forebrain, locus coeruleus and
mesencephalic raphe preparations, is that the
serotonergic neurons in the latter preparations clearly
exhibit a much higher reinnervation potential than
the cholinergic or noradrenergic neurons in the two
former preparations. Third, in most if not all studies,
it has been emphasized that, in the denervated
hippocampus, the distribution pattern of the graft-de-
rived reinnervation closely resembles the pattern
found in intact control rats. Fourth, the activity of
the grafted neurons is controlled and this control may
involve autoregulatory and heteroregulatory mechan-
isms operating at the presynaptic level, as well as
mechanisms operating through afferents from the
host brain. However, one has to be aware that beside
the aforementioned direct effects or mechanisms,
grafts of tissue or cell suspensions from the fetal brain
may also exert effects mediated by more indirect
mechanisms, such as, for instance, the delivery of
neurotransmitters by the way of a diffuse, “minipump
like” or paracrine release phenomenon, or the release
of growth promoting and/or neurotrophic factors
that may act as agents stimulating both the
regeneration of severed axons and the sprouting of
undamaged fibres in the host structure. Interestingly,
there is also evidence from studies combining
cholinergic and serotonergic neurons within the same
suspension that the technique of co-grafting cell
preparations from different anatomically- or neuro-
chemically-defined sources may allow to combine the
individual neurochemical properties of each prep-
aration grafted separately from the other one. Thus,
it is quite easy to accept the idea that grafts rich in
cholinergic, noradrenergic or serotonergic neurons
are able to attenuate or even to normalize some of the
dramatic lesion-induced depletions of cholinergic,
noradrenergic and serotonergic hippocampal mark-
ers. Thus, it can be assumed that there exists a
theoretical possibility for cholinergic, noradrenergic
and serotonergic markers to be compensated for over
time in the extensively denervated hippocampus by
the implantation of a mixture of different kinds of
neurons. Indeed, the grafts rich in cholinergic
neurons may provide the hippocampus with a
cholinergic neurite ingrowth and inhibit the aberrant
reactional phenomenon of sympathetic sprouting,
whilst those rich in noradrenergic and serotonergic
neurons might supply the hippocampus with a new
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noradrenergic and serotonergic innervation.
Although empirically founded, this assumption
remains highly speculative, especially when consider-
ing its applicability to human beings. The major
problem in the experimenter’s practice is that of an
impossibility to get sufficient control over the
reinnervation processes such as to make sure that the
neurochemical markers are actually normalized, but
not more than normalized. Nevertheless, regarding
all these graft-induced neurochemical effects, the
most exciting question to be addressed is that of
whether neurochemical effects such as the aforemen-
tioned ones are sufficient to induce functional
recovery at the level of the organism or, in other
words, whether these effects allow rats with
hippocampal denervations to perform normally in
the behavioral tasks in which their non-grafted
counterparts are disabled? This will be our concern in
the next and last part of this review.
5. BEHAVIORAL EFFECTS OF
INTRAHIPPOCAMPAL GRAFTS
5.1. Grafts Rich in Cholinergic Neurons
One of the first studies to analyze the effects on
cognitive function of intrahippocampal transplants
containing fetal cholinergic neurons has been
conducted by Low et al. (1982) on rats with aspirative
lesions of the dorsal septohippocampal pathways and
intracavitary implantations of tissue blocks from the
septal region of the fetal brain. Using a standard
working memory testing procedure in the 8-arm
radial maze test (all arms accessible and baited), Low
et al. (1982) found that, seven months after grafting
surgery, the performance of their grafted rats was
improved as compared to lesion-only controls, but
only when these rats where pretreated systemically
with the acetylcholinesterase inhibitor, physostigmine
(0.05 mg/kg, i.p.). In lesion-only rats, this treatment
did not induce a significant improvement of
performance. Although this study appeared as
somewhat disappointing because the detection of the
graft-induced effects required additional treatment
with an anticholinesterase agent, it clearly demon-
strated the potential ability of grafted neurons
providing the hippocampus with a new cholinergic
innervation to foster recovery of cognitive function.
Later on, Segal ef al. (1989) reported similar results.
Using rats with electrolytic lesions of the MS or knife
cut lesions of the dorsal septohippocampal pathways,
they grafted minced septal tissue into the hippo-
campus and tested their rats in a Morris water maze
according to a procedure essentially sensitive to the
disruption of spatial reference memory. Whatever
lesion was considered, a beneficial effect of the grafts
on water maze performance was found only when the
grafted rats were tested under the influence of
physostigmine (0.05 mg/kg, i.p). In another study in
which we investigated the behavioral effects of fetal
septal cell suspension grafts after partial damage to
the medial part of fimbria or to the dorsal fornix, we
found that rats with damage to the medial fimbria
and intrahippocampal grafts showed improved radial
maze performance, but only when systemically
treated with a dose of 1.6 mg/kg d-amphetamine
(Cassel et al., 1988). Whereas the studies by Low
et al. (1982) and Segal et al. (1989) suggest that the
level of graft-induced cholinergic reinnervation of the
hippocampus may be insufficient to improve cogni-
tive function in rats with fimbria-fornix lesions, there
are numerous experiments demonstrating that a
sufficient reinnervation may actually contribute to
re-establish a level of cholinergic function allowing
beneficial behavioral effects to be observed in
absence of any additional drug treatment. For
instance, using rats with aspiration lesions of the
dorsal septohippocampal pathways and either iritra-
cavitary grafts of septal tissue blocks, intrahippocam-
pal cell suspension grafts or, as a control, grafts of
locus coeruleus cells, a nucleus virtually devoid of
cholinergic neurons, Dunnett et al: (1982) found that,
seven months after grafting surgery, rats with both
types of septal grafts recovered a close-to-normal
working memory performance in a rewarded T-maze
alternation task. Using the Morris water maze,
Nilsson et al. (1987) found that fimbria-fornix
lesioned rats with intrahippocampal cell suspension
grafts were able to learn the location of an escape
platform hidden in a quadrant of the water tank, a
spatial reference memory capacity that lesion-only
rats failed to exhibit. That grafts rich in cholinergic
neurons may induce recovery of cognitive function
after disruption of the dorsal septohippocampal
pathways, particularly of spatial working and
reference memory, has also been demonstrated in
several other experiments that will not be summar-
ized herein (e.g. Cassel et al., 1990, 1991; Daniloff
et al., 1985; Hodges et al., 1991a, 1991b, 1991c;
Richter-Levin and Segal, 1991;Tarricone et al., 1991,
1993). However, all these findings did not unques-
tionably demonstrate that the mechanism(s) under-
lying the graft-induced behavioral effects is (are)
cholinergic in nature.
The first indication that this mechanism probably
involves the graft-derived cholinergic reinnervation
of the hippocampus comes from studies in which the
degree of behavioral recovery was found to
positively correlate with the graft-induced recovery of
cholinergic markers (e.g. Daniloff et al., 1985;
Dunnett et al., 1982; Tarricone et al., 1991, 1993),
even when the observed recovery was fostered by
grafts including striatal (and thus non-septal)
cholinergic neurons (e.g. Li et al., 1992). A second
line of evidence comes from experiments which used
a lesion paradigm producing more specific damage to
the cholinergic neurons in order to assess the
behavioral effects of intrahippocampal grafts rich in
cholinergic neurons. For instance, in a study by
Emerich et al. (1992), cholinergic denervation of the
hippocampus was produced by i.c.v. injections of
AF64A and the lesion-induced spatial learning
deficits assessed in radial maze task could be
attenuated by intrahippocampal grafts of septal cell
suspensions. Similar findings were reported by
Ikegami et al. (1989a, 1989b); see also Ikegami et al.,
1991) who, in addition to a radial maze task, also
assessed their AF64A lesion- and graft-induced
effects in a rewarded T-maze alternation task. The
grafts also improved performance in this working
memory test having a lower spatial load than the
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radial maze test. In an experiment by Arendt et al.
(1989), the cholinergic lesions were produced by
repeated and long lasting exposure to high doses of
ethanol. These authors also found the cognitive
deficits associated with the cholinergic degeneration
to be attenuated by intrahippocampal (as well as
intracortical) grafts rich in cholinergic neurons. As to
the third series of arguments, there are a few studies
which, additionally to the group of rats with grafts
rich in cholinergic neurons, included a control group
of rats receiving grafts virtually devoid of cholinergic
neurons. In this control group, the non-cholinergic
grafts were placed in exactly the same region as the
grafts rich in cholinergic neurons. When observed,
beneficial graft-induced effects on cognitive function
always occurred in the rats bearing grafts rich in
cholinergic neurons (e.g. Arendt et al., 1989; Cassel
et al., 1991b; Dunnett et al., 1982; but see Cassel
et al., 1990b). Finally, some studies also demon-
strated that the graft-induced effects on cognitive
function did not resist a treatment with an
antimuscarinic agent such as atropine administered at
a dose that also impaired the sham-operated rats (e.g.
Hodges et al., 1990, 1991b; Li et al., 1992; Nilsson
et al., 1987; Segal et al., 1989). Altogether, these
observations point towards the cholinergic nature of
the graft-induced effects on cognitive function.
However, if the cholinergic reinnervation of the
denervated hippocampus is a sine qua none condition
for the grafts to exert beneficial effects on spatial
learning and memory, it can also be questionned
whether this condition is actually sufficient. In one of
our previous experiments (Cassel et al., 1991b), we
have compared the morphological and behavioral
effects of grafts rich in cholinergic neurons prepared
from the brain of fetuses aged of 16 or 14 embryonic
days (ED). It was found that both types of grafts
provided the hippocampus with a comparable
AChE-positive reinnervation pattern and contained
numerous ChAT-positive neurons, but only the grafts
from ED 14 fetuses resulted in a significant
attenuation of spatial memory deficits assessed in a
8-arm radial maze test (Cassel et ai., 1991b).
Interestingly, in the ED14 septal grafts, many
GABAergic neurons expressing the calcium-binding
protein parvalbumin could be immunolabelled (see
also Buzsaki et al., 1992), whereas, in the ED16
grafts, such cells were found only exceptionally. In
other experiments, we (e.g. Cassel et al., 1990a,
1992c; Jeltsch etal., 1994b) and other research groups
(e.g. Buzsaki et al., 1992; Dunnett et al., 1989)
observed that well surviving grafts failed to exert any
significant effect on the lesion-induced behavioral
deficits, in spite of the fact that the hippocampus
exhibited an acceptable organotypic AChE-positive
reinnervation pattern or that hippocampal cholin-
ergic markers were increased to near-normal levels. In
one of the last mentioned studies, Dunnett et al.
(1989) have used fimbria-fornix Iesioned rats given
various types of septal cell suspension grafts (differing
in particular by the lesion-to-grafting delays or the
ages of the donor) and evaluated cognitive perform-
ance in a paradigm of operant conditioning (DRL).
In their article, these authors emphasize that they
were unable to establish a clear relationship between
the level of behavioral recovery and the graft-de-
rived AChE-positive reinnervation pattern of the
hippocampus. Such a statement may also apply to the
data of an experiment by Kelche et al. (1988). These
authors have assessed the behavioral effects of
fimbria-fornix lesions combined to intracavitary
grafts of septal tissue blocks. Behavioral evaluations
used a Hebb and Williams maze. During the delay
from grafting to testing, approximately half their
sham-operated, lesion-only and grafted rats (intra-
cavitary implantation of septal tissue blocks) had
been reared under physically- and socially-enriched
housing conditions (twelve rats per large cage, many
objects in each cage with the objects changed daily;
for further detail, see Rosenzweig et al., 1972), the
other half being held according to standard
maintenance conditions of laboratory rats (3 rats per
cage, no objects). Kelche et al. (1988) reported that
the grafts were actually able to reduce the
lesion-induced deficits, but only when the rats had
been reared under enriched housing conditions. The
grafted rats reared under standard conditions
performed like lesion-only rats. Upon histological
verifications, it came out that despite this clear-cut
difference in the performance of both groups of
grafted rats, the graft-derived AChE-positive reinner-
vation pattern of the hippocampus did not differ
between the rats reared in the enriched and those
reared in the standard environments. Similar
conclusions were drawn more recently from an
experiment in which the behavioral effects of
postsurgical training combined to intrahippocampal
cell suspension grafts were assessed. Actually, Kelche
et al. (1995) found the post-surgical training to
interact positively with the grafts, but only at the level
of behavioral performance. Again, the graft-induced
AChE-positive reinnervation pattern did not differ
between the rats which had sustained training and
those which had not.
Although many of the aforementioned experiments
have been regarded as supporting the hypothesis that
the basal forebrain cholinergic systems critically
contribute to a variety of memory processes, it seems
reasonable to emphasize that the relationship
between the graft-induced recovery of cholinergic
markers and that of behavioral performance is
probably not as simple as correlation approaches
might suggest it. When septal grafts are found to
exert beneficial”effects on cognitive function, at least
a partial graft-induced recovery of cholinergic
markers in the hippocampus is verified systemati-
cally. However, as illustrated above, the recovery of
cholinergic markers in the hippocampus has no
predictive value as concerns the behavioral effects of
the grafts: Graft-derived cholinergic reinnervation of
the hippocampus is necessary but not sufficient for
beneficial effects to be observed at the level of
cognitive functions. In addition, in all studies
reported so far, the behavioral restoration induced
by the grafts was never found to be complete, even
when cholinergic markers had been restored to
near-normal levels in the denervated hippocampus.
Actually, whereas grafted rats are often found to
perform better than do the lesion-only ones, they
almost never reach the level of performance found in
their virtually intact counterparts. Some of the
reasons which might account for this discrepancy
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between the neurochemical or histological effects of
the grafts and their behavioral outcome have been
enumerated recently by Tarricone et al. (1996). To
give just a few examples, it seems that beyond the
normal graft-derived AChE-positive reinnervation
pattern: (i) ultrastructural characteristics of synaptic
graft-host connections may be abnormal (e.g.
Anderson et al., 1986; Clarke, 1985; Clarke et al.,
1986); (ii) electrophysiological characteristics typical
of hippocampal activity (i.e. theta rhythm or place
cells) are not (e.g. Segal, 1987) or are only partially
re-established and, in the latter case, they exhibit
obvious functional abnormalities (e.g. Segal, 1987;
Shapiro et al., 1989); (iii) grafts may produce
functional effects also by neurons other than the
cholinergic ones and both the identity and the
functional effects of these neurons would need
extensive investigations; (iv) when a cell suspension is
injected in the hippocampus, the grafting procedure
itself may result in a partial disorganization of the
hippocampal morphology near the injection sites, an
effect which is not necessarily harmless at the level of
behavioral function (e.g. Cassel et al., 1993a, 1993b
but see Hofferer et al., 1994, 1996); (v) although there
exists evidence that the grafts are under control of the
host brain, due to the ectopic placement of the
grafted neurons, the reconstruction of the severed
neuronal network is neither complete, nor does it
appear to be normal as compared to the structure of
the corresponding neuroanatomical network as it is
found in an intact brain (cholinergic neurons are in
the septum and the DBB in normal rats and in the
hippocampus in grafted rats).
In addition to the question of the completeness of
the graft-induced recovery, one may also raise the
question of whether the graft-induced recovery is
actually a genuine recovery, which means, according
to O’Keefe and Nadel’s theory (0’ Keefe and Nadel,
1978; see also O’Keefe et al., 1975) a recovery
consisting in the restoration of a normal capability to
built up and use a cognitive map. Such a question
appears to be particularly pertinent when the results
reported by Emerich et al. (1992) are examined
carefully. These authors have used a radial-arm maze
task to assess the effects of i.c.v. injections of AF64A
followed by an intrahippocampal injection of a fetal
cell suspension rich in cholinergic neurons. When
they tested their rats according to a standard spatial
working memory testing procedure with all arms
accessible and baited and no trial interruption, the
extent of the lesion-induced deficit was substantially
attenuated by the grafts. However, when the authors
switched to a testing procedure based on the
interruption of a trial, the difference between the
performance of lesion-only and grafted rats was no
longer observed. This observation suggests that the
grafts failed to reestablish a real capacity to deal with
and to memorize spatial information. To completely
measure the meaning of such a result, some
preliminary remarks might be helpful to the reader.
In order to perform the standard version of the radial
maze task, rats can use two equivalently efficient
“strategies”. One of these is basically egocentric and
consists of clockwise or counter-clockwise repetitions
of choice directions such as 45° (they enter the arm
right next to the just-visited arm) or 135° and does
not necessarily rely upon the use of extramaze cues.
Such egocentric choice patterns are observed in both
intact and fimbria-fornix-lesioned rats. Thus, when
rats perform that way, it can be assumed that the
spatial load” of the task is minimal and that a low
number of errors is not necessarily indicative for
normally operating spatial working memory pro-
cesses. The rats perform the task with what we term
a sequential routine. the rats which have developed
such a routine are able to keep it, even when access
to extramaze cues is experimentally compromised
(e.g. testing in red lights). The second strategy is
basically allocentric. It consists of using extramaze
cues in order to memorize the arms that have already
been visited within a given trial and, therefore, it
requires normally operating spatial working memory
processes. In intact rats, both types of choice patterns
can be observed (the egocentric strategy being
probably more economical in terms of cognitive
demand than the allocentric one), but when the
experimenter switches from an uninterrupted to an
interrupted testing procedure, intact rats usually
performing the task with an egocentric strategy are
able to switch to an allocentric one and to complete
the test with a very small number of errors. If intact
rats had persisted in using an egocentric strategy after
the trial interruption, this persistence would have led
to an increased number of errors, a theoretical issue
which we never observed in practice. Conversely,
fimbria-fornix lesioned rats which have developed the
routine of exploring the maze according to an
egocentric choice pattern are unable to operate a
switch such as the one described in intact rats. In
consequence, their number of errors increases
dramatically after the trial interruption. Although
Emerich et al. (1992) did not analyse the choice
patterns of their rats, it can be speculated that the
apparent recovery observed in their grafted rats with
the uninterrupted testing procedure might be relying
upon a higher frequency of egocentric choice
patterns, rather than on a graft-induced recovery of
a real ability to deal with spatial information. If so,
and to come back to the matter of this paragragh, one
must assume that the grafts have failed to foster a
true functional recovery. In a recent unpublished
study, we found that rats with fimbria-fornix lesions
and intrahippocampal grafts of mesencephalic raphe
cell suspensions performed an uninterrupted radial
maze task much better that did the lesion-only rats.
However, analysis of the rats’ strategies revealed that
this graft-induced effect did probably not rely on the
restoration of an ability to deal with spatial cues:
Grafted rats used egocentric choice strategies much
more often than did their lesion-only counterparts
(40% versus less than 10% of all trials, respectively).
5.2. Grafts Rich in Serotonergic Nenrons
The first studies using intrahippocampal grafts rich
in serotonergic neurons aimed essentially at identify-
ing the neurochemical and electrophysiological effects
as well as the morphological characteristics of such
grafts. With findings suggesting that dysfunctions of
serotonergic mechanisms might in one way or
another influence the functional outputs of other
neurotransmitter systems and also interfer with
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cognitive functions (for reviews, see Cassel and
Jeltsch, 1995; Sirvio et al., 1994; Steckler and Sahgal,
1995), experiments assessing the cognitive effects of
grafts rich in serotonergic neurons in rats subjected
to hippocampal denervation have gained interest.
Van Luijtelaar et al. (1991) have investigated some
behavioral effects of i.c.v. injections of the
serotonergic neurotoxin 5,7-DHT combined with
intrahippocampal grafts of a mesencephalic raphe cell
suspension. Although the lesions and the grafts
produced clear-cut neurochemical effects, both the
lesion-only and grafted rats failed to show any
~onsistent behavioral modification, whether in a
task assessing orientation in a social context or in a
Morris water maze test assessing working and
reference memory performance. These findings are in
line with the view that serotonergic lesions alone
produce only modest or no dysfunctions of spatial
working and reference memory (see Section 3.4.3). In
other studies, the effects of grafts rich in serotonergic
neurons were assessed in rats that underwent double
lesions (e.g. 5,7-DHT injections coupled to septal
lesions) or a chronic serotonergic depletion combined
to an acute muscarinic blockade. In one of their
experiments, Richter-Levin and Segal (1989) have
used i.c.v. injections of 5,7-DHT followed, one week
later, by intrahippocampal grafts of small fragments
of fetal mesencephalic raphe. Between 2 and 3
months after grafting, the rats were submitted to a
Morris water maze task. Whilst lesion-only and
grafted rats showed no impairment in this task,
additional pretreatment with a subamnestic dose of
the antimuscarinic agent atropine (20 mg/kg, i.p.)
resulted in impaired performance in the lesion-only
rats, but not in the grafted ones. These findings were
partly consolidated in a second experiment published
later on by the same authors (Richter-Levin and
Segal, 1991). In another study, Richter-Levin et al.
(1993) combined 5,7-DHT i.c.v. injections to
intraseptal injections of colchicine, a neurotoxin
which is able to produce partial damage to the septal
cholinergic neurons when used under such conditions
(e.g. Ginn and Peterson, 1991). Part of their
double-lesioned rats sustained intrahippocampal
grafts of fetal mesencephalic raphe cells. Again, it was
found that 5,7-DHT lesions alone did not impair
spatial working and reference memory performance
in a water maze task. Also single colchicine lesions
were unable to produce consistent impairments.
However, when these two lesions were combined,
both the working and the reference memory
capabilities were perturbated. Interestingly, in rats
given double lesions and grafts, performance was
comparable to that found in the sham-operated
controls. Similar results were obtained with 5,7-DHT
injections combined to electrolytic lesions of the
septal region (Richter-Levin and Segal, 1991). In a
study by Nilsson et al. (1990a), intrahippocampal
grafts of mesencephalic raplze cell suspensions had
no effect on the water-maze learning deficits that
resulted from combined 5,7-DHT i.c.v. injections
and radiofrequency lesions of the MS. In one
of our more recent experiments on rats with
electrolytic lesions of the dorsal fornix and
the fimbria (Jeltsch et al., 1994b), we also found
that intrahippocampal grafts rich in serotonergic
neurons had no effect on the deficits that rats given
electrolytic lesions of the fimbria and the dorsal
fornix exhibited in a radial maze and a Morris water
maze test. Identical conclusions could be drawn
form an earlier experiment in which the lesions were
made by an aspiration technique (Cassel et al.,
1992c).
5.3. Co-Grafts Rich in both Cholinergic and
Serotonergic Neurons
Although most experiments investigating the
behavioral effects of intrahippocampal grafts have
used an opproach based on the implantation of
neurons from only one neuroanatomically -defined
region of the fetal brain, there are some data in the
literature concerning the behavioral effects of
co-grafts of mixed septal and mesencephalic raphe
cells, the neurochemical effects of whose have been
reviewed in Section 4.5. For instance, in rats given
lesions of the MS and i.c.v. injections of 5,7-DHT,
Nilsson et al. (1990a) have studied the behavioral
effects of septal grafts alone (rich in cholinergic
neurons), raphe grafts alone (rich in serotonergic
neurons), and of a combination of both types of
grafts. All grafts were placed as a cell suspension into
the dorsal hippocampus and cognitive function was
assessed in a Morris water maze according to a
reference memory testing protocol. Whereas neither
type of single grafts produced beneficial effects on
water-maze performance, the combined grafts were
found to improve water-maze performance at 10
months after grafting surgery. Using a different lesion
paradigm (i.e. electrolytic lesions of the fimbria and
the dorsal fornix), we also found that combined
septal and raphe grafts placed into the denervated
hippocampus of rats were able to improve (even to
normalize) water-maze probe trial performance
(reference memory protocol), an effect that neither of
the single grafts was able to produce. Such co-grafts,
however, failed to improve spatial working memory
assessed in a radial maze task (Jeltsch et al., 1994b),
as we already found in an earlier experiment on rats
with aspiration lesions of the dorsal septohippocam-
pal pathways (Cassel et al., 1992c).
5.4. Grafts Rich in Noradrenergic Neurons
The functionality of grafts rich in noradrenergic
neurons at the level of the organism has been
essentially investigated in the frame of a seizure
model based on hippocampal kindling. Animals are
considered kindled when a series of electrical
stimulations through an electrode implanted in the
hippocampus induce a generalized convulsive seizure.
When compared to virtually intact rats, rats given
6-OHDA (e.g. Corcoran and Mason, 1980; McIntyre
and Edson, 1982) or DSP-4 (Bortolotto and
Cavalheiro, 1986; Carre and Harley, 1986) lesions of
the central noradrenergic fibres show their first
convulsive seizure after a number of electrical
stimulations lower than that necessary in their intact
counterparts. In rats with such lesions, kindling is
facilitated. Conversely, in intact rats, a stimulation of
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the locus coeruleus or an administration of
pharmacological agents enhancing the noradrenergic
transmission retards the development of convulsive
seizures (e.g. Jimenez-Rivera et al., 1987 and
McIntyre and Edson, 1982, respectively). Using rats
subjected to an i.c.v. injection of 6-OHDA, Barry
et al. (1987) found that intrahippocampal grafts rich
in noradrenergic neurons were able to attenuate the
development of seizures, the degree to which this
attenuation occurred being significantly correlated to
the graft-derived noradrenergic reinnervation of the
hippocampus. In another experiment (Bengzon et al.,
1990), i.c.v. injections of 6-OHDA were followed by
bilateral intrahippocampal implantations of a fetal
locus coeruleus cell suspension. Three months after
transplant surgery, the grafted rats were subjected to
hippocampal kindling, one half with prior idazoxan
treatment (an az-adrenoceptor antagonist), the other
half with vehicle injections. The kindling rate in both
groups was compared to that found in intact rats
treated with idazoxan. In previous experiments,
idazoxan treatment had been shown to facilitate the
development of seizures (e.g. Kokaia et al., 1989),
suggesting that the dampening effect of noradrenaline
is mediated by a mechanism involving cqreceptors. In
both groups of idazoxan-treated rats, the seizures
were found to develop faster than in the group of
untreated grafted rats. This finding demonstrates that
the graft-derived noradrenergic reinnervation of the
denervated hippocampus acts on u, receptors, as does
the noradrenergic hippocampal innervation in intact
rats. Furthermore, it seems that this antiepileptic
effect occurs at synapses established between the
grafted noradrenergic neurons and the host hippo-
campus, as the intrahippocampal implantation of
noradrenaline-releasing polymer matrices was not
able to counterbalance the 6-OHDA-induced in-
crease of the kindling rate (Kokaia et al., 1994a). This
interpretation is also in line with the results of
another experiment in which intracavitary (fimbria-
fornix) grafts of superior cervical ganglion were
found to be ineffective on the 6-OHDA lesion-in-
duced acceleration of kindling development (Kokaia
et al., 1994b). Although the grafts of superior cervical
ganglion were able to release noradrenaline in the
catecholamine depleted hippocampus, the authors
interpreted the lack of influence of such grafts on the
development of kindling as being possibly due to the
absence of conventional synapses between the grafted
neurons and the host hippocampal ones. In another
experiment, Bengzon et al. (1993) confirmed their
findings published in 1990, but also showed that
grafts of locus coeruleus tissue were ineffective on the
kindling rate when implanted into the hippocampus
of intact rats (although the grafts induced a clear-cut
hyperinnervation of the hippocampus) or into the
hippocampus of 6-OHDA lesioned rats that were
subjected to kindling before they received the grafts.
The influence of grafts rich in noradrenergic
neurons placed into the hippocampus was also
assessed using a model of epileptic seizures termed
pilocarpine status epileptics. After a systemic
injection of a high dose of pilocarpine, a muscarinic
agonist, sustained seizures are observed for approxi-
mately 1 day. Therefater, a “silent” period will last
for several days before a new spontaneous seizure
appears as the first of now a chronic state of recurrent
seizures. Using this model, Bortolotto et al. (1990)
have shown that intrahippocampal grafts of fetal
locus coeruleus cells reduced the number of
spontaneous seizures from approximately 11 per
week to less than 1 par week, with the effect starting
between 5 and 6 weeks after grafting surgery and
being maximal at about 9 weeks. In the nongrafted
rats, the average weekly number of seizures was
constant throughout the observation period.
The effects of noradrenergic grafts on memory
impairments have rarely been assessed in relation
with surgical paradigms of amnesia. That noradren-
ergic grafts might also exert cognitive effects has been
suggested in an experiment by Collier et al. (1988)
who have compared the passive avoidance perform-
ances of 5-month-old rats with those of 24-month-old
rats. Although this experiment was not based on an
experimental lesion paradigm such as the ones
considered in this article, it is interesting to note that
Collier et al. (1988) reported that whereas the old rats
were severely impaired in retention of a passive
avoidance response (24 h delay), those with intraven-
tricular (third ventricle) grafts of locus coeruleus-con-
taining tissue blocks showed retention performances
comparable to the performances found in the group
of younger rats. This graft-induced effect could be
blocked by administration of propranolol, a blocker
of adrenergic receptors. Also, the grafted old rats
showed reduced activity in an open field as compared
with both their age-matched nongrafted counterparts
and the 5-month-old rats. Furthermore, Collier and
Sladek (1989) have provided some preliminary
evidence that such grafts mi~ameliorate the spatial
memory deficit that aged rats exhibit in a Morris
water maze task. However, these graft-induced effects
are probably not mediated by an action on
hippocampal function, but rather, as stated by the
authors (Collier et al., 1988) by an action on
structures close to the third ventricle such as, for
instance, the hypothalamus. Close to the scope of this
review, effects of grafts rich in noradrenergic neurons
have also been assessed on some fimbria-fornix
lesion-induced memory impairments. In rats with
fimbria-fornix transections, Wang et al. (1994)
have found that intrahippocampal grafts of
superior cervical ganglion tissue which provided
the hippocampus with a substantial noradrenergic
fibre ingrowth were also able to induce improved
retention performance in a passive avoidance test
(24 h delay).
Altogether, it seems clear that intrahippocampal
grafts rich in noradrenergic cells may attenuate the
sensitivity to hippocampal kindling and, in some
respects, exert beneficial effects on the cognitive
disturbances induced by fimbria-fornix lesions.
Whether the beneficial effects on the lesion-induced
cognitive dysfunctions are direct or are rather due to
an indirect mechanism involving the antiepilepto-
genic effects of the noradrenergic neurons remains to
be addressed experimentally. Whatever may be, the
possibility that graft-derived noradrenaline actually
influences the behavioral outcome of fimbria-fornix
lesions by inhibiting some epileptogenic effects of
such lesions and thereby augment cognitive processes
related to hippocampal functions might be an
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alternative explanation to the findings reported by
Wang et al. (1994) and an interesting issue of future
research. It is also interesting to note that whereas
grafts rich in noradrenergic neurons may hamper the
susceptibility to epileptogenic manipulations in rats
subjected to central noradrenergic depletion, other
types of grafts may act as epileptic generators (e.g.
Buzsaki et al., 1988) or as factors that alter the
susceptibility to epileptogenic treatments such as
pentylenetetrazol injections or exposure to a sound
with characteristics appropriate to induce audiogenic
seizures in seizure-prone animals (e.g. Cassel et al.,
1987, 1991c).
5.5. Summary and Conclusions
As reviewed in this section, non-selective damage
to the rostrally coursing afferents of the hippocampus
induces pronounced depletions of markers of
cholinergic, noradrenergic and serotonergic hippo-
campal innervations. Unquestionably, such lesions
also produce dramatic impairments of cognitive
functions and modifications in the hippocampal
epileptic threshold. Using appropriate neurotoxins, it
is possible to induce each of these neurochemically-
characterized denervations separately, but only
damage to the cholinergic component of these
pathways seems able to mimick, in some respects even
closely, the cognitive characteristics of the be-
havioral deficits found after non-selective lesions.
With grafts containing the appropriate cell popu-
lations, each of these neurochemical deficits can be
attenuated, compensated for or, sometimes, even
overcompensated. Regarding the behavioral effects
of these grafts, there exists evidence demonstrating
that: (i) the cholinergic reinnervation of the
hippocampus may attenuate some aspects of the
lesion-induced cognitive “syndrome”, particularly as
concerns the spatial working and reference memory
dysfunctions; (ii) the serotonergic reinnervation of
the hippocampus does not induce or induces only
modest or subtle effects on the deficits induced by
non-specific denervation of the hippocampus; (iii) in
case of lesions producing multitransmitter denerva-
tions of the hippocampus, co-grafts of cholinergic
and serotonergic neurons are more efficient in
fostering cognitive recovery than cholinergic grafts
alone, at least as regards spatial reference memory
performance; (iv) noradrenergic grafts may act by
raising the epileptic threshold towards near-normal
values after it had been decreased by hippocampal
denervation. All these findings suggest that the
morphological, electrophysiological, pharmacologi-
cal and neurochemical effects that grafted neurons
exert locally (i.e. within or in the vicinity of the
denervated host structure) may be sufficient for
lesion-induced dysfunctions to be attenuated also at
the level of the whole organism. As such, intracere-
bral transplantation techniques are and should stay a
tool of potential interest not only for neurobiologists
who try to understand how the brain is working to
produce function, but also for clinicians who are
confronted to the tragic, and for most incurable,
symptoms associated with neurodegenerative disease
or brain injury in humans.
6. GENERAL DISCUSSION AND
CONCLUSIONS
In this review, we focused on the neurochemical
and behavioral effects associated with various lesion
paradigms used to more or less extensively damage
the dorsal components of the rostrally-coursing
hippocampal afferents. Originating from the septal
region, the locus coeruleus and the mesencephalic
raphe, the majority of these afferents regroup in two
dorsal pathways (cingular bundle and fimbria-fornix)
which provide the hippocampus with a substantial
part of its cholinergic, extrinsic GABAergic, nor-
adrenergic and serotonergic inputs. Of course, these
two pathways, often termed the dorsal septo-
hippocampal pathways, also contain many hippo-
campal efferents as well as other types of afferents,
but relative to the grafting experiments that were
taken into account, the consideration of these other
components was obviously beyond the scope of this
article.
Non-selective damage to the fimbria-fornix and the
cingular bundle results in dramatic cholinergic,
noradrenergic and serotonergic denervations of the
hippocampus, each of which can be quantitatively
mimicked with appropriate use of neurotoxins such
as AF64A or 192 IgG-saporin for cholinergic
neurons, 6-OHDA or DSP-4 for noradrenergic
neurons and 5,7-DHT for serotonergic neurons.
From a behavioral point of view, one extremely
consistent finding after such non-selective lesions is a
dramatic impairment of working and reference
memory capabilities, a deficit which is particularly
prominent in all tasks requiring to deal with spatial
information. While there is evidence that the
disruption of the cholinergic innervation of the
hippocampus plays a crucial role in the majority of
these cognitive dysfunctions, there is some evidence
suggesting that also the disruption of the serotonergic
hippocampal afferents may be involved, in a way or
another, in these cognitive perturbations. However,
the sole serotonergic denervation of the hippocampus
does not seem able to mimick the aforementioned
deficits, whether qualitatively, or quantitatively, an
observation suggesting that serotonergic neurons
innervating the hippocampus might contribute to
cognitive function by an interaction with other
neurotransmitter systems (e.g. Cassel and Jeksch,
1995; Steckler and Sahgal, 1995). As to the
noradrenergic hippocampal afferents, it seems that
these fibres exert some inhibitory modulation of
hippocampal activity as their destruction results in a
decreased threshold towards experimental manipula-
tions known to induce convulsive seizures (e.g.
kindling).
Morphological, neurochemical and pharmacologi-
cal studies have shown that subsequently to
denervation, various types of reactive reorganizations
may occur in the hippocampus, all of which appear
to push the residual parts of the hippocampal
formation to compensate for the missing inputs or the
denervation-induced dysfunctions. These reactional
phenomena include homotypic and heterotypic
sprouting, up- or downregulations of various
receptor types as well as increased neurotransmitter
turnover in the fibres spared by the lesions. Although
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the magnitude of these modifications depends on the
extent of the lesions and may become tremendous
when the lesions are very large, in case of extensive
denervation they seem unable to foster recovery of
the disrupted behavioral functions: After aspiration
or knifecut transection of the septohippocampal
pathways, lesions restricted to only the fimbria and
the dorsal fornix and even after more specific
cholinergic denervation, whether the latter is
combined or not to other experimentally-induce
neurotransmitter dysfunctions, the cognitive deficits
are lasting. Whereas such observations might be
regarded as extremely disappointing, at least from a
clinical point of view, they make all lesion paradigms
in which recovery is weak or non-existent very helpful
models to study the structural and functional effects
of intrahippocampal grafts.
In that concern, evidence reviewed in the second
part of the present article clearly shows that, under
appropriate technical conditions, grafts defined
according to their anatomical origin (and thus, with
some neurochemical specificity) survive and can be
integrated in the circuitry of the host hippocampus.
These grafted neurons are also able to reinnervate the
host hippocampus according to the neurochemical
identity of the nuclei from wich the fetal neurons
had been dissected out. Such grafts do not only
provide the hippocampus with a locally functional
reinnervation, they also produce effects at the level
of behaviour: Grafts rich in cholinergic neurons
may attenuate the cognitive deficits due to the
lesions, perhaps even much better when they
are co-grafted with serotonergic neurons, while
grafts rich in noradrenergic neurons may compensate
for the increased susceptibility to epileptogenic
experimental manipulations such as hippocampal
kindling. Furthermore, there is now sufficient
evidence showing that grafts rich in cholinergic,
noradrenergic or serotonergic neurons are function-
ing in the host hippocampus: These grafts are clearly
able to release the neurotransmitter corresponding
to the afferences which they were supposed to
replace. In some respects, this release can even
be considered as regulated by the means of
autoregulatory mechanisms, as well as by neurons
originating in either the host brain or in the grafts
themselves.
However, when the denervated hippocampus is
regarded an element of a larger system (the limbic
system) in which the integration of a graft is analyzed
from both a structural and functional point of view,
it appears that there exists a major feature that does
not show normal characteristics as compared with the
organization of the corresponding system in the
intact rat. In the intact brain, the cell bodies of the
neurons projecting to the hippocampus are located
outside the hippocampus, within nuclei (the MS and
the DBB, the locus coeruleus and the mesencephalic
raphe) where their activity is controlled or modulated
by afferences arising from various other brain
structures. In a grafted rat with partial, specific or
extensive disruption of the fimbria-fornix/cingular
bundle pathways, the graft is placed into or close to
the hippocampus, thus in a location distant from that
where the activity of the grafted cells is ,normally
controlled in an intact brain. In other words, the graft
is integrated into an unusual connectivity network as
the entire cells (axons, cell body and dendrites) are
inserted directly into the intrinsic circuitry of the
hippocampus which normally receives only the
axonal terminals of these cells. Thus, the denervated
hippocampus bearing a graft appears as a new
experimental construction with truncated neu-
roanatomical (and probably functional) character-
istics in the brain of the recipient. This has a major
consequence from a theoretical point of view.
Actually, the question of whether such a new
organization is functional can be addressed in two
ways that are not necessarily related one another.
One way concerns the local mechanisms or
operations which the grafted neurons can reestablish
(e.g. neurochemical effects, auto- or hetero-regulat-
ory processes) and will provide the scientist with
information about whether the grafted neurons are
working. The second way concerns the effects which
such grafts may exert at the level of the organism (e.g.
effects on learning and memory deficits or other
behavioral alterations) and will provide the scientist
with information about whether the locally identified
operations have behavioral relevance. Whereas the
causal relationship between the locally-operating
effects of the grafts and their behavioral outcome is
not always easy to demonstrate unquestionably (e.g.
Cassel and Will, 1995), there are now converging and
complementary arguments suggesting that this
relationship may actually be causal. It is not our
intention to affirm here that the graft-derived
reinnervation of the hippocampus and the various
associated functional effects are the only way by
which grafts can contribute to compensate for the
lesion-induced behavioral and other deficits. Other
possible mechanisms may be effective as well (for
reviews, see Cassel et al., 1992a; Dunnett, 1994;
Dunnett and Bjorklund, 1987; Sinden et al., 1995)
and some of these might even account for some
unexpected graft-induced behavioral deficits (e.g.
Dalrymple-Alford, 1994; Dalrymple-Alford et al.,
1988; Will et al., 1989). However, if it is sometimes
sufficient to reestablish a certain level of neurotrans-
mitter release in the denervated hippocampus for
observing grafts to become behaviorally active, this
observation suggests that the hippocampal cholin-
ergic, noradrenergic and serotonergic afferents do
work, at least partly, as level-setting systems that
contribute to hippocampal function by secreting a
given amount of neurotransmitters. As such, the
grafted neurons work as an elaborate inexhaustible
drug delivery system with at least three major
advantages as compared to other drug delivery
systems available so far (e.g. subcutaneously im-
planted minipumps): Grafting requires only one
surgical operation, grafts may work over the entire
life span of the experimental subject and, finally, this
drug delivery system can be regulated. One obvious
drawback, however, is that grafted neurons require a
given postsurgical delay before they can be con-
sidered operational. Regarding cognitive functions in
general and spatial memory in particular, the
aforementioned observations might also have some
theoretical fallouts in the field of hippocampal
function. Actually, as the restoration of some
behavioral function after hippocampal denervation
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may be achieved by a local delivery of neurotransmit-
ters such as acetylcholine and, perhaps, noradrena-
line or serotonin, one may wonder whether one
should not pay attention to a theoretical view that
would, on the one hand, consider the hippocampus
as the central station in which operations involved in
various types of memory are processed and, on the
other hand, that would regard the role of some of the
rostrally-coursing dorsal afferents as being to provide
some of the basic neurotransmitter-specific con-
ditions for the processes going on in the hippocampus
to operate adequately.
As pointed out by Ridley (1995) in a recent
comment to a target article by Sinden et al. (1995),
“It is clearly easier to show that grafts can work than
it is to explain how they work. ” If none of us would
contest this statement, it is our belief that in this
article we have reviewed some evidence suggesting
that one of the possible ways by which neuronal
grafts rich in cholinergic, noradrenergic or serotoner-
gic neurons do work is the local release of
neurotransmitters that are missing or severely
depleted after lesions in the fimbria-fornix pathways.
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